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General introduction
Hypodontia is a condition whereby one or more permanent teeth are congenitally missing. When this 
concerns six or more teeth (third molars excluded), the term ‘oligodontia’ is used.1 The most severe 
form of hypodontia is anodontia, a rare phenomenon that is characterized by the absence of all 
permanent teeth. In Europe, the prevalence of tooth agenesis is 5.5%.2 The prevalence of oligodontia 
in Caucasian populations in North America, Australia, and Europe is estimated at 0.14%.2 Hypodontia is 
usually noticeable between 6-12 years of age when the deciduous teeth fail to shed or permanent teeth 
do not emerge. In this thesis, all research is about patients with several agenetic teeth (≥4, excluding 
third molars; also named severe hypodontia for the purpose of the PhD research): a condition which is 
usually challenging to treat.
  Tooth agenesis can be the result of environmental (e.g., systemic diseases or malnutrition) and/or 
genetic factors. Its aetiology is complex as >200 genes are responsible for tooth development.3 Tooth 
agenesis can occur as an isolated anomaly or as a feature of a large variety of syndromes.4 Hypodontia 
is common in ectodermal dysplasia patients.5 
  Common clinical characteristics of patients with several agenetic teeth include dysgnathia, 
underdevelopment of the jaw bone in the area with the agenetic teeth and local resorption of the 
alveolar bone after loss of a deciduous tooth without a successor (Fig. 1). Other common phenomena 
due to the absence of successors are: compromised interdental spacing, titling of the teeth and a class 
II relationship with a deep bite (Fig. 2). As a result, the facial aesthetics of patients with several agenetic 
teeth are often unfavourable. Moreover, dental appearance and compromised oral functioning have 
been shown to negatively affect oral health-related quality of life (OHrQoL) as well as the fact that the 
patients usually need rather complex oral rehabilitation.6
  As the presentation of the dentition in patients with several agenetic teeth is very heterogeneous, 
every patient requires an individual treatment plan.7 According to the literature, there are several 
treatment options for patients with several agenetic teeth.8 The least invasive treatment approaches 
are preservation of deciduous teeth, auto-transplantation and orthodontic space closure, possibly in 
combination with composite veneers on small teeth. Retaining several deciduous teeth is, besides the 
aesthetic restrictions, accompanied by a non-predictable long-term treatment outcome because, with 
time, root resorption, ankylosis and consecutive infraocclusion, and/or tooth decay can occur (Figs. 3 
and 4).8,9 Orthodontic closure of the diastema or autotransplantation is only feasible when a limited 
number of teeth are missing which is, per definition, usually not the case in patients with several 
agenetic teeth. Moreover, experience has taught that orthodontic treatment of patients with several 
agenetic teeth is time consuming and complex.10 Thus, in most patients with several agenetic teeth, the 
missing teeth have to be complemented by prosthetic means. 
  Tooth supported fixed prosthetics (conventional crowns, bridges) are often hard to design due to the 
unfavourable distribution and titling of the available teeth. Their often unfavourable shape (microdontia 
or taurodontia) may also preclude conventional restorative means.11 Removable prostheses (with or 
without implant-retention) are generally only indicated when fixed prosthodontics are not an option 
e.g., in young patients with anodontia. Although this treatment is quite exceptional, there is a need for 
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the evaluation of the satisfaction, surgical and prosthetic care and aftercare of such treatments. 
  Bone volume, interdental spaces and/or titling of the neighbouring teeth are often limited for 
implant placement. Thus, in most cases, there is a need for orthodontic treatment and/or bone 
augmentation prior to implant placement. Implant treatment will be more predictable with the use of 
three-dimensional computer-guided workflows for planning implant placement, especially in regions 
where bone quantity is scarce and interdental spaces are limited.
  While implant survival in patients with several agenetic teeth is presumed to be acceptable,12 
only short-term implant survival rates have been reported while long-term survival of implant-retained 
prosthodontics has not been suitably assessed. Long-term survival results are needed, both for implants 
and prosthodontics. Even more strikingly, the effect of implant treatment on the oral health-related 
quality of life has only been assessed generally in hypodontia patients (≥1 agenetic teeth) and not 
specifically in patients with several agenetic teeth (≥4).13-16 
Aim of the thesis
The overall aim of the PhD research presented in this thesis was to assess the long-term treatment 
outcome (implant survival, peri-implant health, prosthodontics, quality of life) of dental implant 
treatment in patients with severe hypodontia. 
The specific aims were:
- To systematically review the literature and assess which prosthetic treatments are applied to   
 patients with several agenetic teeth (chapter 2).
- To assess satisfaction, and surgical and prosthetic aftercare of implant-retained mandibular   
 overdentures in young oligodontia children without erupted mandibular teeth (chapter 3).
- To assess the oral health-related quality of life in children with non-syndromic oligodontia prior  
 to the commencement of their orthodontic treatment (chapter 4).
- To assess the oral health-related quality of life, general health status and satisfaction 1-year after  
 implant therapy in patients with several agenetic teeth (chapter 5). 
- To assess the long-term survival and performance of dental implants provided with fixed   
 prosthodontics in oligodontia as well as the accompanying patient satisfaction and oral   
 health-related quality of life (chapters 6 and 7).
- To show the benefit of a full three-dimensional workflow to guide implant placement in   
 oligodontia (chapter 8).
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Figure 1. Panoramic radiograph of a 12-year old girl with oligodontia. Ten out of 28 permanent teeth are missing. In the third 
quadrant, the jawbone is underdeveloped as a result of the congenitally absent teeth in this area. The vertical bone height above 
the alveolar nerve is limited.
Figure 2. Intraoral view of a 11-year old girl with oligodontia and a deep bite. The permanent teeth are small (microdontia) and the 
interdental spaces are large.
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Figure 3. Panoramic radiograph of a 13-year old girl with retained deciduous teeth due to oligodontia. Multiple deciduous teeth are 
retained as a result of the agenesis of multiple permanent teeth. Note the root resorption of tooth numbers 55, 54, 53, 52, 62, 63, 
64, 65, 71 and 81. 
Figure 4. Intraoral view of a 14-year old girl with oligodontia and retained deciduous teeth. Secondary retention of tooth numbers 
64, 65 and 75 is evident. 
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Abstract
Severe hypodontia is associated with aesthetic and functional problems. Its presentation is heterogenic, 
and a variety of treatment modalities are used resulting in different treatment outcomes. As there 
is currently no standard treatment approach for patients with severe hypodontia, the literature was 
systematically reviewed with the focus on treatment outcomes. Medline, Embase and The Cochrane 
Central Register of Controlled Trials were searched (last search 24 August 2015). This was completed 
with a manual search of the reference lists of the selected studies. To be included, studies had to 
describe dental treatment outcome measure(s) in patients with severe hypodontia; there were no 
language restrictions. The methodological quality was assessed using MINORS criteria. Twenty-one 
studies were eligible, but the diversity in type and quality did not allow for a meta-analysis; seventeen 
studies had a retrospective design; sixteen studies described the results of implant treatment. 
Treatment with (partial) dentures, orthodontics, fixed crowns or bridges was sparsely presented in the 
eligible studies. Implant survival, the most frequently reported treatment outcome, ranging from 35.7% 
to 98.7%, was influenced by ‘location’ and ‘bone volume’. The results of implant treatment in severe 
hypodontia patients are promising, but due to its heterogenic presentation, its low prevalence and the 
poor quality of the studies, evidence based decision-making in the treatment of severe hypodontia is 
not yet feasible, thus prompting further research.
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Background
Tooth agenesis or hypodontia refers to situations where one or more teeth fail to develop. In its most 
severe presentation, no teeth are present at all (anodontia). The term ‘oligodontia’ is the condition 
whereby ≥6 permanent teeth are agenetic, third molars excluded.1,2 The reported prevalence of 
oligodontia is 0.14%.3 Severe hypodontia can negatively affect skeletal growth and local alveolar bone 
quantity. Teeth that are present, especially in patients with ectodermal dysplasia, can be tapered, 
malformed, or widely spaced.4 Consequently, this influences a person’s appearance, oral function 
(chewing, speech) and oral health-related quality of life.5-7
  In severe hypodontia, the functional and psychosocial impact of missing teeth is more profound 
and its restorative management is more complex than in non-hypodontia patients.8 Counselling requires 
input from several dental and other professional fields such as orthodontics, restorative dentistry, oral 
and maxillofacial surgery and implantology, speech pathology and psychology.
  As there is currently no standard approach or favourable dental treatment option to treat patients 
with severe hypodontia, we systematically reviewed the literature, focusing on different treatment 




Medline (via PubMed), Embase and The Cochrane Central Register of Controlled Trials were searched 
according to the strategy shown in Table 1 (last search August 24, 2015). The references of the selected, 
suitable publications were searched manually, which enhanced the search.
Eligibility
Clinical studies reporting on the achieved treatment in patients with severe hypodontia were eligible for 
inclusion in this study. The inclusion criteria are listed below: 
• Reported results had to be specifically for patients with severe hypodontia and the mean number  
 of teeth which had failed to develop was ≥6 (third molars excluded) per study;
• Dental treatment outcome measure(s) were described (e.g., quality of life, patients’ satisfaction,  
 implant survival, treatment complication);
• ≥5 cases were reported;
• When different research groups were compared in a study, at least one group met the inclusion  
 criteria. 
No language restrictions were applied. Both retrospective and prospective study designs were eligible.
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Validity and data extraction
The initial screening (title, abstract) was performed by one reviewer (M.A.F.), after which the remaining 
full-texts were screened by two reviewers (M.A.F., A.V.). The methodological index for non-randomized 
studies (MINORS),9 assessed independently by the two reviewers, was used to estimate the 
methodological quality and risk of bias. Intra-class correlation coefficient (one way) was used to test 
the inter-rater reliability. Agreement was reached by a consensus discussion. When necessary, a third 
reviewer (M.S.C.) was consulted.
  The included literature was categorized as follows: orthodontics, removable (partial) dentures, 
conventional crowns and bridges and dental implant treatment. Regarding the latter search phrase, 
the following implant-related subheadings were assessed: survival, surgery/bone augmentation prior 
to implant therapy, clinical parameters, radiographic findings and peri-implant health, complications, 
patient satisfaction and quality of life after implant therapy and facial growth. 
Results
Study selection
The search resulted in 2044 hits of which 840 were doubles. After the initial screening of the remaining 
1204 studies, 1164 were excluded (Fig. 1). In cases where the title and abstract did not justify exclusion 
or inclusion, the full-texts were screened and analysed. Additional information was needed for seven 
studies. The corresponding author of those studies was contacted by email for the missing information; 
if authors did not respond (after several emails), their studies were excluded (n=1). Another 21 studies 
were excluded after the full-text screening but two studies were added after the manual search. The 
selection procedure resulted in 21 eligible studies (Fig. 1). The methodological quality of the eligible 
studies was low and the risk of bias was high due to the retrospective design of most studies. The level 
of inter-rater reliability, as assessed with the MINORS score, was high (0.92; 0.803-0.967, 95% CI), but 
the overall MINORS score was low relative to the achievable maximum score (Table 2). 
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Table 1. Medline search strategy (via PubMed). The search strategy was revised appropriately for Embase, the Cochrane Register of 
Controlled Trials.
Topic Medline Embase Cochrane Register
Prosthetic 
treatment
Fixed or Removable 
Prostheses
#1 “Prosthodontics”[Mesh] 
OR “Tooth Preparation, 
Prosthodontic”[Mesh] 
#1 ‘dental prosthesis 
and implant’/exp OR 
‘dental surgery’/exp 
OR prosth*:de,ab,ti OR 
proth*:de,ab,ti
#1 [Prosthodontics] explode all trees 
#2 [Tooth Preparation, 
Prosthodontic] explode all trees 
#3 [Dental Implants] explode all 
trees 
#4 [Dental Prosthesis] explode all 
trees 











‘Other’ 4# “Prostheses and 
Implants”[Mesh:noexp] OR 
prosth*[tw] OR proth*[tw])
Teeth failed to 
develop
5# “Anodontia”[Mesh] 
OR anodontia[tw] OR 
hypodontia[tw] OR 
oligodontia[tw] OR “tooth 
agenesis”[tw]




‘tooth agenesis’:de,ab,ti OR 
‘dental agenesis’:de,ab,ti OR 
‘tooth agenesia’:de,ab,ti)





Search strategy (#1 OR #2 OR #3 OR #4) 
AND #5
#1 AND #2 (#1 or #2 or #3 or #4 or #5 or #6 
or #7) and (#8 or #9 or #10 or #11 
or #12)
Last data search 24th of August 2015 24th of August 2015 24th of August 2015
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Figure 1. Flowchart.
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Table 2. Estimation of the methodological quality and risk of bias (MINORS, Slim et al. (2003)9). The inter-rater reliability (intra-class 
coefficient) of the MINOR score was 0.92 (0.803-0.967, 95% CI).
Author Year Reviewer 1 (M.A.F.) Reviewer 2 (A.V.) Maximal score *
Implantology
Becelli et al.40 2007 11 10 16
Bergendal et al.16 2008 9 11 16
Créton et al.19 2010 19 21 24
Dustberger et al.41 1999 7 14 16
Finnema et al.20 2005 11 11 16
Garagiola et al.22 2007 16 20 24
Grecchi et al.4 2010 9 10 16
Guckes et al.21 2002 11 9 16
Heuberer et al.26 2011 9 10 16
Johnson et al.28 2002 17 16 24
Kearns et al.23 1999 11 13 16
Standford et al.25 2008 8 12 16
Sweeney et al.17 2005 12 10 16
Worsaae et al.35 2007 10 10 16
Zou et al.24 2014 12 10 16
Implant-supported and tooth-supported fixed dental prostheses 
Dueled et al.27 2008 18 18 24
Orthodontics
Levander et al.11 1998 19 16 24
Orthodontics and fixed dental prostheses/bridges
Anweigi et al.10 2013 20 20 24
Removable (partial) dentures
Lexner et al.13 2009 9 7 16
Montanari et al.12 2012 6 5 16
Hobkirk et al.14 1989 7 4 16
Total score 251 257 384
* Maximum score: 16 for non-comparative studies, 24 for comparative studies.
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Literature evaluation
The design of 17 of the 21 studies was retrospective. Sixteen studies described the results of implant 
treatment of which 13 studies described implant survival. The reported follow-up period ranged from 
0.1 to 18.3 years. A summary of the treatment outcome per study is given in Table 3. 
Orthodontic treatment prior to prosthetic treatment
Orthodontic treatment and its outcome in patients with severe hypodontia is rarely described (Table 3). 
Orthodontic treatment prior to restorative dental care was shown to have a temporary negative impact 
on oral health-related quality of life in children.10 The latter may be due to the change in patients’ 
appearance (e.g., on creating diastema for implant and/or prosthetic treatment) during orthodontic 
treatment, before restoring the tooth spaces. Levander et al. (1998) stated that the degree of apical 
root resorption is significantly larger after orthodontic treatment in the case of multiple absent teeth 
(≥4).11 The number of missing teeth, root form, and treatment time seem to be conditions with a high 
hazard of root resorption.11 
Treatment with removable (partial) dentures
Partial dentures are commonly applied to treat severe hypodontia, as an ‘interim phase’ before implant 
therapy or as a definitive treatment. Oral rehabilitation with removable (partial) dentures in young 
patients was shown to be successful as it can improve oral function, phonetics and aesthetics, and 
reduce social impairment.12 Lexner et al. (2009) described the successful use of removable prostheses 
in children, from the perspective of the patient, parents and dentist.13 The young patients often adapted 
well to their prostheses; the prostheses were retained well and were stable. In 30% of the cases, 
however, the dentist was not satisfied with the treatment outcome due to external factors, such as lack 
of cooperation or motivation for treatment by the patient and/or family.13 Furthermore, Hobkirk et al. 
(1989) showed that removable definitive partial dentures (cobalt-chromium bases, acrylic resin onlays, 
anterior bases, Co-Cr-Mo crib clasps) had a relatively short lifespan.14 Particularly the partial dentures 
in the maxilla needed to be replaced within 3.5-4 years on average. Reasons for replacement were as 
follows: dissatisfaction of the patients with the appearance of the prosthesis, fracture, wear or oral 
changes.14 
 
Conventional prostheses: crowns and bridges
The prospective study by Anweigi et al. (2013) is the only study that described treatment outcomes 
of conventional fixed bridges (resin bonded bridges) after orthodontic pre-treatment.10 Bridges 
were cantilevered or fixed-fixed in design, spanning approximately one tooth unit in terms of size. A 
significant difference was seen in pre- and post-treatment oral health-related quality of life (Oral Health 
Impact Profile, OHIP-49); the median OHIP-49 summary scores point towards improvement in the oral 
health-related quality of life.10,15 None of the included studies mentioned the treatment outcome of 
conventional crowns. 
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Dental implants to retain fixed prostheses: survival 
The literature on the treatment outcome for patients with severe hypodontia focused mostly on 
dental implant treatment (Table 4). Thirteen studies described implant survival, ranging from 35.7% 
to 98.7% (mean 93.7%). The implant location seems to be the most obvious risk factor: more implants 
were lost in the maxilla than in the mandible (Table 4). Ample bone volume is essential for successful 
osseointegration of dental implants. The jaw size in patients with severe hypodontia and ectodermal 
dysplasia is usually small (low bone quantity) which probably contributes to a higher implant loss in 
these patients compared to healthy subjects.16-18 Créton et al. (2010) suggested that the unfavourable 
anatomic conditions and subsequent need for bone augmentation most likely compromises implant 
survival rate,19 while Finnema et al. (2005) reported that implant loss was equally distributed between 
bone graft-augmented sites and ungrafted sites.20 Age does not seem to influence implant survival,17,21 
and ectodermal dysplasia is not a contraindication for implant therapy (Table 4).4,22-24 
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(‘range’) in years 
and moment 





Available information about 
oral and maxillofacial surgery 
Procedure 
information                                        
(H= implants 
healing period in 
months) n= nr. of 
implants
Available implant 
information  (B= 
brand, L= length,  D= 
diameter)   




n= nr. of implants







n= nr. of implants







7.8)                     
60 µ=8.5 (n.t.) t=0: 
n.t.
n.a. Rehabilitative pre-prosthetic 
surgical procedures were carried 
out in 5 patients: sinus lift with 
immediate position of 3 implants 
(2), heterologous bone graft (4), 
resorbable biomembrane (1). 
Fifty-six implants were placed 
immediately, 4 implants were 
placed delayed. Ten implants were 
inserted following rehabilitative 
pre-prosthetic surgery (immediate 
(6), delayed (4)). Twenty-four 
implants were placed in post-
extractive sites. (immediate (20), 
delayed (4)).





Healing caps were 
positioned at third 
post-surgical month. 
n.t.  34 26 60 97.1 
(1)
96.2 (1) 96.7 
(2)
n.t. n.t. Two lost implants were inserted with 
immediate positioning in post-extraction 
sites in alveolar bone ridge class IV, 
according to Cawood and Howell, and 
supported a single crown. 
Bergendal        
200816 
5 5-12 (7.4)          
- at implant 
placement
14 µ=n.t. (± 3-23)                     
Operation year: 
t=0
100 n.t. The patient who 
suffered no implant 
loss had undergone 
a prolonged healing 
time of 6 months. 
B= Nobel Biocare. 
L=10-13. D=3.3-3.75.
 0 14 14  n.t. (9) 35.7 
(9)
9 0 Implants were only placed in anterior 
region of mandible. In 4 patients, 1-3 
implants were lost before loading (100% 
in healing period). The patient who 
suffered no implant loss had undergone 
a prolonged healing time of 6 months 
before abutment operation. The major 
risk factor in the surgeon’s discussion was 
the low quantity of bone. All 4 patients 
had successful reoperations. 
Créton            
201019 
44 16.6-48.5 
(25.1)                  
- at implant 
placement
214 µ=2.9 (0.1- 18.3)         
Implant 
placement: t=0 
14 100% = 44 (nr. of patients). 
43.2% no augmentation. 
Augmentation: calvaria (6.8%), 
iliac (20.5%), mandibular ramus 




gide(4.6%), iliac/chin (2.3%), 
calvaria/bio-gide (2.3%).
n.t. B= Frialit Xive/
Synchro (n=70), 
Astra Osseospeed 
(n=121), IMZ (n=1), 
Straumann standard 
plus (n=18), Steri-
oss (n=4). L=8-15. 
D=3.3-5.5.
   214 n.t. 
(12)
n.t. (6) 91.6 
(18)
≥16 ≤2 Eighteen implants were lost in 6 
patients. One patient lost 8 implants, 
1 patient lost 4 implants and 1 patient 
lost 3 implants. Most implants were 
lost within the first year. One patient 
with ED lost 1 implant. Fourteen 
lost implants had been placed in 






72 5 (n.t.)                                                    
Start of treatment 
plan: t=0
n.t. In 9 patients, supplementary 
surgical measures were 
necessary (sinus lift, 
mandibular augmentation, 
mandibular splitting, Gore-Tex).
n.t. n.t.    72   95.8 
(3)
3 0 Three implants lost in same person due 
to lack of osseointegration following sinus 
floor elevation in the posterior maxilla.
Finnema        
200520 
13 17-30 (20)       
- at time of 
surgery 




n.t. Eleven patients received bone 
augmentation with bone from 
chin (3) retromolar (2) or iliac 
(6).
n.t. B=Nobel Biocare.    87 86 96 89.7 
(9)
n.t. n.t. Nine implants were lost in 5 patients, 
loss of implants was equally distributed 
between bone graft-augmented sites and 
ungrafted sites. No details about causes.
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Procedure 
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(H= implants 
healing period in 
months) n= nr. of 
implants
Available implant 
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brand, L= length,  D= 
diameter)   




n= nr. of implants







n= nr. of implants
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100 n.t. The patient who 
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loss had undergone 
a prolonged healing 
time of 6 months. 
B= Nobel Biocare. 
L=10-13. D=3.3-3.75.
 0 14 14  n.t. (9) 35.7 
(9)
9 0 Implants were only placed in anterior 
region of mandible. In 4 patients, 1-3 
implants were lost before loading (100% 
in healing period). The patient who 
suffered no implant loss had undergone 
a prolonged healing time of 6 months 
before abutment operation. The major 
risk factor in the surgeon’s discussion was 
the low quantity of bone. All 4 patients 
had successful reoperations. 
Créton            
201019 
44 16.6-48.5 
(25.1)                  
- at implant 
placement
214 µ=2.9 (0.1- 18.3)         
Implant 
placement: t=0 
14 100% = 44 (nr. of patients). 
43.2% no augmentation. 
Augmentation: calvaria (6.8%), 
iliac (20.5%), mandibular ramus 
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(n=121), IMZ (n=1), 
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plus (n=18), Steri-
oss (n=4). L=8-15. 
D=3.3-5.5.
   214 n.t. 
(12)
n.t. (6) 91.6 
(18)
≥16 ≤2 Eighteen implants were lost in 6 
patients. One patient lost 8 implants, 
1 patient lost 4 implants and 1 patient 
lost 3 implants. Most implants were 
lost within the first year. One patient 
with ED lost 1 implant. Fourteen 
lost implants had been placed in 
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Start of treatment 
plan: t=0
n.t. In 9 patients, supplementary 
surgical measures were 
necessary (sinus lift, 
mandibular augmentation, 
mandibular splitting, Gore-Tex).
n.t. n.t.    72   95.8 
(3)
3 0 Three implants lost in same person due 
to lack of osseointegration following sinus 
floor elevation in the posterior maxilla.
Finnema        
200520 
13 17-30 (20)       
- at time of 
surgery 




n.t. Eleven patients received bone 
augmentation with bone from 
chin (3) retromolar (2) or iliac 
(6).
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(9)
n.t. n.t. Nine implants were lost in 5 patients, 
loss of implants was equally distributed 
between bone graft-augmented sites and 
ungrafted sites. No details about causes.

















(‘range’) in years 
and moment 





Available information about 
oral and maxillofacial surgery 
Procedure 
information                                        
(H= implants 
healing period in 
months) n= nr. of 
implants
Available implant 
information  (B= 
brand, L= length,  D= 
diameter)   




n= nr. of implants







n= nr. of implants




Garagiola      
200722 
Total: 33       




ED: 16-45         
Non-ED: 
16-68
186 3 (n.a.)                                 
Functional 
loading: t=0
39 ED: bio-absorbable 
Resolute membranes (10), 
non-resorbable Gore-Tex 
(21) in combination with 
autogenous bone and Bio-







n.t. ED 15 51 66 86.7 
(2)
92.2 (4) 91 
(6)
9 2 ED: lost during healing period (n=4), 
during functional loading (n=2).                                           
Non-ED: lost at second stage surgery/ 
healing period (n=5).
non-ED 36 84 120 91.7 
(3)
97.6 (2) 95.8 
(5)
total 51 135 186 90.2 
(5)
95.6 (6) 94.1 
(11)
Grecchi             
20104 
8 19-46 (n.a.) 78 µ=1.75  (0.4-5)                  
Implant 
placement: t=0
100 Five patients had a Le Fort 1 
osteotomy. Six implants were 
inserted after mandibular nerve 
transposition, 54 implants were 
placed in grafted sites all via 
inlay technique. Type of graft: 
46 implants with iliac crest, 8 




(n=12), 6 months 
healing period 
(n=45), not loaded 
(n=21).
B= Neoss (n=34), 
Sweden (n=22), 3i 
(n=10), Alpha Bio 
(n=12). L=11-18. 
D=3.5-6.
 34 44 78   98.7 
(1)
n.t. n.t. No details about implant lost. N.b. 
in 20 of 77 implants, the prosthetic 
restoration was not yet realized.
Guckes                  
200221 
51 8-68 (20.5)    
- at implant 
placement
264 µ=n.t. (0-6.5)                           
Secondary 
surgery: t=0
100 n.a. Two-stage surgery,  
Maxilla: H=5-6, 
Mandible: H=3-4
B= Nobel Biocare. 
L=10-18. D=4/3.75.






25 2 Twenty-five of 27 failure occurred 
before or at second stage surgery. 
Heuberer      
201126 
6 6-14 (n.a.)       








16  µ=n.t. (1- 7.1)                   
Implant 
placement: t=0             
Maxilla: 5 
(3.5-7.1)                                         
Mandible: 3 (1-5). 














1 0 One onplant was lost 1 month after 
placement for presumably iatrogenic 
reasons, but successfully replaced in 
the following month. 
Kearns           
199923 
6 5-7 (11.2)          
- at implant 
placement
41 µ=7.8 (6-11)                               
Implant 
placement: t=0
100 Alveoloplasty, bone grafting, 
and maxillary sinus membrane 
elevation were completed as 
required by the anatomical 
characteristics. When 
necessary, bone grafts were 
harvested from the anterior 
iliac crest.  Four subjects 
had implants in the maxilla, 
3 with bone grafting, 2 with 
sinus membrane elevation. 
All subjects had implants in 
the mandible, 2 subjects had 
mandibular bone grafts with 
autogenous bone.   
Two-stage surgery,  
Maxilla: H= ≥6, 
Mandible: H= ≥4 









1 0 One implant in maxilla failed due 
to lack of osseointegration and was 
removed at stage II surgery. 
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diameter)   




n= nr. of implants
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non-resorbable Gore-Tex 
(21) in combination with 
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(2)
92.2 (4) 91 
(6)
9 2 ED: lost during healing period (n=4), 
during functional loading (n=2).                                           
Non-ED: lost at second stage surgery/ 
healing period (n=5).
non-ED 36 84 120 91.7 
(3)
97.6 (2) 95.8 
(5)
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(5)
95.6 (6) 94.1 
(11)
Grecchi             
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8 19-46 (n.a.) 78 µ=1.75  (0.4-5)                  
Implant 
placement: t=0
100 Five patients had a Le Fort 1 
osteotomy. Six implants were 
inserted after mandibular nerve 
transposition, 54 implants were 
placed in grafted sites all via 
inlay technique. Type of graft: 
46 implants with iliac crest, 8 




(n=12), 6 months 
healing period 
(n=45), not loaded 
(n=21).
B= Neoss (n=34), 
Sweden (n=22), 3i 
(n=10), Alpha Bio 
(n=12). L=11-18. 
D=3.5-6.
 34 44 78   98.7 
(1)
n.t. n.t. No details about implant lost. N.b. 
in 20 of 77 implants, the prosthetic 
restoration was not yet realized.
Guckes                  
200221 
51 8-68 (20.5)    
- at implant 
placement
264 µ=n.t. (0-6.5)                           
Secondary 
surgery: t=0
100 n.a. Two-stage surgery,  
Maxilla: H=5-6, 
Mandible: H=3-4
B= Nobel Biocare. 
L=10-18. D=4/3.75.






25 2 Twenty-five of 27 failure occurred 
before or at second stage surgery. 
Heuberer      
201126 
6 6-14 (n.a.)       








16  µ=n.t. (1- 7.1)                   
Implant 
placement: t=0             
Maxilla: 5 
(3.5-7.1)                                         
Mandible: 3 (1-5). 














1 0 One onplant was lost 1 month after 
placement for presumably iatrogenic 
reasons, but successfully replaced in 
the following month. 
Kearns           
199923 
6 5-7 (11.2)          
- at implant 
placement
41 µ=7.8 (6-11)                               
Implant 
placement: t=0
100 Alveoloplasty, bone grafting, 
and maxillary sinus membrane 
elevation were completed as 
required by the anatomical 
characteristics. When 
necessary, bone grafts were 
harvested from the anterior 
iliac crest.  Four subjects 
had implants in the maxilla, 
3 with bone grafting, 2 with 
sinus membrane elevation. 
All subjects had implants in 
the mandible, 2 subjects had 
mandibular bone grafts with 
autogenous bone.   
Two-stage surgery,  
Maxilla: H= ≥6, 
Mandible: H= ≥4 









1 0 One implant in maxilla failed due 
to lack of osseointegration and was 
removed at stage II surgery. 

















(‘range’) in years 
and moment 





Available information about 
oral and maxillofacial surgery 
Procedure 
information                                        
(H= implants 
healing period in 
months) n= nr. of 
implants
Available implant 
information  (B= 
brand, L= length,  D= 
diameter)   




n= nr. of implants







n= nr. of implants




Sweeney        
200517 
14 12-21 (n.t.)   
- at implant 
placement      
Maxilla: 
17- 20 (18)    
Mandible: 
12-21 (17) 
61 µ=3.3 (1.5-5)                    
Implant 
placement: t=0
100 n.t n.t. L=10-18. D=3.1-4.0.  15 46 61 80 (3) 91.3 (4) 88.5 
(7)
7 0 Seven implants in 5 of the 14 patients 
fail prior to abutment connection. Two 
implants in 1 patient with maxillary 
osteotomy and iliac crest graft. 
One in region 35. One in region 43 
(immediately after extraction placed). 
Two in mandible after extraction of 
impacted teeth.  
Worsaae         
200735 
46 8-48 (20.5)    
out of a 
total of 112 
patients            
283 µ=2.3 (0.1-5.7)                  
Start treatment 
plan: t=0





Surgical procedures were used 
for 51 patients who finished 
treatment. Orthognatic surgery: 
Bimaxillary osteotomy (5), le fort 
1 osteotomy (4), mandibular 
sagittal split osteotomy with 
nerve transpositon (5). Sinus 
floor augmentation (Bio-Oss 
and fibrin glue) was generally 
performed. Augmentation of 
alveolar process (onlay with 
autogenous cortical bone, 
GTR-procedure or splitting 
osteotomy). Autogenous bone 
was harvested intraorally or, in 5 
cases, from the iliaca.
n.t. B= Nobel Biocare, 
Astra.
   283 n.t. 
(6)
n.t. (0) 97.7 
(6)
6 0 Six implants were lost in the anterior 
maxilla alveolar ridge augmentations, 
both 3 in 2 patients, all before 
abutments were connected. 
Zou                           
201424 
25 17-28 (n.a.) 179 3 (n.a.)                                                          
Prostheses 
completions:  t=0
100 In cases of severe bone 
atrophy, the first step was 
bone augmentation using 
1-3 methods (onlay, vertical 
distraction, artificial bone 
material). Maxilla: iliac (n=5), 
fibular (n=1), GBR (n=11). 
Mandible: Distraction (n=2), 
fibular graft (n=2), GBR (n=7). 
n= nr. of cases. 
3-6 months after 
augmentation, 
bone volume was 
reviewed, H=3-6. 
For anodontia 
patients: 6 implants 
in maxilla (2 zis; 4 
cis) and 2-4 implants 
in mandible (cis). 
Conventional 
implants (n=169): 
B =Nobel Biocare 
Replaced (L=10-







 94 85 179   98.3 
(3)
n.t. n.t. Three of the 169 conventional 
implants and 0 of the 10 zygomatic 
implants were removed. 
Abbreviations: n.a.: not applicable; n.t.: not traceable; ED: ectodermal dysplasia.
Calculation overall mean survival percentage: ∑ placed (n) = 1,555; ∑ lost (n) = 98; mean survival percentage (1- (98/1,555))* 100% = 93.7% 
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out of a 
total of 112 
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sagittal split osteotomy with 
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floor augmentation (Bio-Oss 
and fibrin glue) was generally 
performed. Augmentation of 
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autogenous cortical bone, 
GTR-procedure or splitting 
osteotomy). Autogenous bone 
was harvested intraorally or, in 5 
cases, from the iliaca.
n.t. B= Nobel Biocare, 
Astra.
   283 n.t. 
(6)
n.t. (0) 97.7 
(6)
6 0 Six implants were lost in the anterior 
maxilla alveolar ridge augmentations, 
both 3 in 2 patients, all before 
abutments were connected. 
Zou                           
201424 
25 17-28 (n.a.) 179 3 (n.a.)                                                          
Prostheses 
completions:  t=0
100 In cases of severe bone 
atrophy, the first step was 
bone augmentation using 
1-3 methods (onlay, vertical 
distraction, artificial bone 
material). Maxilla: iliac (n=5), 
fibular (n=1), GBR (n=11). 
Mandible: Distraction (n=2), 
fibular graft (n=2), GBR (n=7). 
n= nr. of cases. 
3-6 months after 
augmentation, 
bone volume was 
reviewed, H=3-6. 
For anodontia 
patients: 6 implants 
in maxilla (2 zis; 4 
cis) and 2-4 implants 
in mandible (cis). 
Conventional 
implants (n=169): 
B =Nobel Biocare 
Replaced (L=10-







 94 85 179   98.3 
(3)
n.t. n.t. Three of the 169 conventional 
implants and 0 of the 10 zygomatic 
implants were removed. 
Abbreviations: n.a.: not applicable; n.t.: not traceable; ED: ectodermal dysplasia.
Calculation overall mean survival percentage: ∑ placed (n) = 1,555; ∑ lost (n) = 98; mean survival percentage (1- (98/1,555))* 100% = 93.7% 
Prosthetic treatment outcome in patients with severe hypodontia: a systematic review | 3938 | Chapter 2
Surgery / bone augmentation prior to implant placement 
The alveolar bone is underdeveloped in many cases in those areas lacking teeth making bone 
augmentation surgery mandatory before implant placement. To create sufficient alveolar bone volume 
for implant placement, distraction osteogenesis (n=1), maxillary sinus floor elevation surgery (n=4), 
guided tissue regeneration (n=3), osteotomy (n=3) and bone grafting (n=9) were applied (Table 4). 
Bone grafts (autogenous bone, allogenous bone, xenografts, synthetic bone) with or without the use 
of a (resorbable or non-resorbable) membrane were commonly applied.4,22,24 Bone augmentation was 
equally successful in ectodermal dysplasia and non-ectodermal dysplasia patients.4,22
Clinical parameters, radiographic findings & peri-implant health related to dental 
implants 
Deepened peri-implant sulci and radiographic crestal bone resorption were common in severe 
hypodontia patients, and the depth of the pockets and bone loss were occasionally excessive.20,24 It was 
suggested that most bone resorption occurs in the first year after placement and remains at a relatively 
constant level afterwards.24 In that study, peri-implantitis was observed in eight of the 25 cases, three of 
which required implant removal.24 In another study, Garagiola et al. (2007) observed uncovered implant 
threads in patients with bad oral hygiene.22 
Dental implant complications
Most implants were lost during the first year after placement (Table 4). No long-term results (>10 years) 
are available. Standford et al. (2008) asked the patients about perceived complications, and 50% of them 
reported some form of post-operative complications after implant therapy, for example, infections, 
loose or broken screws or loose dentures.25 The rate of reported implant or prosthetic complications 
was comparable for children (<18 years) and adults (≥18 years).25 
Satisfaction / quality of life after implant treatment 
Some studies scored patients’ satisfaction level after implant treatment (Table 3). The majority of the 
patients were satisfied to very satisfied.20,24-26 The oral health-related quality of life (OHIP-49) after 
treatment was high in oligodontia patients (85% with dental implants) and was independent of the 
number of missing teeth (hypodontia versus oligodontia).27 
Implants and facial growth
Implants are preferably not placed in growing patients, with the exception of the interforaminal area 
of the mandible, because of the risk that implants may submerge relative to the neighbouring natural 
teeth.17,23 Johnson et al. (2002) studied the influence of implant treatment on craniofacial morphology 
and showed no significant differences between implant-treated and non-treated children, suggesting 
that implant treatment itself does not affect craniofacial growth and development.28 Three studies 
described implant treatment in young growing patients (all ≤15 years old). In the studies by Heuberer 
et al. (2012) and Kearns et al. (1999), implants were placed in both the maxilla and mandible; implant 
survival was 93.8% and 97.6%, respectively, that is, dental implants in the mandible and maxilla is a 
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successful treatment option.23,26 This is in contrast to Bergendal et al. (2008) who placed implants in 
the anterior region of the anodontic mandible in five children; nine of the 14 implants (four patients) 
were lost (implant survival 35.7%).16 They concluded that the high implant failure rate in children was 
not related to age but more because of limited bone quantity.16 However, the failing implants of two 
patients were replaced when they were in their teens and in the other two patients immediately after 
primary healing; none of these implants failed.29
Meta-analysis 
The variety in outcome measures and quality of the studies did not allow for meta-analysis.
Discussion
Current information regarding dental treatment modalities and treatment outcomes in patients with 
severe hypodontia was systematically assessed in this review. The quality of the included studies was 
generally low; most studies focused on implant treatment and few of the eligible studies reported 
other treatment modalities. Notwithstanding the rather low quality of the studies, it was evident that 
treatment with dental implants is promising even though implant failure is higher in hypodontia than 
in healthy subjects. Implant placement is often preceded with orthodontics, but there is a hazard of 
root resorption, particularly due to the rather long duration and the increased orthodontic force levels. 
Finally, removable (partial) dentures can be applied in young subjects as an ‘interim treatment’ and is 
also a low-cost option in adults.
  In a critical literature review by Yap et al. (2009) on dental implants in patients with ectodermal 
dysplasia and tooth agenesis, implant survival in hypodontia patients ranged from 88.5 to 97.6%.30 The 
lower implant survival rates reported in our review are due to different inclusion criteria, for example; 
the study by Bergendal et al. (2008) with a implant survival rate of 35.7%,16 was excluded by Yap et al. 
(2009).30 Congruent to implant loss in healthy subjects, most implant failures occur during the first year 
after placement.31 Unfortunately, peri-implant bone loss, peri-implant mucositis and peri-implantitis are 
not well assessed in severe hypodontia patients and the long-term (>10 years) results are lacking.
  The lower implant survival rate in severe hypodontia patients compared with healthy subjects,18 
may be associated with the bone quality. The jawbone density in ectodermal dysplasia patients, for 
example, is higher.32,33 The latter seems to apply to ectodermal dysplasia patients only, as Créton et 
al. (2012) could not demonstrate notable radiographic differences in the structure of mandibular 
trabecular bone between hypodontia patients without ectodermal dysplasia and healthy subjects.34 So, 
other factors are responsible for the higher loss of implants in patients with severe hypodontia such 
as location and amount of available bone.16,17,20-23,26,35 Due to the controversial conclusions of Créton et 
al. (2010) and Finnema et al. (2005) about the potential influence of bone augmentation on implant 
survival, it is not clear whether bone augmentation is a contributing risk factor.19,20 However, despite 
the potentially higher risk of implant loss in augmented areas, bone augmentation has to be performed 
when the bone volume is inadequate in height and width, for reliable implant placement. 
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  Artificial bone substitutes are applicable for small defects when bone augmentation surgery is 
needed; however, autologous bone grafts are still preferable for large defects and/or compromised 
conditions. The latter is commonly the case in hypodontia as horizontal and vertical augmentation is 
often required, and this benefits greatly from the specific properties of autogenous bone, viz., the 
capacity to rapidly form woven bone and remodel it to lamellar bone.36 Autografts are particularly 
popular in this context because they have osteogenic, osteoinductive and osteoconductive properties, 
and contain a high number of viable cells and are rich in growth factors.36 
  Also, it has to be accepted that there is a higher risk of implant failure in young patients, due the 
low quantity of the bone and not because the patients are not fully grown.16 
  It is generally not recommended to insert dental implants in growing subjects, except in the 
interforaminal area of the mandible,37 because they act as ankylosed teeth.38 Pre- and post-adolescent 
craniofacial growth, as well as continued eruption and migration of natural teeth, will result in the 
implant submerging, a condition comparable to secondary retention of teeth.23
  Due to the lack of retention, the short lifespan and discomfort for the patients, treatment with 
removable dentures is substituted by treatment with fixed dentures. In our opinion, children adapt 
easily to removable (partial) dentures, and thus this treatment option can be considered as a valuable 
treatment modality, as an ‘interim phase’. Positive arguments for adults to choose this treatment 
modality are its low costs and no need for surgery. Treatment with tooth-supported fixed dental 
prostheses was hardly described. Our experience with many patients with severe hypodontia is that a 
tooth-supported fixed dental prostheses is hard to design due to the unfavourable distribution of the 
available teeth and their often unfavourable shape (microdontia or taurodontia).
  The unfavourable distribution of the developed teeth over the jaw makes contemporary orthodontic 
treatment indispensable for the majority of hypodontia patients: to establish optimal conditions for 
definite treatment.11 However, as orthodontic treatment is usually more time-consuming in severe 
hypodontia than in healthy subjects, there is an increased hazard of root resorption.11 Therefore, to 
decrease the risk of root resorption, it is important to keep orthodontic force levels as low as possible 
in such patients.39  
  The conclusion is that the ability to make decisions for the treatment of patients with severe 
hypodontia based on evidence is not feasible yet. Although the results of implant treatment in 
hypodontia are favourable, implant failure in severe hypodontia is higher than in non-compromised 
subjects, which seems to be mainly associated with the ‘location’, the ‘bone volume’ and the need for 
augmentation. 
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Implant-retained overdentures for young 
children with severe oligodontia: 
a series of four cases
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Abstract 
Purpose
The treatment need is high in children with severe oligodontia and anodontia, because they often 
have functional and aesthetic problems owing to missing teeth. Because the interforaminal region 
barely grows after eruption of the permanent mandibular incisors, dental implant treatment should 
be considered a treatment option for these children. The purpose of our study was to assess the 
treatment outcomes regarding satisfaction and the care and aftercare of implant-retained mandibular 
overdentures in a series of four young children without erupted mandibular teeth from either severe 
oligodontia (n = 3) or anodontia (n = 1).
Patients and methods
Four children without erupted mandibular teeth, aged 6 to 13 years, were provided with an 
implant-retained overdenture on two implants. The surgical and prosthetic care and aftercare were 
scored by the clinicians. Also, the patients and their parents were queried about how satisfied they 
were with the overdenture.
Results
The median follow-up of the patients was 5.2 years (range 3.2 to 8.4). No implants were lost, no cases 
of peri-implantitis occurred, and the need for treatment and aftercare was low. Patient and parent 
satisfaction with this treatment was high.
Conclusions
A two-implant retained overdenture in children with no erupted mandibular teeth is a safe treatment 
modality when appropriate treatment and aftercare can be provided.
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Introduction
Oligodontia is defined as the congenital absence of six or more permanent teeth, excluding third 
molars.1 Anodontia, a rare phenomenon, is characterized by the absence of all teeth. Oligodontia and 
anodontia can occur as an isolated manifestation or as part of a syndrome (e.g., ectodermal dysplasia).2 
  Because of missing teeth, patients with oligodontia can develop functional and aesthetic problems. 
Furthermore, in areas in which teeth are missing, not only can functional and/or aesthetic problems 
develop, but also a physiological problems, because the alveolar bone and/or jaws will not develop well 
in areas with missing teeth. The results can range from local underdevelopment of the alveolar ridge to 
underdevelopment of the maxillofacial skeleton.
  In oral rehabilitation of children with missing teeth, the golden principle has been to strive for good 
aesthetics and oral function, preferably, from a psychosocial viewpoint, with optimal use of remaining 
teeth.3 In cases in which 1 to 4 permanent teeth are missing, such a prosthodontic rehabilitation 
can be achieved by maintaining the deciduous teeth that have no successor, guided tooth eruption, 
orthodontic treatment, and/or autologous transplantation of teeth.3 In children with oligodontia and 
anodontia, such treatments are difficult or impossible. For severe cases of oligodontia and anodontia, 
treatment with fixed and removable (partial) prostheses has been suggested, with or without the use 
of dental implants.4 
  Although treatment with dental implants has been considered a reasonable adjuvant to 
prosthodontic treatment in patients with oligodontia,2,5,6 placement of dental implants in young subjects 
is generally considered to be contraindicated.7 The main reason for this contraindication has been that 
in growing patients, the alveolar ridge with natural teeth will also be developing and growing. However, 
a dental implant cannot grow with physiological growth. Thus, the implant will develop in infraposition, 
a process comparable to secondary retention of teeth (ankylosis).8-10 One exception exists, however. 
Cronin et al. (1998) reported that after the age at which the permanent mandibular incisors emerge into 
the oral cavity, the interforaminal region of the mandible will barely grow.11 Therefore, implant-retained 
mandibular overdentures have been considered as a potential treatment option for young patients 
with severe oligodontia and anodontia.7,12-14 However, these studies have lacked information about the 
care and aftercare these patients might need. In the present case series, we report on the treatment 
and aftercare given to, and satisfaction of, patients without erupted mandibular teeth provided with an 
implant-retained mandibular overdenture.  
Patients and methods
Patient selection and treatment
From 2005 till 2010, four children (3 males and 1 female; median age at dental implant placement 
8 years, range 6 to 13; Table 1) were diagnosed with severe oligodontia (3) or anodontia (1) at the 
Department of Oral and Maxillofacial Surgery (University Medical Center Groningen). The patients 
with severe oligodontia had ectodermal dysplasia; the cause of the anodontia in the fourth patient 
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was unknown. All four patients had no erupted mandibular teeth and requested better function and 
aesthetics. Fabricating conventional dentures in the underdeveloped mandible was uneventful; the 
dentures lacked stability and retention. Therefore, the patients and their parents were offered implant 
treatment (i.e., placement of two dental implants in the mandible and an implant-retained mandibular 
overdenture). All patients and their parents agreed on the implant-retained overdenture treatment 
modality. 
Surgical and prosthetic procedures
All patients received two dental implants (Straumann Standard SLA® implants, Institut Straumann AG, 
Basel, Switzerland; length 10 mm for 2, 12 mm for 4, 14 mm for 2) in the interforaminal area of the 
mandible in a one-stage procedure. No bone augmentation was needed. All implants were placed 
with the patient under general anesthesia. Antibiotics (amoxicillin) were started before surgery and 
continued for one week post-operatively. Post-operative treatment consisted of chlorhexidine 0.2% 
mouth rinse for two weeks and analgesics (acetaminophen), as needed. An osseointegration period 
of three months was applied, during which no temporary prostheses were worn. After three months, 
the prosthetic treatment was performed by fabricating a conventional (partial) maxillary denture and 
an implant-retained mandibular overdenture (Fig. 1). Bilateral balanced occlusion and articulation were 
performed. No metal reinforcements were used in the acrylic resin denture base.  
Clinical assessments
To gain insight into the treatment and aftercare given to the patients, all prosthetic and surgical 
complications were scored, including implant loss, repair of loose clips or attachments, repair of 
denture teeth, repair of denture base, fabrication of new mesostructures, release of sore spots, and so 
forth. At the follow-up visit, the plaque index,15 gingival index,16 calculus index (0= absence of calculus; 
1= presence of calculus), bleeding index,15 peri-implant probing depth, gingival recession around the 
implants and pain during probing (0= no pain during probing; 1= pain during probing) were scored. The 
probing depths were measured at four sites for each implant (mesially, labially, distally, and lingually) 
using a periodontal probe (Merit B, Hu Friedy, Chicago, USA). The distance between the marginal border 
of the mucosa and the tip of the periodontal probe was scored as the probing depth. Recession of the 
mucosa around the implants was also measured at four sites of each implant (i.e., mesially, labially, 
distally, and lingually). The distance between the marginal border of the mucosa and the top of the 
abutment was measured with a periodontal probe. 
Radiographic assessments 
To assess whether changes had occurred in the peri-implant bone levels and maxillofacial skeleton, 
panoramic radiographs and lateral cephalometric radiographs were taken at 2- to 3- year intervals 
during follow-up period. It was not possible to take dental radiographs owing to the relatively high floor 
of the mouth. Peri-implant bone loss (vertical bone loss) was classified on the panoramic radiograph 
according to the following scale (radiographic score): 0= no apparent bone loss; 1= reduction of the 
bone level not exceeding more than one third of the implant length; 2= reduction of the bone level 
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exceeding one third of the implant length, but not exceeding one half of the implant length; and 3= 
reduction of the bone level one half of the implant length; 4= a total reduction of bone along the 
implant. To analyze the alternations in the position of the implants in the sagittal plane, two lines on all 
lateral cephalometric radiographs were drawn: one through the vertical axis of the implants and one 
along the lower edge of the mandible (Fig. 2). 
Patient and parent satisfaction
At the last follow-up visit, the patients and their parents completed a satisfaction questionnaire (scale 
to 10).  The questionnaire included questions related to the treatment itself and whether the treatment 
had the desired effect. In addition to the satisfaction levels, the patients and their parents were asked 
whether the children could clean their implants and overdenture themselves, whether it was difficult to 
clean the implants and overdenture, how often the implants and overdenture had been cleaned, how 
the implants and overdenture had been cleaned, and whether the parents had helped their child with 
performing proper oral hygiene. 
  The present study was based on the analyses of routine care. Owing to the prospective nature of 
our study, it was granted an exemption in writing by the University of Groningen institutional review 
board. The present study followed the Declaration of Helsinki on medical protocol and ethics.
Results 
Patients and clinical assessments
Median follow-up was 5.2 years (range 3.2 to 8.4; Table 1). The bleeding index and probing depths 
were greatest in the patients with the longest follow-up. In all patients, the aesthetics had improved. 
Complete dental arches were shown during smiling, and the anterior face height had also improved 
(Fig. 1). 
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Table 1. Patients characteristics and clinical assessments at last follow-up visit.
Patient 1 Patient 2 Patient 3 Patient 4
Age at time of implant placement (years) 13 8 8 6
Follow-up period (years) 7.0 8.4 3.3 3.2
Erupted teeth in maxilla at implant placement (n) 0 6 4 4
Erupted teeth in mandible at implant placement (n) 0 0 0 0
Region in which implants were placed 33 43 33 43 33 43 33 43
Plaque index score 2 2 1 1 0 0 2 2
Gingival index score 0 0 0 0 0 0 0 0
Calculus index score 0 0 1 1 0 0 0 0
Bleeding index score 2 1 1 0 0 0 0 0
Pocket depth (mm) 
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Pain during probing 1 1 0 0 1 1 0 0
Surgical and prosthetic aftercare 
An overview of the surgical and prosthetic aftercare is provided in Table 2. No implants were lost, 
and prosthetic aftercare was hardly needed. The number of visits to release sore spots or deactivate 
or activate retentions was low. The patient with the longest follow-up period (8.4 years) received a 
new mesostructure and overdenture because the first overdenture had become worn. In none of the 
patients, had changes occurred in the interimplant distance.
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Table 2. Need for surgical and prosthetic aftercare during follow-up.
Patient 1 Patient 2 Patient 3 Patient 4
Follow-up period (years) 7.0 8.4 3.3 3.2
Implants lost (n) 0 0 0 0
New mandibular overdentures (n) 0 1 0 0
New mesostructures required (n) 0 1 0 0
Repair of overdentures required (n)*1 3 0 0 1
Sore spot releases (n) 0 2 1 0
Visits to (de)activate retention (n) 0 2 1 2
Oral hygiene instructions 2 3 0 1
*1 Repair of overdentures, including: replacing of acrylic teeth after loosening, reocclusion, fracture of acrylic denture base.
Radiographic analysis
Hardly any peri-implant bone loss was observed in all patients on the panoramic radiographs. A 
counterclockwise rotation of the implants in the sagittal plane was observed in two patients (Fig. 2).
Oral hygiene and satisfaction of patients and parents
All the patients and their parents were very positive about the implant treatment. However, but 
performing proper oral hygiene was not always easy (Table 3). 
Table 3. Patients’ satisfaction and oral hygiene skills. 
P1 A1 P2 A2 P3 A3 P4 A4
Patient age when completing questionnaire (years) 19 16 10 8
Treatment had the desired results? Yes Yes Yes Yes Yes Yes Yes Yes
Satisfaction after implantation with overdentures* 9 9 10 10 10 10 8 8
Who cleaned the implants and overdentures?** 1 1 1 1+2 
Is it difficult for you to clean your implants and overdenture?*** 1 0 0 2
How often each day do you clean your implants and overdenture? 2 2 2 1
How do you clean your implants and overdenture? Htb Htb Htb/Etb Etb/ Idb
Do you smoke cigarettes? No Yes^ No No 
Abbreviations: A1, adult 1; A2, adult 2; A3, adult 3; A4, adult 4; Etb, electric toothbrush; Htb, hand toothbrush; Idb, interdental brush; 
P1, patient 1; P2, patient 2; P3, patient 3; P4, patient 4.
* Scale 1-10.
** 1, patient; 2, parent.
*** 0, no; 1, a little; 2, yes.
^ Aged 14 years.
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Figure 1a.
Figure 1b.
3Implant-retained overdentures for young children with severe oligodontia: a series of four cases | 5352 | Chapter 3
Figure 1c. 
Figure 1d.
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Figure 1e.
Figure 1f.
Figure 1. A six-year-old patient with mandibular anodontia was provided with an implant-retained mandibular overdenture. a, Profile 
before implant placement. Her profile and smile line mimicked the face of an old woman. b, Intraoral view before implant placement. 
She could eat very well, but her aesthetics was unsatisfactory. c, Profile after placing the implant-retained mandibular overdenture. 
d, Intraoral view after implant placement. e, Upper partial prostheses and mandibular overdenture on two implants. f, View of our 
satisfied patient at 10 years old.
3Implant-retained overdentures for young children with severe oligodontia: a series of four cases | 5554 | Chapter 3
Figure 2a. Figure 2b. 
Figure 2. Radiographic analyses of one of the patients. a, Lateral cephalometric radiograph three weeks after implant placement. b, 
Lateral cephalometric radiograph two years after implant placement showing that the angulation of the implants had changed owing 
to counterclockwise rotation of the mandible.
Discussion
An implant-retained overdenture on two implants in children with severe oligodontia was shown to be a 
good and safe treatment modality, with high satisfaction of patients and their parents. No implants were 
lost, no peri-implantitis occurred, and the patients and their parents were satisfied. Our findings are in 
line with the case reports of Kramer et al. (2007),7 Kargül et al. (2001),12 Giray et al. (2003),13 and Visser 
et al. (2006).14 Moreover, the need for aftercare was even lower than that reported for implant-retained 
dentures in adults.17-19 Thus, just as in adults, an implant-retained mandibular overdenture on two 
implants can be a very useful treatment option for children, with good functional results and high 
patient satisfaction.7,20,21 
  Growth in the interforaminal region of the mandible has seemed to be negligible after the 
eruption of the permanent mandibular incisors into the oral cavity.11 As shown in Figure 2, growth of 
the mandible in other directions will continue. Our observations were in agreement with the study 
by Becktor et al. (2001), who analyzed the growth in a 9-year-old child.22 On a lateral cephalometric 
radiograph, they showed that in their patient, the inclination of the implants changed from 70⁰ to 68.5⁰ 
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owing mandibular rotation. 
  On the basis of our clinical experience and the results obtained to date, we believe that children 
with severe oligodontia or anodontia can be treated with two endosseous implants in the interforaminal 
region of the mandible to support a mandibular overdenture from the age of six years onward. Once 
the overdenture has been fabricated, the child should be scheduled for routine follow-up visits every six 
months. A clinical assessment to monitor the peri-implant health should be repeated at every follow-up 
visit, with radiographic assessments performed every two to three years. Moreover, when the motor 
skills of the child are not sufficient to maintain proper peri-implant health, the parents must support 
their child in cleaning the mesostructure. Finally, to ease cleansing, we would recommend choosing 
locators. 
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Abstract
Background
The impact of oligodontia on the children’s oral health-related quality of life (OHrQoL) requires 
further verification because the OHrQoL has only been reported on the basis of non-condition specific 
questionnaires.
Objectives
To obtain an insight into condition specific oral health-related quality of life in Dutch children with 
oligodontia.
Methods
Between October 2014 and March 2017, 11-17 year old oligodontia patients were approached to 
join a study assessing the impact of oligodontia on condition specific oral health-related quality of 
life (OHrQoL). The patients received a condition specific OHrQoL questionnaire prior to the start of 
orthodontic treatment. Non-oligodontia children in the same age group, but also requiring orthodontic 
treatment, were approached to serve as a control. The Fisher’s Exact test was used for comparison 
purposes with the control group. Mann-Whitney U tests were applied for subgroup analyses for gender, 
age, orthodontic classification and microdontia. P-values of <.05 were considered statistically significant.
Results
Twenty-eight oligodontia patients and 23 controls agreed to participate. The oligodontia patients’ 
scores were comparable to the controls except for the items about dental appearance and treatment 
complexity. 
Conclusions
The impact of oligodontia on OHrQoL in youngsters is limited and mainly concerns dental appearance 
and the complexity of the treatment.
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Introduction
Hypodontia is a condition in which one or more teeth are missing as a consequence of tooth agenesis. 
The term oligodontia is generally used when six or more teeth (third molars excluded) are congenitally 
absent.1 As a consequence of missing teeth, children with oligodontia can develop functional or 
aesthetic problems that may result in a physical and emotional burden, especially during the turbulent 
years of adolescence.2 
  Having congenitally missing teeth is likely to have an impact on perceived oral health-related 
quality of life (OHrQoL) in children.3-5 However, it was also reported that the OHrQoL in patients with 
congenitally missing teeth is comparable to that of routine orthodontic controls.6 Thus, the impact 
of congenitally absent teeth on the children’s OHrQoL requires further verification, also because the 
OHrQoL has only been reported on the basis of non-condition specific questionnaires.3-6 
  Several non-condition specific questionnaires have been developed to assess OHrQoL in 
youngsters,7 such as: the Child Oral Health Quality of Life questionnaire (COHQoL);8 the Child Oral 
Health Impact Profile (COHIP);9 the Child-Oral Impacts on Daily Performances (Child-OIDP);10 the Early 
Childhood Oral Health Impact Scale (ECOHIS);11 and the Scale of Oral Health Outcomes (SOHO-5).12 The 
COHQoL questionnaire consists of two age-dependent Child Perceptions Questionnaires (CPQ), viz. for 
8-10 year olds (CPQ8-10) and for 11-14 year olds (CPQ11-14), which restricts its use in prospective 
studies.7 The CPQ has been used to investigate the quality of life in children with congenitally missing 
teeth.3-6 However, the CPQ and the other aforementioned questionnaires have one thing in common 
and that is they were developed to measure OHrQoL in children who are not diagnosed with oligodontia, 
cleft palate or other craniofacial afflictions.5 
  As the management of oligodontia is a complex process and is likely to differ from children not 
diagnosed with oligodontia, there is a need for a condition specific OHrQoL questionnaire.13 Akram et 
al. (2011; 2013) tried to bridge that omission by developing a condition specific quality-of-life-in-chil-
dren-with-developmentally-absent-teeth (ChildQoLDAT) measure for children between 11-18 years of 
age.13-14 Oligodontia-condition specific problems can be recognized and understood better with the 
items of this questionnaire, yet it has never been used to describe the differences in OHrQoL between 
children with oligodontia and unaffected controls. Moreover, the potential differences in OHrQoL 
between primary school children (≤12 years) and secondary school children (≥13 years) is interesting as 
it is presumed that appearance may become more important during puberty and adolescence.
  The aim of this study was to assess the condition specific OHrQoL in 11-17 year old Dutch 
oligodontia children compared to non-affected controls. None of the patients and controls had been 
treated with fitting orthodontic appliances at the time of completing the OHrQoL questionnaire. 
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Methods
Patient selection 
Between October 2014 and March 2017, patients diagnosed with oligodontia who were referred to 
Dutch centres for special dental care (University Medical Center Groningen (UMCG) and University 
Medical Center Utrecht (UMCU)) were considered eligible for the study when they fulfilled the following 
criteria:
- 11-17 years of age;
- Agenesis of ≥6 teeth, excluding the third molars (oligodontia);
- Absence of a syndrome or a mental handicap;
- Patients are at the start of their orthodontic treatment, prior to fitting orthodontic appliances.
Regarding the control group, children between 11-17 years of age without any congenitally missing 
teeth, who were referred to the orthodontic department of the University Medical Center Groningen, 
were selected and approached prior to the start of their orthodontic treatment. The parents/caregivers 
of the patients and controls were informed about the prospective study. All the included patients 
and controls received a questionnaire by regular mail. The patients and controls had to complete the 
questionnaire at home and send it back with a postage paid response envelop. This is because we 
preferred the familiar environment (home) for these children to complete the questionnaire rather 
than the more stressful environment in the hospital. The Groningen medical ethical committee was 
approached for permission, but an exemption was granted as this research was an evaluation of routine 
dental care (M13.146644). 
Questionnaire 
For this purpose, the items of the ChildQoLDAT, developed by Akram et al. (2011; 2013),13-14 were 
translated into Dutch. The Guillemin et al. (1993) and Wink et al. (2013) translation approach was used 
on the ChildQoLDAT for the Dutch setting.15,16 After the questionnaire was translated, the face- and 
content validity was checked and considered high. The ChildQoLDAT includes 40 items and a graded 
response scale (1-5) is used for most of them, ranging from strongly agree to strongly disagree.13 A low 
score represents a poor oral health-related quality of life. The same translated questionnaire was given 
to the oligodontia and control patients. 
Statistics 
The returned questionnaires were screened for missing values and/or items, which were noted as ‘not 
applicable’. When ≥15% of the patients had not answered a specific item, it was presumed that this 
item was either poorly understood or not applicable and the item was excluded from further analysis. 
When <15% of the patients did not answer a specific item, the missing value was filled in with the 
median of the group.
  The scores of the relevant items of both the oligodontia and control groups were compared 
using the Fisher’s Exact test (p=.05) because of the small group sizes. Differences in total score were 
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calculated for the following factors: gender (male/female), age (11-12 versus 13-17 years), orthodontic 
classification (class I/II/III) and microdontia (no microdontia versus microdontia). For the latter analyses, 
we applied non-parametric tests (Mann-Whitney U test; Kruskal Wallis test) because the small sample 
size. P-values of <.05 were considered statistically significant (IBM SPSS Statistics 23).
Results
Patients
Of the 39 selected oligodontia patients who met the inclusion criteria, 28 (72%) patients (and their 
parents/caregivers) agreed to participate; 19 from the UMCG and 9 from the UMCU. The other eleven 
patients did not return the questionnaire after several requests. The median number of agenetic teeth 
was 10 (IQR [7;12]; range 6-18). Twenty-two patients (78.6%) had one or more agenetic teeth in the 
anterior region (cuspid to cuspid). Twenty-three of the 29 asked controls agreed to participate. The 
characteristics of both groups are shown in Table 1. 
  Only the ‘graded response scale items applicable to everyone’ of the ChildQoLDAT were included 
in the OHrQoL analyses and therefore the following items were excluded: informative items (1a, 1b, 1d, 
1e, 2d, 2e and 6a), Yes/No items (1c, 3b and 5j) and the ‘graded response scale items not applicable 
to everyone’ (2f and 5k).13,14 Two items were left unanswered by ≥15% of the oligodontia patients (2b 
and 3h) and these were excluded as well. The results of the included 26 items are shown in Table 2. 
Regarding ‘treatment’, the oligodontia patients felt that their treatment was more complicated than that 
of their friends (2a), hence this score was significantly lower than the controls. Also, dental appearance 
was scored worse by the oligodontia patients. Thus oligodontia patients are more aware and certainly 
worry about their appearance; for example the scores of item 4a (“I feel embarrassed about the way my 
teeth look”) and 4f (“Most of my friends have teeth that look better than mine”) differed significantly 
than those of the controls. In contrast, eating, speaking, performing oral self-care and taking part in 
contact sports were not negatively influenced by having oligodontia (3a, 3c, 3d, 3e, 3f, 3g). Besides, the 
oligodontia patients were not restricted in their social contact and/or by the reaction of other people 
(5a, 5b, 5c, 5d, 5e, 5f, 5g) and their treatment was supported by their family (5h). 
  Subgroup analyses revealed that older children with oligodontia (13-17 years) scored significantly 
lower than younger ones (11-12 years old), meaning that the oral health-related quality of life of the 
younger ones was less negatively influenced (p=.042; Table 3). The total item score of the oligodontia 
group was not influenced by gender, orthodontic classification for occlusion and microdontia. Subgroup 
analyses were performed on the control group in terms of ‘age’ and ‘gender’ with a Mann-Whitney U 
test and ‘orthodontic classification for occlusion’ with a Kruskal Wallis test. The control group analyses 
did not demonstrate any differences. 
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Table 1. Oligodontia- and control group characteristics.
 
Oligodontia group  
(≥6 agenetic teeth)
Control group  
(no agenetic teeth)
Number of patients 28 23
Gender (male/female) 14/14 15/8
Median age at questionnaire completion [IQR] 12 [11;13] 12 [11;13]










Table 2. Included item-scores (median, IQR) of the oligodontia and control patients. All questionnaires were completed prior to the 
onset of orthodontic treatment.
Included items Oligodontia Control P-value 
(95%CI)
Treatment 
2a I feel that my treatment is more complicated than the treatment my 
friends are having.
2 [1;3] 3 [3;4] <0.001
2c I’m worried about how my teeth will look at the end of my treatment. 4 [3;4] 4 [3;4] 0.815
Activities
3a It takes me a lot longer to brush my teeth because of the gaps. 4 [4;4] n.a.
3c Food gets stuck in the gaps between my teeth. 4 [2;4] n.a.
3d Having missing teeth affects my speech, for example, I have a lisp or find 
it difficult to pronounce certain words.
4 [3;5] n.a. 
3e I don’t eat in public places because of the way my teeth are. 5 [4;5] 5 [4;5] 0.777
3f I am nervous about speaking aloud in public. 5 [4;5] 5 [4;5] 0.408
3g I don’t take part in contact sports because I worry about hurting my 
teeth.
5 [4;5] 5 [4;5] 0.769
Appearance
4a I feel embarrassed about the way my teeth look. 3 [2;4] 4 [3;5] 0.023
4b I don’t smile for photographs because of the way my teeth are. 3 [2;5] 5 [4;5] 0.154
4c I think my teeth look out of proportion, for example, they look too big 
or too small.
3 [2;4] 4 [3;5] 0.065
4d The gaps in my teeth bother me. 3 [2;4] n.a.
4e I worry about being left with a gap when my baby teeth fall out. 2 [2;3] n.a. 
4f Most of my friends have teeth that look better than mine. 2 [1;3] 3 [2;4] 0.010
4g I don’t laugh out loud with friends because of the way my teeth look. 4 [4;5] 5 [4;5] 0.242
4h I worry about the size of the false teeth I will have fitted. 4 [4;5] n.a.
4i I worry about the colour of the false teeth I will have fitted. 4 [4;5] n.a. 
The reaction of other people
5a I worry about how people will react to my missing teeth. 4 [3;4] n.a.
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5b I feel embarrassed about meeting people for the first time because of 
the way my teeth are.
4 [4;5] 5 [4;5] 0.053
5c I wouldn’t want my friends to know I have missing teeth. 4 [4;5] n.a.
5d People have commented on me having baby teeth. 4 [3;5]  n.a.
5e I worry that people might think it’s weird if I have a false tooth. 4 [4;4]  n.a.
5f People laugh at me because of the way my teeth look. 4 [4;5] 5 [4;5] 0.103
5g People have made me feel uncomfortable about the size of my teeth. 4 [4;5] 5 [4;5] 0.225
5h My family supports the treatment I am having for my missing teeth. 5 [4;5] n.a.
5i My family treat me differently because I have missing teeth, for example, 
they worry or are protective.
4 [4;5] n.a. 
Patients could give a score between 1-5 per item. The higher the score, the less negative the patient was about that item. Not all 
items were applicable (n.a.) to the controls. A Fisher’s Exact test (95%CI) was performed to compare the results of the items that were 
completed by both the oligodontia patients and controls. 









Age 11-12 years old (n=19)
















The higher the score, the less negative the patient is about the OHrQoL. Mann-Whitney U tests (95%CI) were performed for all 
subgroup comparisons.
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Discussion
The results of the condition specific ChildQoLDAT indicate that the impact of oligodontia on the Dutch 
youngsters’ OHrQoL is limited and mainly concern dental appearance and the complexity of the 
treatment. Remarkably, OHrQoL was significantly worse in patients above the age of 12 compared to 
younger patients. 
  According to the literature, it is presumed that the absence of several permanent teeth has a 
negative impact on the OHrQoL of those aged between 11-15 years.3-5 However, the questionnaires 
used in previous OHrQoL studies do not give detailed information about the various problems 
experienced by children with oligodontia and about the impact of these problems. Considering the 
various items of the condition specific ChildQoLDAT questionnaire applied in our study, additional 
insights have come to light about the condition specific problems related to oligodontia. First, 
eating and speaking (in public) is not influenced by having oligodontia. This can be explained by the 
fact that most of these children have not lost their deciduous teeth yet. This is in agreement with 
the results of Laing et al. (2010) where only chewing difficulties were seen in patients who had lost 
their deciduous teeth without successors.6 Secondly, it also seems that the patients are not too 
concerned about the reaction of other people despite their consciousness of having oligodontia. 
Thus, the impact of the aforementioned items is limited and this can, at least in part, be explained 
by the fact that in the Netherlands most of these patients visit the centres for special dental care 
at an early age and they know that they will receive dental help for their missing permanent teeth. 
Conversely, oligodontia patients are concerned about their dental appearance and treatment 
complexity in comparison to their peers. This could be a consequence of becoming more aware about 
appearance during puberty at secondary school as older (≥13 years of age) oligodontia children had 
significantly lower (more negative) scores in comparison to the younger ones (11-12 years of age).   
  Our results are not in line with the studies of Wong et al. (2006) and Locker et al. (2010) whereby 
in both studies it was mentioned that most patients with congenitally missing teeth reported functional 
and psychosocial problems measured with the CPQ.3-4 Neither of the studies used a control group 
which may underlie the different conclusions.6 Kotecha et al. (2013), however, used a control group 
and concluded that, in contrast to our results, tooth agenesis had a significant psychosocial impact 
on the OHrQoL of children in comparison to the control group.5 As Kotecha et al. (2013) also used 
the non-condition specific CPQ, it is difficult to compare these results with our results. However, the 
overall differences between Kotecha et al. (2013) and our results can be declared because orthodontic 
treatment need for our control group is general high as the UMCG is a specialist center. Thus our controls 
are more comparable to oligodontia patients who are also in high need for orthodontic treatment while 
Kotechia et al. (2013) only included controls with low treatment need for orthodontic treatment and 
differences in scores between the hypodontia and control group will be more obvious.5 The latter is 
supported by the results of Laing et al. (2010), as he reported that tooth agenesis did not affect quality 
of life in comparison with a control group of orthodontic patients with a similar (high) treatment need.5-6
  In the Netherlands, children with oligodontia generally visit centres for special dental care at an 
early age. This approach may limit the potential negative effect on OHrQoL. Aesthetic and functional 
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concerns in children are tackled as much as possible and as soon as possible by prosthodontic treatments, 
e.g., by restoring deciduous teeth and/or microdontic permanent teeth, but definitive prosthodontic 
treatment starts after growth has finished. Moreover, extra attention is given during the visits to oral 
self-care to preserve the deciduous teeth and thus prevent the presence of diastemas. Importantly, the 
Dutch national health insurance scheme pays for the dental treatment of oligodontia patients which 
makes dental treatment of oligodontia available to all inhabitants. The impact of oligodontia on OHrQoL 
is probably greater in countries were dental treatment of oligodontia is not reimbursed.     
  The translated ChildQoLDAT was used for this study.13,14 A disadvantage of this questionnaire is the 
negative formulation of almost all the items. For example, “I don’t smile for photographs because of the 
way my teeth are”. This could make children more aware of problems which they had not been aware of 
before. The questionnaire was developed for children between the ages of 11-18 years and this restricts 
its use in long-term prospective studies. Furthermore, it has to be mentioned that the overall sample 
size of the study was relatively small and results have to be interpreted with caution. The small sample 
size is a consequence of the low prevalence of oligodontia.  
Conclusions
The impact of oligodontia on OHrQoL in 11-17 year old children is limited and mainly concerns dental 
appearance and the complexity of the treatment. Dentists should take the dental appearance in children 
diagnosed with oligodontia into consideration.
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Abstract 
Background
The effect of fixed prosthodontics on patients with several agenetic teeth is not well understood.  
Purpose 
To assess the effect of implant-based fixed prosthodontics on oral health-related quality of life (OHrQoL), 
general health status, and satisfaction regarding dental appearance, ability to chew and speech in 
hypodontia patients.
Materials and methods
For this prospective cohort study, all patients (≥18 years) with several agenetic teeth who were 
scheduled for treatment with implant-based fixed prosthodontics between September 2013 and July 
2015 at our department were approached. Participants received a set of questionnaires before and 
one year after implant placement to assess OHrQoL (OHIP-NL49), general health status (SF-36) and 
satisfaction regarding dental appearance, ability to chew and speech. 
Results
Twenty-five out of 31 eligible patients (10 male, 15 female; median age: 20 [19; 23] years; agenetic teeth: 
7 [5;10]) were willing to participate. Pre- and post-treatment OHIP-NL49 sum-scores were 38 [28;56] 
and 17 [7;29], respectively (p<.001). Scores of all OHIP-NL49 subdomains decreased too, representing 
an improved OHrQoL (p<.05) as well as that satisfaction regarding dental appearance, ability to chew 
and speech increased (p<.001). General health status did not change with implant treatment (p>.05).
Conclusions
Treatment with implant-based fixed prosthodontics improves OHrQoL and satisfaction with dental 
appearance, ability to chew and speech, whilst not affecting general health status.
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Introduction 
Hypodontia is a condition in which one or more teeth are absent because they failed to develop. In 
Europe, the prevalence of agenesis of a tooth is 5.5%, while the prevalence of congenital absence of 
six or more teeth (excluding the third molars) in Caucasian populations in North America, Australia, 
and Europe is estimated at 0.14%.1 Tooth agenesis can be the result of environmental and/or genetic 
factors and can occur as an isolated anomaly or as a feature of a large variety of syndromes (for 
example, ectodermal dysplasia).2,3 The aetiology of tooth agenesis is complex: more than 200 genes are 
responsible for tooth development.4  
  Hypodontia is usually noticed between 6-12 years of age when deciduous teeth fail to shed or 
permanent teeth do not emerge. As a result, a variety of problems can become evident such as problems 
with dental appearance, chewing and speech. Hypodontia also affects the oral health-related quality of 
life (OHrQoL) negatively, as measured with the Child Perceptions Questionnaire (CPQ) in children,5,6 and 
the Oral Health Impact Profile (OHIP-49) in young adults.7,8  
  A wide range of prosthetic treatment options are available to improve function and dental 
appearance in hypodontia patients, of which fixed prosthodontics on dental implants is currently 
the preferred treatment.9,10 However, the effect of such treatment on patients with ≥4 agenetic 
teeth (third molars excluded) is not well understood as it has only been assessed in patients with 
≥1 agenetic teeth.11-14 Therefore, the aim of this prospective study was to assess whether treatment 
with implant-based fixed prosthodontics has a beneficial effect on OHrQoL, general health status, and 
satisfaction regarding dental appearance, ability to chew and speech in comparison to the pre-implant 
treatment phase in patients with several agenetic teeth (≥4; third molars excluded). 
Materials and methods
Patient selection
Between September 2013 and July 2015 all patients (≥18 years of age) with ≥4 agenetic teeth (third 
molars excluded) who were scheduled for treatment with implant-based fixed prosthodontics at the 
department of Oral and Maxillofacial Surgery, University Medical Center Groningen (The Netherlands), 
were approached. Informed consent was obtained and the patients received a set of questionnaires 
two months before implant placement. A second set of questionnaires was sent one year after implant 
placement. The Groningen medical ethical committee was approached for permission, but an exemption 
was granted due to the non-invasive nature of this study (M13.147701). 
Treatment schedule
The routine treatment schedule of hypodontia patients comprised of pre-implant, surgical and 
prosthodontic procedures. 
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1. Pre-implant treatment
Orthodontic pre-implant treatment was performed in all our included patients. Such treatment was 
needed as the interdental diastema are usually too small or too large and the roots are too angulated 
to allow for implant placement at the preferred positions from a prosthodontic perspective. When 
needed, the orthodontics were combined with orthognathic surgery prior to implant placement.
2. Surgical procedure
All surgical procedures (two-stage) for implant placement were performed under general anaesthesia. 
Implants of Nobel Biocare and Biomet 3i were placed according to the manufacturer’s protocol. Bone 
augmentation, if and when required, was performed simultaneously with the implant placement, 
unless the patient needs extensive bone augmentation and adequate primary stability of the implant 
could not be ensured. In that case, augmentation surgery was performed prior to implant placement, 
and the implants were placed four months after augmentation. A surgical guide was always used when 
placing the implants. After an osseointegration period of three months, the implants were uncovered.
3. Prosthetic procedure and aftercare
Two weeks after uncovering the implants, surgical aftercare was performed and impressions of the 
implants were made. The implant-based suprastructures were placed three weeks later. Thereafter, 
orthodontic treatment was finalised when applicable (Table 1). Routine prosthetic aftercare was 
performed one week, six months, one year and thereafter every two years after suprastructure 
placement. The number of single crowns and bridges were scored for the included patients. 
Questionnaires
The following set of questionnaires had to be completed two months before and one year after implant 
treatment: 
1. Oral Health Impact Profile (OHIP-49)
The OHIP-49 is a reliable and valid instrument to measure the social impact of oral disorders.15 The 
Dutch version of the OHIP-49 (Dutch OHIP-NL49) was used to measure the OHrQoL.16 The questionnaire 
consists of 49 questions and is subdivided into seven subdomains (1, functional limitation; 2, physical 
pain; 3, psychological discomfort; 4, physical disability; 5, psychological disability; 6, social disability and 
7, handicap). With each question, the patients were asked how frequently they had experienced the 
impact of that item in the last month. Answers were given on a 5-point Likert-scale (0, never; 1, hardly 
ever; 2, occasionally; 3, fairly often and 4, very often). The total score per subdomain was calculated. 
Sum-scores range from 0-196 where a high score represents a low OHrQoL.  
2. Health Survey (SF-36)
The Dutch 36-Item Short Form Healthy Survey (SF-36) is a validated questionnaire with items about a 
patients’ general health status.17 The SF-36 consists of 36 items of which 35 items are subdivided into 
eight health concepts (1, physical functioning; 2, bodily pain; 3, role limitations due to physical health 
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problems; 4, role limitations due to personal or emotional problems; 5, emotional well-being; 6, social 
functioning; 7, energy/fatigue; and 8, general health perceptions). The other single item addresses 
changes in health condition. Answer options differ per item but all questions were scored on a 0 to 100 
range. Items in the same scale were averaged to create the eight scale scores. The lower the score, the 
more the disability.  
3. Satisfaction questionnaire 
Patients’ satisfaction was assessed with a custom-made questionnaire as there are no disease-specific 
questionnaires available for measuring satisfaction in hypodontia patients. All questions had to be 
completed on a 10-point scale (score 1 = extremely negative; score 10 = extremely positive). Both the pre- 
and post-treatment questionnaires assessed how satisfied patients were about their dental appearance, 
their ability to chew and speech. In addition, the pre-implant treatment questionnaire contained 
questions about what patients’ expected from the effect of the implant-based fixed prosthodontics on 
their dental appearance, ability to chew and speech. The post-treatment questionnaire, on the other 
hand, contained one additional question to score whether the implant treatment had satisfied their 
expectations. The higher the score, the more the satisfied. 
Statistics
Pre-implant treatment scores were compared with the post-treatment scores. The Shapiro-Wilk test was 
used to test the normality of the data (p=.05). The paired T-test was used on the normally distributed 
data. When the data were not normally distributed, the Wilcoxon signed rank test was applied to test 
for statistical significance differences (IBM SPSS Statistics 23). The effect size (r) was calculated for the 




Of the 31 eligible patients, three patients did not return the questionnaire because they were not 
willing to complete the questionnaire. Another three patients were not willing to complete the one 
year evaluation. The baseline demographics of the six non-responders did not differ from those of the 
25 included patients (Table 1). In these 25 patients, 148 implants were placed and 127 full ceramic 
suprastructures were made: single crowns (n=109), single crowns with cantilever (n=7), multi-unit 
bridge (n=8) and multi-unit bridge with cantilever (n=3). All suprastructures were screw-retained. 
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Table 1. Participants characteristics.
Participants Non-responders
Number of patients                                                                           25 6
Gender (male; female) 10;15 1;5
Median age at implant placement [IQR] 20.0 [19.0;23.0] 21.5 [19.3;28.3]
General health (number of patients) 
   Ectodermal dysplasia                                                                                  
   Cleft                                                                                                                
   Congenital heart disease                                                                            
   Psoriasis                                                                                                         
   Asthma          













Number of patients with smoking habits           
  Non smokers                                                                                                  
  Smokers                                                                                                         







Median number of agenetic teeth (third molars excluded) [IQR]        7 [5;10] 7 [7;8]
Number of patients with pre-implant orthodontic treatment  
Number of patients whose orthodontic treatment was completed 





Number of patients with pre-implant osteotomy                                    4 1
Total number of placed implants                                                                
Number lost implants <1 year after placement                                        
Median number of placed implants per patient [IQR]
148





Number of Nobel Biocare implants







The median (IQR) pre- and post-treatment OHIP-NL49 sum-scores were 38 [28;56] and 17 [7;29], 
respectively (Wilcoxon signed rank test, p<.001). The scores of all the subdomains decreased significantly 
after implant treatment, representing an improved OHrQoL after implant treatment (Wilcoxon signed 
rank test, p<.05; Table 2). The effect sizes (r) were medium to large. 
2. SF-36
The scores of the eight health concepts, perceived-change-in-health-question and the total SF-36 did 
not differ significantly between the pre- and post-treatment questionnaires. Thus, no effect of implant 
treatment on general health status was observed (Wilcoxon signed rank test, p>.05; Table 3). The data 
indicate that the effects of the implant-treatment are notably limited to the oral component. 
3. Satisfaction-questionnaire 
The post-treatment scores increased significantly in comparison to the pre-implant treatment scores, 
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hence the patients’ satisfaction regarding their dental appearance, chewing and speech ability improved 
after treatment (Wilcoxon signed rank test, p<.001; Table 4). The effect sizes were large. 
  The patients had high pre-operative expectations regarding the result of the treatment that they 
were facing, viz. the median expectation scores for the dental appearance, ability to chew and ability 
to speak were 9 [8;9], 9 [8;9] and 9 [8;9], respectively. The actual post-treatment scores indicated that 
these expectations were met (Table 4). Moreover, the patients scored highly on the question ‘To what 
extent did your expectations regarding the treatment manifest themselves?’ (8 [7;9]). 
Table 2. Oral health-related quality of life (OHrQoL), OHIP-NL49 (median [IQR]).
Pre-treatment One year post-treatment p-value (95%CI) Effect size (r)
Functional limitation (max. score 36) 8 [7;13] 5 [3;7] <0.001 -0.48
Physical pain (max. score 36) 9 [6;14] 5 [2;8] <0.001 -0.49
Psychological discomfort (max. score 20) 7 [5;11] 2 [0;5] <0.001 -0.48
Physical disability (max. score 36) 6 [4;11] 3 [0;5] 0.002 -0.44
Psychological disability (max. score 24) 3 [1;6] 0 [0;3] 0.036 -0.30
Social disability (max. score 20) 1 [0;4] 0 [0;2] 0.036 -0.30
Handicap (max. score 24) 2 [0;4] 0 [0;1] 0.027 -0.31
Sum-score (max. score 196) 38 [28;56] 17 [7;29] <0.001 -0.48
Table 3. Health Survey, SF-36 (median [IQR]). 
Pre-treatment One year post-treatment p-value (95%CI)
Physical functioning 100 [93;100] 100 [93;100] 0.843
Role limitations due to physical health problems 100 [100;100] 100 [100;100] 0.443
Role limitation due to personal or emotional problems 100 [67;100] 100 [100;100] 0.572
Energy/fatigue 70 [60;80] 65 [60;78] 0.603
Emotional well-being 84 [66;86] 84 [68;86] 0.987
Social functioning 100 [81;100] 100 [75;100] 0.750
Bodily pain 80 [69;95] 90 [84;100] 0.500
General health perceptions 75 [70;90] 80 [65;88] 0.848
Perceived change in health 50.0 [50;63] 50 [50;75] 0.593
Sum-SF36-score 757 [682;793] 754 [651;801] 0.957
Table 4. Satisfaction questionnaire (median [IQR]). 
Pre-treatment One year post-treatment P-value (95%CI) Effect size (r)
Opinion about the appearance of the dentition 6 [5;8] 8 [8;9] <0.001 -0.58
Ability to chew     7 [7;8] 9 [8;10] <0.001 -0.52
Ability to speak                                                                            8 [7;9] 10 [8;10] <0.001 -0.50
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Discussion
This study examined the effect of treatment with implant-based fixed prosthodontics on OHrQoL, 
general health status, and satisfaction with regard to dental appearance, ability to chew and speech in 
patients with several agenetic teeth (≥4; third molars excluded). It was shown that implant treatment 
had a beneficial effect on OHrQoL and patient satisfaction with regard to dental appearance, ability 
to chew and speech, while no effect of this treatment on the perceived general health status was 
observed. 
  As was to be expected, pre-implant treatment OHIP scores were higher for all subdomains 
compared to the scores reported in the literature for healthy university students with a mean age of 
21.2 years.19 The pre-implant treatment OHIP score will be negatively influenced by the oral discomfort 
as a consequence of an incomplete dentition. Our pre-implant treatment OHIP scores may have been 
possibly negatively influenced further by the discomfort the patients experienced as a result of the 
pre-implant treatment; the questionnaire was completed shortly before implant placement (e.g., 
orthodontic treatment). However, as the OHIP-49 score reported for patients with ≥1 agenetic teeth 
(33.5 [24.6;6.0]), who did not receive any treatment at the moment of completing the OHIP-49, was 
comparable to the OHIP score of our hypodontia patients (≥4 agenetic teeth, third molars excluded), we 
presume that the effect of the pre-implant treatment on the OHrQoL was minor and the OHrQoL was 
mainly influenced by the discomfort of having hypodontia.7   
  Our patients’ post-treatment OHIP-49 scores were generally comparable to those reported for 
healthy patients,19 and to the post-treatment OHIP-scores for patients with ≥1 agenetic teeth (after 
implant-based and tooth-supported fixed prosthodontics).11,12 The exception is the Functional Limitation 
subdomain, which was more limited for both our patients as for the patients with ≥1 agenetic teeth in 
comparison to healthy patients.11,12,19 The remarkable thing about the post-treatment OHIP-question 
‘Have you had food catching in your teeth or dentures?’, which belongs to the subdomain Functional 
Limitation, is that 22 of the 25 patients gave a ≥1 score to this question. This might serve as a potential 
explanation for the higher score of the subdomain Functional Limitation since food gets caught around 
implants more often in hypodontia because it is difficult to create ideal tissue morphology in areas 
where the bone quantity is limited.  
  The SF-36 scores did not show any significant differences between the general health status 
before and after treatment with implant-based fixed prosthodontics as well as that the scores of our 
hypodontia patients were comparable to the SF-scores in healthy patients.19 This is in line with our 
expectations as we presumed that hypodontia will not have a great impact on general health status, 
but this was never shown before. Moreover, Allen et al. (1999) indicated that the OHIP-49 is of greater 
use for measuring outcomes of oral disorders than generic measures such as SF-36.20 This was also our 
reason to apply both the SF-36 and OHIP-49 in our study. Thus, based on the results of this study, in 
patients with several agenetic teeth the OHrQoL is influenced by this disorder, but without an impact 
on their general health. 
  A limitation of this study was that an applicable and validated satisfaction-questionnaire for 
hypodontia patients was not available; we had to devise one. The results of our survey revealed that 
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satisfaction regarding dental appearance, ability to chew and speech one year after implant placement 
was very high. These results are in line with the results of Dueled et al. (2009) which reported that 98% 
of the patients with ≥1 agenetic teeth treated with implant-based fixed prosthodontics were satisfied to 
very satisfied.11 It cannot be excluded, however, that the high satisfaction of our patients when having 
received their implant-based fixed prosthodontics is, at least to some extent, due to the fact that the 
patients got rid of the wear temporary solutions and/or orthodontic appliances they had to wear in the 
period before the placement of the implants. 
Conclusion
Implant treatment with implant-based fixed prosthodontics in patients with several agenetic teeth 
results in an improved OHrQoL and satisfaction regarding dental appearance, ability to chew and 
speech. 
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Chapter 6
Dental implants with fixed prosthodontics 
in oligodontia: A retrospective cohort study 
with a follow-up of up to 25 years
This chapter is an edited version of the manuscript:
Filius MAP, Vissink A, Cune MS, Koopmans PC, Raghoebar GM, Visser A. 
Dental implants with fixed prosthodontics in oligodontia: 
A retrospective cohort study with a follow-up of up to 25 years.
 Journal of Prosthetic Dentistry 2018, in press.
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Abstract 
Purpose
The purpose of this retrospective clinical study was to assess which factors determine a long-term 
implant survival and treatment outcome of up to 25 years in a cohort of patients with oligodontia.
Materials and methods
The medical records of all patients with oligodontia treated with implant-based fixed prosthodontics 
between January 1991 and December 2015 in the department of Oral and Maxillofacial Surgery at 
the University Medical Center Groningen (UMCG), the Netherlands were assessed. Specifically, this 
involved the retrieval of records on the need for and mode of bone augmentation, implant survival, 
and survival of and adverse events associated with the prosthodontics. The Kaplan Meier estimator 
was used to analyze implant and suprastructure survival. Log Rank tests were applied to compare the 
survival of subgroups.
Results 
A total of 126 patients with oligodontia were treated with dental implants. Of 777 implants in total, 
56 were lost, resulting in a 5-year cumulative survival of 95.7% (95%CI 94.2-97.2%) and a 10-year 
cumulative survival of 89.2% (95%CI 86.2-92.2%). The survival of implants placed in regions where bone 
augmentation surgery had been applied was significantly lower. The 5-year cumulative suprastructure 
survival was 90.5% (95%CI 87.6-93.5%), and the 10-year cumulative suprastructure survival was 
80.3% (95%CI 75.3-85.3%). The performance of the screw-retained and cemented suprastructures 
was comparable, but the survival of single crowns was significantly higher than the survival of bridges 
(p<.001).
Conclusions
Implant treatment is a predictable treatment option for patients with oligodontia with a favourable 
long-term outcome. Survival of implants in augmented areas is lower.
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Introduction
Oligodontia is defined as the congenital absence of six or more permanent teeth, excluding third 
molars.1 The prevalence of oligodontia in the Caucasian populations of North America, Australia, and 
Europe is estimated to be 0.14%.2 Tooth agenesis can be the result of environmental and/or genetic 
factors and can occur as an isolated anomaly or as a feature of a large variety of syndromes (for 
example, ectodermal dysplasia).3,4 The aetiology of tooth agenesis is complex: more than 200 genes 
are responsible for tooth development.5 Patients with oligodontia commonly suffer from functional and 
aesthetic problems resulting from the high number of missing teeth. Such patients usually need rather 
complex oral rehabilitation.6 
  Several treatment options are available for patients with congenitally missing teeth. The least 
invasive are the retention of deciduous teeth, autotransplantation, and orthodontic space closure. 
Retaining numerous deciduous teeth not only presents aesthetic concerns but often does not have 
a predictable long-term outcome due to root resorption, secondary retention, and caries.7 The 
orthodontic closure of a diastema or autotransplantation are only feasible when a limited number of 
teeth are missing, which is not the case in oligodontia. Moreover, orthodontic treatment in patients 
with oligodontia can be time consuming and complex.8 In addition, tooth-supported crowns or bridges 
may not be feasible due to the unfavourable distribution of the available teeth, and the unfavourable 
shape (microdontia or taurodontia) may also preclude conventional restoration.6 Oral rehabilitation 
using implant-retained fixed or removable prostheses is the treatment of choice for most patients with 
oligodontia, while removable prostheses (with or without implant retention) are generally only indicated 
when fixed prosthodontics are not an option, for example, in patients missing all teeth (anodontia).9-11
  Dental implant treatment (often in combination with orthodontic treatment) is therefore the 
most favourable treatment option for patients with oligodontia.6,12 Favourable implant survival has 
been reported for fixed and removable implant prosthodontics in patients with oligodontia, although 
these studies only report short-term implant survival rates.12-23 The authors are unaware of published 
long-term (≥10 years) implant and prosthodontic survival rates in larger series of patients or on the 
effect of bone augmentation on treatment outcome.6 Bone augmentation is of great significance as 
it is often required in patients with oligodontia due to the underdevelopment of the alveolar bone in 
the area with the congenitally missing teeth. The frequent need for bone augmentation may influence 
implant survival, and bone quality may differ in patients affected by oligodontia. Therefore, the purpose 
of this study was to assess which factors are associated with long-term implant survival and treatment 
outcome in a large cohort of patients with oligodontia. The records of these patients were analyzed for 
a period of up to 25 years regarding factors such as implant position, suprastructure type, need for bone 
augmentation, and age at implant placement. It was presumed that implant survival in augmented 
areas was lower.  
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Materials and methods
Since the early 1990s, patients with oligodontia requiring implant-based fixed prosthodontics at the 
department of Oral and Maxillofacial Surgery at the University Medical Center Groningen (UMCG), the 
Netherlands, have been routinely treated according to a standardized protocol with Nobel Biocare or 
3i Biomet implants. Treatment options and patients’ treatment willingness were always discussed prior 
to treatment. In the Netherlands, no relevant financial constraint exists because dental treatment of 
patients with oligodontia has been covered by the national health insurance scheme. Thus, all patients 
who needed implant treatment and who had no medical and/or mental contraindications, have been 
eligible for this treatment. At the UMCG, these patients were treated by a multidisciplinary team, which 
included an experienced surgeon, a restorative dentist, an orthodontist, and a dental technician.
  Bone augmentation, if and when required, was performed simultaneously with the implant 
placement, unless the patient needed extensive bone augmentation and primary stability of the implant 
could not be ensured. In that situation, augmentation surgery was performed before implant placement, 
and the implants were placed four months after augmentation. Bone was harvested intraorally in the 
retromolar and/or tuberosity areas or, if a large volume of bone was required, from the posterior iliac 
crest. A surgical guide was always used in placing the implants. When the deciduous teeth were still in 
situ, implants were immediately placed after tooth extraction when primary stability could be ensured 
and favourable mucosal conditions were present. Antibiotics (amoxicillin) were started before surgery 
and continued for one week. Post-operative treatment consisted of chlorhexidine 0.2% mouth rinse for 
two weeks and analgesics (acetaminophen) when needed. Three months after placement, the implants 
were uncovered and implant-based fixed suprastructures provided (single crowns or bridges). Initially, 
these were metal-ceramic, but more recently, complete ceramic restorations were provided for better 
aesthetics. 
  Patients were eligible for inclusion in this study if they had been treated with implant-based fixed 
prosthodontics at the UMCG between January 1991 and December 2015. Patients had to be diagnosed 
with oligodontia, which is defined as the congenital absence of six or more permanent teeth, excluding 
third molars. Exclusion criteria were the presence of systemic disease and a history of head and neck 
radiotherapy. 
  The medical records of all eligible patients were assessed. Patient characteristics, such as age, 
sex, general health, and the number of missing teeth, were scored and potential confounding factors 
(bruxism, diabetes mellitus, and smoking behaviour) were identified.
  With regard to surgical treatment, the need for and method of bone augmentation and implant 
loss were noted. Information on the type of prosthodontic rehabilitation and adverse technical 
events accompanying the prosthodontics were noted too. Because this study involved a retrospective 
evaluation of routine dental care, the medical ethical committee of the University Medical Center 
granted ethical exemption (M16.188270).
Implant survival and follow-up period were defined as the period between implant placement and 
the last follow-up or loss of the implant. Reasons for the loss of implants were recorded and included 
lack of initial osseointegration, peri-implantitis, and fracture of the implant. Peri-implant mucositis 
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was defined as bleeding upon probing, with or without suppuration and <2mm radiographic bone 
loss. Peri-implantitis was defined as bleeding upon probing with or without suppuration and ≥2mm 
radiographic bone loss.24,25 
  Suprastructure survival and the corresponding follow-up period were defined as the period 
between definitive suprastructure placement and the end of follow-up or loss of the suprastructure. 
The data reported in the present study concerned the survival and technical complications of definitive 
restorations made in the UMCG. A suprastructure was defined as lost when replacement was considered 
for the following reasons: fracture of porcelain, required improvement of the fit of the suprastructure 
or required replacement with a different kind of suprastructure (due to loss of an neighbouring implant 
or teeth), or replacement for aesthetic reasons. Reversible adverse events of the suprastructure, that is, 
events that did not result in replacement of the suprastructure, were also recorded using the following 
parameters: chipping/porcelain fracture, loose screws, cement failure, loss or discoloration of screw 
access restoration, and broken screws.
  Implant and suprastructure survival were analyzed at the implant level using Kaplan Meier analyses. 
The 5- and 10-year cumulative survival scores were calculated with 95% confidence intervals (95%CI) 
with statistical software (IBM SPSS Statistics v22; IBM Corp). Subgroup analyses were performed for 
sex (male;female), number of missing teeth (<10 versus ≥10), age at implant placement (as continuous 
and categorial variable), general health (including ectodermal dysplasia), implant brand, implant 
location (maxilla versus mandible; anterior versus distal to canine region), augmentation of implant site, 
source of bone needed for bone augmentation (intraoral versus extraoral), type of implant placement 
(immediate versus delayed) and type of suprastructure (crown or bridge). The survival of subgroups 
was compared using the Log Rank test. Censored and non-censored data were plotted against time to 
evaluate the assumption that censored and non-censored data arose from the same distribution. The 
distributions across the subgroups were also evaluated for similarity. In order to estimate hazard ratios, 
a marginal Cox model was applied using software (SAS 9.4; SAS Institute Inc) to account for correlated 
data in patients with multiple implants. The proportionality assumption was examined by graphical 
checks or by applying supremum tests using the Assess statement in Proc PHREG in SAS.26 An implant 
and suprastructure was lost once it was removed permanently from the mouth. Replaced implant(s) or 
suprastructure(s) were excluded for further (survival) analyses. Results were expressed as hazard ratios 
with 95% confidence intervals. The variables were examined in the univariate and multivariate analyses. 
A two-sided p-value <5% was considered significant. 
Results
A total of 126 patients with oligodontia were included (Table 1). No patient was excluded because 
of systemic disease or a history of radiotherapy in the head/neck region. The influence of potential 
confounding factors (bruxism, diabetes mellitus, smoking behavior) was limited. Therefore, no 
confounding analyses were performed. The plot of censored and non-censored data against time 
showed no particular patterns, so the assumption that censored and non-censored data arose from the 
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same distribution was not violated. This also held for the various subgroups.
  Median follow-up of the 777 implants was 6 [2;10] years (range 0-25 years). Of a total of 777 
placed implants, 56 were lost. This resulted in a 5-year cumulative survival of 95.7% (95%CI 94.2-97.2%) 
and a 10-year cumulative survival of 89.2% (95%CI 86.2-92.2%) (Table 2, Fig. 1). Subgroup analyses 
showed no statistical significant difference in survival between sexes (p=.554, Log Rank), number of 
missing teeth (<10 versus ≥10) (p=.477, Log Rank), presence of ectodermal dysplasia (p=.362, Log Rank), 
implant brand (p=.725, Log Rank), implant location (anterior versus distal to canine region) (p=.101, Log 
Rank), source of bone needed for bone augmentation (intraoral versus extraoral bone) (p=.925, Log 
Rank), and type of implant placement (immediate versus delayed) (p=.964, Log Rank).
  The need for bone augmentation was significantly associated with implant survival (Fig. 2; hazard 
ratio 5.30, 95%CI=1.99-14.16; p<.001), while a higher age at implant placement was associated with 
more implant failure (Fig. 3; mean hazard ratio 1.80, 95%CI=1.25-2.59 per 10 years; p=.002). Location 
(maxilla versus mandible) did not affect implant survival as the average hazard ratio from the Cox 
regression analyses was not significant (p=.126). Because the proportionality assumption was not met, a 
stratified multivariate analysis on location was performed. Augmentation and age at implant placement, 
influenced implant survival independently of each other with hazard ratios of 4.75 (95%CI=1.74-12.97) 
for augmentation (p=.002) and 1.70 (95%CI=1.29-2.23) per each additional 10 years of age at which the 
implant was placed (p<.001). 
  Of the 721 implants still in situ, peri-implant adverse events were reported for 160. The most 
common adverse events were peri-implantitis, peri-implant mucositis, and/or gingiva recession. 
  Definitive suprastructure evaluation was not possible for 96 of the 777 implants because 
the definitive restorations were made by dentists outside the UMCG (n=11) and definitive fixed 
prosthodontics was not provided because of early loss of implant(s) (n=25), recent placement of 
implants (n=59), or unfavourable implant placement (n=1). All the patients had multiple implants 
and therefore a patient could have 1 or more suprastructure-related adverse events (2 patients had 2 
different events). Suprastructures made to replace a failed implant were not analyzed. Consequently, 
a total of 578 definitive suprastructures supported by 681 implants (n=113 patients, Table 3) were 
available for evaluation. Median follow-up of the 578 suprastructures was 3 [1;8] years (range 0-25 
years). The 5-year cumulative suprastructure survival was 90.5% (95%CI 87.6-93.5%), and the 10-year 
cumulative suprastructure survival was 80.3% (95%CI 75.3-85.3%). Screw-retained and cemented 
suprastructures performed similarly, but survival was significantly higher for single crowns than for 
bridges (Fig. 4). The reasons for replacing definitive suprastructures and reversible adverse events are 
given in Table 3. 
  Of all the implants attached to a definitive suprastructure (n=681, 113 patients), 31 implants were 
lost. Of these lost implants, 6 supported a cantilever bridge on 2 or more implants, 12 were provided 
with a single crown, 6 incorporated a bridge on 2 implants, and 7 involved a bridge on more than 2 
implants. Implant survival was significantly higher for implants provided with single crowns than for 
implants with bridges (Fig. 5; p=.003, Log Rank; hazard ratio 2.88 (95%CI=1.06-7.83), p=.038). 
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Table 1. Patient characteristics and dental implant information.
PATIENTS
Total                                                                                                                                                126
Median age at implant placement in years (IQR)                                                                            21 [19;27]
Current median age in years (IQR)                                                                                                  31 [25;37]
Sex (male/female) (%)                                                                                                   44 (35%)/ 82 (65%)
Number of patients diagnosed with ectodermal dysplasia (%)                                                       10 (7.9%)
Number of patients with bruxism                                                                                                    1 (0.8%)
Number of smokers                                                                                                                         15 (11.9%)
Median number of missing teeth  (IQR)                                                                                       10 [7;12]
Prevalence (mean %) of absent tooth types in sequence (n=126 patients):    
Third molar                                                                                                                                  
Mandibular second premolar                                                                                                       
Maxillary second premolar                                                                                                          
Maxillary lateral incisor                                                                                                              
Maxillary first premolar                                                                                                              
Mandibular second molar; mandibular central incisor                                                               
Maxillary second molar                                                                                                              
Maxillary cuspid                                                                                                                         
Mandibular first premolar                                                                                                           
Mandibular lateral incisor                                                                                                           
Maxillary first molar                                                                                                                   
Mandibular cuspid                                                                                                                      
Mandibular first molar                                                                                                               
















Total                                                                                                                                             777
Nobel Biocare     
Biomet 3i                                                                                                                                                                                                                                                              
515
262
Implants per tooth  region (%)
Right maxillary central incisor                                                                                                    
Right maxillary lateral incisor                                                                                                       
Right maxillary  cuspid                                                                                                                  
Right maxillary  first premolar                                                                                                      
Right maxillary second premolar                                                                                                    
Right maxillary  first molar                                                                                                            
Right maxillary second  molar                                                                                                         
Left maxillary central  incisor                                                                                                          
Left maxillary lateral incisor                                                                                                            
Left maxillary  canine                                                                                                                       
Left maxillary first premolar                                                                                                           
Left maxillary second premolar                                                                                                       
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Table 1. (continued)
Left maxillary second molar                                                                                                             
Left mandibular central incisor                                                                                                       
Left mandibular lateral incisor                                                                                                           
Left mandibular  canine                                                                                                                      
Left mandibular  first premolar                                                                                                         
Left mandibular second premolar                                                                                                       
Left mandibular  first molar                                                                                                                
Left mandibular second  molar                                                                                                           
Right mandibular central incisor                                                                                                         
Right mandibular lateral incisor                                                                                                            
Right mandibular  canine                                                                                                                     
Right mandibular  first premolar                                                                                                            
Right mandibular second premolar                                                                                                        
Right mandibular  first molar                                                                                                                   
















Number of implants requiring bone augmentation (%)                                                      484 (62%)
only intraoral bone                                                                                                                  
(intra- and) extraoral bone                                                                                                     
242 (50%)
242 (50%)  
Number of implants placed directly after extraction of the deciduous teeth (%)                64 (8%)
Table 2. Information about lost and surviving implants.
PLACED IMPLANTS
Total                                                                                                                                      777
LOST IMPLANTS
Total, of which:         56     
In the maxilla (%)                              
In the mandible (%)
40 (71%)        
16 (29%)                                                                                                         
Reasons for failure (n)
Lack of osseointegration/mobility                                                                                      
Peri-implantitis                                                                                                                   
Placed too close to mandibular nerve                                                                                  
Unknown
29    
23      
1                                                                                                                      
3
Number of lost implants <1 year after placement                                                                27 (48%) in 21 patients
Number of re-implantation after loss (n)
Re-implanted                                                                                                                     
Planned re-implantations                                                                                                    
No need for re-implantation                                                                                             
22 (of which 21 are still in situ)
6
28
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Table 3. Suprastructure information.
DEFINITIVE SUPRASTRUCTURES 
                                                                                                                                  Placed (S/C)                 Lost (S/C)
Total, of which:                                                                                                      578    (68%/32%)        70 (50%/50%)
Single crowns                                                                                                      
Single implant cantilever bridge                                                                            
Implant-based cantilever bridge on 2 or more implants    
Implant-based bridge on 2 implants  
Implant-based bridge on more than 2 implants        
Tooth-implant-based bridge                                                                                                                                          
482    (68%/32%)        
31      (58%/42%)   
32      (81%/19%)      
20      (65%/35%)          
11      (64%/36%)   







REASON FOR REPLACING DEFINITVE SUPRASTRUCTURES (total=70)
Fracture of suprastructure  porcelain                                                              
Loss of (one of) suprastructure  implant(s)                                                    
Replacement because of change in suprastructure  type   
due to loss of neighbouring  implant                
Replacement because of change in suprastructure  type    
due to loss of neighbouring tooth            
Replacement for aesthetic reasons       
Replacement to improve fit of suprastructure         








SUPRASTRUCTURE  RELATED REVERSIBLE ADVERSE EVENTS 
Total of all definitive suprastructures with one or more  noticeable suprastructure  
related reversible adverse events 
124 (22%)                                  
Percentage of most common noticed suprastructure  related                   
reversible adverse events in sequence:
Total is 100%
Chipping/ porcelain fracture                                                                             
Loose suprastructure  due to screw loosening                                                   
Loose cemented suprastructure  due to debonding                                           
Loss or discoloration of screw access restoration                                                
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Figure 1. Cumulative implant survival  (n=777) in 126 patients (Kaplan Meier). Cumulative survival after 5 years was 95.7% (95%CI 
94.2-97.2%) and after 10 years was 89.2% (95%CI 86.2-92.2%). CI, confidence interval.
Figure 2. Cumulative implant survival in situations with or without bone augmentation (Kaplan Meier). Log Rank test significant 
(p<.001) and proportionality assumption met. Implant survival is significantly lower in augmented regions (hazard ratio 5.30, 
95%CI=1.99-14.16, p<.001). CI, confidence interval.
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Figure 3. Cumulative implant survival of age at implant placement of different age groups (≤24 years (n=571); 25-34 years (n=120); 
≥35 years (n=86))(Kaplan Meier). Higher age at implant placement is associated with a higher chance on implant failure (p<.001, Log 
Rank; mean hazard ratio 1.80, 95%CI=1.25-2.59, per 10 years; p=.002). CI, confidence interval.
Figure 4. Cumulative suprastructure survival of single crowns versus bridges (Kaplan Meier). Survival is significantly higher for single 
crowns compared to bridges (p<.001, Log Rank; hazard ratio 2.28, 95%CI=1.15-4.51, p=.018). CI, confidence interval. 
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Figure 5. Cumulative implant survival in relation to suprastructure type (Kaplan Meier). Implant survival significantly higher for 
implants with single crowns than for bridges (p=.003, Log Rank; hazard ratio 2.88 (95%CI=1.06-7.83), p=.038). CI, confidence interval. 
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Discussion
This study assessed factors that determine long-term implant survival and treatment outcome in a cohort 
of patients with oligodontia. The results of this study show that implant-based fixed prosthodontics are 
a favourable treatment option for patients with oligodontia. This is reflective of the reasonable 5- and 
10-year survival of the implant and suprastructure and the fact that the outcome of the implant-based 
fixed prosthodontics was favourable. As presumed, implants placed in native bone were more likely to 
survive than implants placed in augmented bone. 
 The 10-year implant survival in oligodontia (89.2%) was lower than that reported for implants 
with fixed prosthodontics placed in non-compromised patients.27,28 However, this can be considered as 
reasonable for compromised bone and thus supports the use of implant-based fixed prosthodontics in 
patients with oligodontia. The main reasons for implant failure were comparable with those reported 
previously for non-compromised patients.27,28 Lower implant survival in oligodontia can be explained by 
the fact that bone augmentation is often needed because bone quantity is lacking. 
  Agenesis of permanent teeth is usually accompanied by vertical and horizontal alveolar bone 
atrophy and the absence of supporting bone.29 Therefore, bone augmentation is often needed to allow 
for reliable implant placement in patients with oligodontia.29 Augmented bone is, however, considered 
more susceptible to bone resorption than native bone, particularly when a vertical defect has to be 
reconstructed.30 When resorption of the augmented bone progresses, the implants placed in such 
regions are prone to develop peri-implantitis and subsequently to implant loss.30,31 In comparison with 
vertical defects, the outcome regarding bone loss after horizontal bone defect reconstruction is more 
favourable and more predictable.32,33 Unfortunately, vertical defects are more common in patients 
with oligodontia relative to non-compromised patients because in oligodontia a dental precursor to 
prevent vertical alveolar atrophy is lacking.29 This may underlie the less favourable implant survival rate 
in patients with oligodontia relative to non-compromised patients. In older patients, bone resorption 
had progressed. Thus, more implants needed to be placed in augmented bone, which may explain the 
higher implant failure rate for implants placed in older patients. Therefore, an implant should be placed 
soon after the loss of a deciduous tooth without a successor so that the implant can be placed in native 
bone.29 Unfortunately, no records were available as to when a patient lost a deciduous tooth. For this 
study, therefore, analyzing the factor ‘time since the loss of deciduous teeth’ was impossible.  
  Muddugangadhar et al. (2015) reported a meta-analysis of the cumulative survival of 
implant-supported fixed prosthodontics in non-compromised patients.34 They concluded that survival 
rate was higher for single crowns than bridge constructions, consistent with the results of the present 
study. This may be because single crowns are less loaded, unfavourable forces are avoided, and are 
easier to clean. The 5-year survival rates of fixed prosthodontics as reported by Muddugangadhar et 
al. (2015) were slightly higher than the 5-years results of the present study (Fig. 4).34 In addition, the 
long-term risk for suprastructure replacement in oligodontia due to loss of a neighbouring tooth or 
implant is probably higher in comparison with non-compromised patients. 
  For the 5-year and 10-year implant survival probabilities, Kaplan Meier estimates were used for 
the independent model in the present study. However, as the implants are nested within patients, the 
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standard errors and the confidence interval width would be underestimated.35 For events with high 
survival rates, the assumptions regarding dependency of events would have a small effect on the point 
estimate and the variance.35 In this study, the 5-year and 10-year survival probabilities were all >89%, 
except for 10-year cumulative suprastructure survival, which had a survival probability of 80%. Thus, the 
confidence interval of the 10-year suprastructure survival should be interpreted with caution.
  A major limitation of this study is its retrospective design. During the 25-year follow-up, a variety of 
innovations took place. For example, metal-ceramic suprastructures have been superseded by ceramic 
suprastructures. Unfortunately, determining the exact influence of these innovations on the results 
was not possible. As none of the patients with oligodontia who were treated with implant-based fixed 
prosthodontics were excluded for this study, attrition bias does not apply. Many variables were analyzed 
in this study and therefore potential capitalization on chance has to be considered.
Conclusions
Based on the findings of this retrospective study, the following conclusions were drawn:
1. Implant treatment is a predictable treatment option for oligodontia, both with respect to the   
 survival of the implants and the fixed prosthodontics;
2. Implants placed in augmented regions or in older patients have a poorer prognosis; 
3. With regard to prosthodontics, single crowns have a better prognosis than bridges. 
6Dental implants with fixed prosthodontics in oligodontia: A retrospective cohort study | 99 
with a follow-up of up to 25 years 
References
1. Schalk-Van der Weide Y, Beemer FA, Faber JA, Bosman F. 
Symptomatology of patients with oligodontia. J Oral Rehabil. 
1994; 21:247-261.
2. Polder BJ, Van’t Hof MA, Van der Linden FP, Kuijpers-Jagtman 
AM. A meta-analysis of the prevalence of dental agenesis of 
permanent teeth. Community Dent Oral Epidemiol. 2004; 
32:217-226.
3. Schalk-Van der Weide Y, Steen WH, Bosman F. Distribution 
of missing teeth and tooth morphology in patients with 
oligodontia. ASDC J Dent Child. 1992; 59:133-140.
4. Van den Boogaard MJ, Créton M, Bronkhorst Y, van der 
Hout A, Hennekam E, Lindhout D, et al. Mutations in WNT10A 
are present in more than half of isolated hypodontia cases. J 
Med Genet. 2012; 49;327-331.
5. De Coster PJ, Marks LA, Martens LC, Huysseune A. Dental 
agenesis: genetic and clinical perspectives. J Oral Pathol Med. 
2009; 38:1-17.
6. Filius MA, Cune MS, Raghoebar GM, Vissink A, Visser 
A. Prosthetic treatment outcome in patients with severe 
hypodontia: a systematic review. J Oral Rehabil. 2016; 
43:373-387.
7. Bjerklin K, Al-Najjar M, Kårestedt H, Andrén A. Agenesis of 
mandibular second premolars with retained primary molars: 
A longitudinal radiographic study of 99 subjects from 12 
years of age to adulthood. Eur J Orthod. 2008; 30:254-261.
8. Levander E, Malmgren O, Stenback K. Apical root 
resorption during orthodontic treatment of patients with 
multiple aplasia: a study of maxillary incisors. Eur J Orthod. 
1998; 20:427-434.
9. Filius MA, Vissink A, Raghoebar GM, Visser A. 
Implant-retained overdentures for young children with 
severe oligodontia: a series of four cases. J Oral Maxillofac 
Surg. 2014; 72:1684-1690. 
10. Alsayed HD, Alqahtani NM, Levon JA, Morton D. 
Prosthodontic rehabilitation of an ectodermal dysplasia 
patient with implant telescopic crown attachments. J 
Prosthodont. 2017; 26:622-627.
11. Kilic S, Altintas SH, Yilmaz Altintas N, Ozkaynak O, 
Bayram M, Kusgoz A, et al. Six-year survival of a mini dental 
implant-retained overdenture in a child with ectodermal 
dysplasia. J Prosthodont. 2017; 26:70-74.
12. Worsaae N, Jensen BN, Holm B, Holsko J. Treatment of 
severe hypodontia-oligodontia–an interdisciplinary concept. 
Int J Oral Maxillofac Surg. 2007; 36:473-480.
13. Durstberger G, Celar A, Watzek G. Implant-surgical and 
prosthetic rehabilitation of patients with multiple dental 
aplasia: a clinical report. Int J Oral Maxillofac Impl. 1999; 
14:417-423.
14. Kearns G, Sharma A, Perrott D, Schmidt B, Kaban L, 
Vargervik K. Placement of endosseous implants in children 
and adolescents with hereditary ectodermal dysplasia. Oral 
Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88:5-10.
15. Guckes AD, Scurria MS, King TS, McCarthy GR, Brahim JS. 
Prospective clinical trial of dental implants in persons with 
ectodermal dysplasia. J Prosthet Dent. 2002; 88:21-25.
16. Finnema KJ, Raghoebar GM, Meijer HJ, Vissink A. Oral 
rehabilitation with dental implants in oligodontia patients. Int 
J Prosthodont. 2005; 18:203-209. 
17. Sweeney IP, Ferguson JW, Heggie AA, Lucas JO. Treatment 
outcomes for adolescent ectodermal dysplasia patients 
treated with dental implants. Int J Paediatr Dent. 2005; 
15:241-248.
18. Becelli R, Morello R, Renzi G, Dominici C. Treatment of 
oligodontia with endo-osseous fixtures: experience in eight 
consecutive patients at the end of dental growth. J Craniofac 
Surg. 2007; 18:1327-1330. 
100 | Chapter 6
19. Garagiola U, Maiorana C, Ghiglione V, Marzo G, Santoro 
F, Szabo G. Osseointegration and guided bone regeneration 
in ectodermal dysplasia patients. J Craniofac Surg. 2007; 
18:1296-1304.
20. Créton M, Cune M, Verhoeven W, Muradin M, Wismeijer 
D, Meijer G. Implant treatment in patients with severe 
hypodontia: a retrospective evaluation. J Oral Maxillofac 
Surg. 2010; 68:530-538.
21. Grecchi F, Zingari F, Bianco R, Zollino I, Casadio C, Carinci 
F. Implant rehabilitation in grafted and native bone in patients 
affected by ectodermal dysplasia: evaluation of 78 implants 
inserted in 8 patients. Implant Dent. 2010; 19:400-408.
22. Heuberer S, Dvorak G, Zauza K, Watzek G. The use of 
onplants and implants in children with severe oligodontia: 
a retrospective evaluation. Clin Oral Implant Res. 2012; 
23:827-831.
23. Zou D, Wu Y, Wang XD, Huang W, Zhang Z, Zhang Z. A 
retrospective 3- to 5-year study of the reconstruction of oral 
function using implant-supported prostheses in patients with 
hypohidrotic ectodermal dysplasia. J Oral Implantol. 2014; 
40:571-580.
24. Lang NP, Berglundh T. Working Group 4 of Seventh 
European workshop on periodontology. Periimplant diseases: 
where are we now? Consensus of the Seventh European 
Workshop on Periodontology. J Clin Periodontol. 2011; 38 
Suppl11:178-181. 
25. Sanz M, Chapple IL. Clinical research on peri-implant 
diseases: consensus report of Working Group 4. J Clin 
Periodontol. 2012; 39 Suppl12:202-206.
26. Lin BY, Wei LJ, Ying Z. Checking the Cox model with 
cumulative sums of martingale-based residuals. Biometrika. 
1993; 80:557-572. 
27. Jung RE, Zembic A, Pjetursson BE, Zwahlen M, Thoma DS. 
Systematic review of the survival rate and the incidence of 
biological, technical, and aesthetic complications of single 
crowns on implants reported in longitudinal studies with a 
mean follow-up of 5 years. Clin Oral Implants Res. 2012; 23 
Suppl6:2-21. 
28. Pjetursson BE, Thoma D, Jung R, Zwahlen M, Zembic A. 
A systematic review of the survival and complication rates 
of implant-supported fixed dental prostheses (FDPs) after 
a mean observation period of at least 5 years. Clin Oral 
Implants Res. 2012; 23 Suppl6:22-38. 
29. Wang Y, He J, Decker AM, Hu JC, Zou D. Clinical outcomes 
of implant therapy in ectodermal dysplasia patients: 
a systematic review. Int J Oral Maxillofac Surg. 2016; 
45:1035-1043.
30. Verhoeven JW, Cune MS, Ruijter J. Permucosal implants 
combined with iliac crest onlay grafts used in extreme 
atrophy of the mandible: long-term results of a prospective 
study. Clin Oral Implants Res. 2006; 17:58-66.
31. Simion M, Ferrantino L, Idotta E, Zarone F. Turned 
implants in vertical augmented bone: A retrospective study 
with 13 to 21 Years follow-Up. Int J Periodontics Restorative 
Dent. 2016; 36:309-317. 
32. Rocchietta I, Fontana F, Simion M. Clinical outcomes 
of vertical bone augmentation to enable dental implant 
placement: a systematic review. J Clin Periodontol. 2008; 
35:203-215.
33. Esposito M, Grusovin MG, Felice P, Karatzopoulos G, 
Worthington HV, Coulthard P. The efficacy of horizontal and 
vertical bone augmentation procedures for dental implants 
- a Cochrane systematic review. Eur J Oral Implantol. 2009; 
2:167-184.
34. Muddugangadhar BC, Amarnath GS, Sonika R, Chheda 
PS, Garg A. Meta-analysis of failure and survival rate of 
implant-supported single crowns, fixed partial denture, and 
implant tooth-supported prostheses. J Int Oral Health. 2015; 
7:11-7.
6Dental implants with fixed prosthodontics in oligodontia: A retrospective cohort study | 101 
with a follow-up of up to 25 years 
35. Chuang SK, Tian L, Wei LJ, Dodson TB. Kaplan-Meier 
analysis of dental implant survival: a strategy for estimating 




Long-term implant performance and 
patients’ satisfaction in oligodontia
This chapter is an edited version of the manuscript:  
Filius MAP, Vissink A, Cune MS, Raghoebar GM, Visser A. 
Long-term implant performance and patients’ satisfaction in oligodontia.
Journal of Dentistry 2018; 17:18-24. Epub. doi: 10.1016/j.jdent.2018.01.007.
104 | Chapter 7
Abstract 
Objectives
To assess long-term (≥10 years) implant survival, peri-implant health, patients’ satisfaction and oral 
health-related quality of life (OHrQoL) in oligodontia patients rehabilitated with implant-based fixed 
prosthodontics.
Methods
All oligodontia patients treated ≥10 years previously with implant-based fixed prosthodontics at the 
University Medical Center Groningen, The Netherlands, were approached to participate. Clinical 
(plaque index, bleeding index, pocket probing depth) and radiographic (marginal bone level) data were 
collected between February and May 2016. Surgical implant details (e.g., bone augmentation) and 
implant loss were recalled from the medical records. Patients completed a satisfaction questionnaire 
(maximum score 10, high score favourable satisfaction) and the Oral Health Impact Profile (OHIP-NL49, 
maximum score 196, low score favourable OHrQoL) to rate OHrQoL. Implant survival was expressed 
according to Kaplan Meier. The Mann-Whitney U test was used for the other analyses.
Results
Forty-one patients had been treated with implant-based fixed prosthodontics (n = 258 implants) ≥10 
years previously. Cumulative 10-year implant survival of these 41 patients was 89.1% (95%CI 85.2-93.0%). 
Twenty-eight of them (n = 163 implants) were willing to visit us for additional clinical and radiographic 
assessments. In these 28 patients, highest peri-implant bone loss was observed for implants placed in 
augmented bone (p < .001). Peri-implant mucositis (65.4%) and peri-implantitis (16.1%) were rather 
common. Patients’ satisfaction (8.3 ± 1.5) and OHIP-NL49 scores (32.6 ± 30.1) were favourable and not 
associated with number of agenetic teeth (≤10 versus >10).
Conclusions
Long-term survival, satisfaction and OHrQoL results reveal that implant treatment is a predictable and 
satisfactory treatment modality for oligodontia, although peri-implant mucositis and peri-implantitis 
are common.
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Introduction
Oligodontia is the congenital absence of six or more permanent teeth, excluding third molars.1 
Oligodontia patients commonly suffer from functional and aesthetic problems due to the large number 
of missing teeth and usually need rather complex oral rehabilitation. 
   It has been reported that implant treatment is a favourable option to functionally and aesthetically 
rehabilitate oligodontia patients,2 but the long-term performance of implant-based rehabilitations in 
such patients is not known yet. Knowledge concerning the long-term implant performance for oligodontia 
patients is eagerly needed as, in comparison to non-compromised patients, bone augmentation is 
more often required as the native bone is vertically and horizontally underdeveloped in areas with 
the missing teeth. It is well known that implant survival is lower in areas needing bone augmentation. 
Therefore, it is presumed, but not yet proven, that the bone quality differs between oligodontia patients 
and non-compromised patients, which could be an additional factor affecting implant survival. The 
lack of native bone, the high need for bone augmentation and a possible different bone quality may 
also compromise peri-implant health with potentially a higher risk on the onset and/or progression of 
peri-implant mucositis and peri-implantitis. Peri-implant mucositis and peri-implantitis are common 
late phenomena in non-compromised patients with dental implants that may jeopardize long-term 
function and have an impact on long-term cost-effectiveness.3-5 The lack of external validity due to 
the complex nature of the dental state prohibits translation of these findings in non-compromised 
patients to a population of oligodontia patients. Such data are eagerly awaited because oligodontia 
patients often need dental implants. Moreover, the congenitally absence of teeth negatively impacts 
oral health-related quality of life (OHrQoL).6-7 It has been shown that absence of several teeth negatively 
affects well-being, oral function and dental appearance of oligodontia patients.6 It is presumed that 
implant-based fixed prosthodontics will result in better oral function and dental appearance in these 
patients. 
   To adequately advise oligodontia patients and dental professionals about the expectations of 
implant-based fixed prosthodontic rehabilitation in oligodontia, insight is needed into long-term 
implant performance in these patients. This includes the condition of the peri-implant tissues as well 
as the factors that may potentially affect the treatment outcome, e.g., the need for bone augmentation 
surgery. Such data are lacking in literature. Therefore, we performed a study to assess the long-term 
(≥10 years) implant survival, peri-implant health, patients’ satisfaction and OHrQoL in oligodontia 
patients rehabilitated with implant-based fixed prosthodontics.  




Implants were placed after growth was finished. In the early days, when treatment need was high and 
the patient was younger than 18 years of age, a radiograph of the carpal and tarsal bones of the hands 
was made. When the cartilaginous zones of the epiphyses became obliterated, it was presumed that no 
further lengthening of the bones would occur. Later on, no implants were placed before the age of 18. 
All implants were placed according to the manufacturer’s protocol by the same surgeon (GMR). Bone 
augmentation was performed, as and when required, during the same surgical procedure, unless the 
patients needed extensive bone augmentation. In those cases, augmentation surgery was performed 
prior to implant placement and the implants were placed four months after augmentation (see Table 1). 
Prosthetic procedure
After an osseointegration period of three months, the implants were uncovered and implant-based 
fixed suprastructures were provided (single crown or bridges, see Table 1). 
Table 1. Patient, surgical and suprastructure information. 
PATIENT INFORMATION
Number of patients 28
Current median age, years (IQR) 33 [31;39]
Gender (male/female) 12/16
Median number of agenetic teeth (third molars excluded) (IQR) 10 [8;14]
SURGICAL INFORMATION
Total number of placed implants ≥10 years ago 184
Median age at implant placement, years (IQR) 20 [19;21]
Number of implants placed in regions where bone augmentation was performed (% of 184), with 
the following donor regions:
   intraoral bone (%)
   extraoral bone (%)
96 (52%) (in 23 patients)
31 (32%)
65 (68%)
Number of implants placed in regions where bone augmentation was performed as a pre-implant 
procedure




Number of implants with single crowns (%) 118 (64%)
Number of implants with bridges (%) 61 (33%)
Number of implants which never received a suprastructure due early implant loss (%) 5 (3%)
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Patient selection
All oligodontia patients treated ≥10 years previously with dental implants (Nobel Biocare implants, 
Gothenborg, Sweden) and fixed prosthodontics at the department Oral and Maxillofacial Surgery of 
the University Medical Center Groningen (UMCG), Groningen, The Netherlands, were identified and 
contacted by mail. Patients who did not respond were contacted by telephone. Those who could not 
be reached by any means were excluded. Routinely, three years after providing the patients with the 
fixed prosthodontics, the general practitioners of the patients were asked to take over routine dental 
care and follow-up.
   The responding patients came to the hospital and were asked if they had any complaints regarding 
their implants over the period since their last hospital visit. Subsequently, with permission of the patient, 
a thorough clinical and radiographic implant examination was performed. All clinical and radiographic 
data were collected between February and May 2016. The need for bone augmentation, implant loss 
and its presumed cause were recalled from the medical records. As this research was an evaluation of 
routine dental care, the medical ethical committee of the University Medical Center Groningen granted 
this study an exemption (M16.188270). 
Implant survival
The cumulative survival was calculated for all implants placed ≥10 years previously, i.e., from the time 
of placement of the implants until the date of implant loss or patients’ last visit to the UMCG or general 
practitioner. 
Clinical assessments
The following clinical parameters were scored during the clinical examination:
- Plaque according to the modified plaque index8: 0 = No visible plaque; 1 = Plaque only recognized by  
 running a periodontal probe across the smooth marginal surface of the implant; 2 = Plaque can be  
 seen by the naked eye; 3 = Abundance of soft matter. 
- Bleeding on probing (bleeding index) according to the modified sulcus bleeding index8: 0 = No   
 bleeding when a periodontal probe is passed along the gingival margin; 1 = Isolated bleeding spots  
 visible; 2 = Blood forms a confluent red line on the gingival margin; 3 = Heavy or profuse bleeding.
- Probing pocket depth (PPD): Pocket probing depth was assessed at six sites per implant (distobuccal, 
 buccal, mesiobuccal, distolingual, lingual, mesiolingual) using a manual standardized pressure   
 periodontal probe (Click-ProbeR, Kerr, Bioggio, Switzerland), measured to the nearest mm. 
Marginal bone loss
Panoramic radiographs and standardized intraoral radiographs (baseline, made shortly after completion 
of the prosthodontic rehabilitation and current situation) of each patient were uploaded in ImageJ.9 
Peri-implant mucositis and peri-implantitis
Peri-implant mucositis was defined as bleeding upon probing with or without suppuration and 
<2mm radiographic bone loss. Peri-implantitis was defined as bleeding upon probing with or without 
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suppuration and ≥2mm radiographic bone loss.10-11 The translation from the bleeding index to Bleeding 
on Probing (BoP) had a score of 0=BoP- and score 1,2 and 3=BoP+ according to Meijer et al. (2014).12 
The prevalence of peri-implant mucositis and peri-implantitis was calculated. 
Patients’ satisfaction and oral health-related quality of life (OHrQoL)
The patients were asked to complete questionnaires on:
- Satisfaction: Five questions focusing on ability chew, perceived dental appearance and ability to   
 speech, treatment process and treatment result (score 1=extremely dissatisfied; score 10=extremely  
 satisfied).  
- Oral health-related quality of life (OHrQoL): A validated Dutch translation of the oral health
  impact profile questionnaire (Dutch OHIP-NL49, total score ranges from 0 to 196 in which a high score
 represents a low OHrQoL).13
Statistical analyses
Implant survival was calculated using the Kaplan Meier analyses with 95% confidence intervals 
(95%CI; IBM SPSS Statistics 22). Confidence intervals were added to the survival curve by computing 
and combining the survival function, upper confidence intervals and lower confidence intervals in an 
overlay scatterplot in SPSS. For patients and their general practitioners who could not be reached by 
any means, the data was censored to the last date for which their information was available. Regarding 
radiographic assessments, statistical analyses were performed on the bone augmentation subgroup. 
The satisfaction and OHIP-NL49 subgroup were analysed in relation to the number of agenetic teeth 
(≤10 versus >10). The Mann-Whitney U test was used on both statistical subgroups and r was calculated 
to measure the effect size. An r of 0.1, 0.3 and 0.5 corresponds with a small, medium and large effect 
size, respectively (IBM SPSS Statistics 22). 
Results
Patient selection and implant survival
Forty-one patients, 17 men and 24 women, with a median age of 20 (IQR [19;24]) years at implant 
placement, met the selection criteria (Fig. 1). A total of 258 implants were placed ≥10 years previously 
in these 41 patients in order to provide them with fixed prosthodontics. 
   A total of 29 implants were lost in 12 patients. Two patients lost all their implants (n=11 implants). 
Eight implants (6 patients) were lost ≤1 year after placement. The median follow-up of all 258 implants 
was 12 years (IQR [10;16]; range 0-25 years). One patient still had two implants in situ after 25 years 
of follow-up. The 10-year cumulative implant survival of all 258 implants (n=41 patients) was 89.1% 
(95%CI 85.2-93.0%; Fig. 2). 
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Clinical evaluation
The 39 patients with remaining implants installed ≥10 years previously were approached. Twenty-eight 
of them (12 male; 16 female) were willing to visit UMCG and were clinically and radiographically 
evaluated (for details see table 1). Eleven patients did not participate for the following reasons: not 
reachable (n=4); could not participate because of work (n=2); travel distance (n=1); medical reasons 
(n=1); personal issues (n=1); or unclear reasons (n=2) (Fig. 1). 
   The median age of the remaining clinical evaluation group (n=28) was 33 (IQR [31;39]). Four of 
them had ectodermal dysplasia (14.3%). The median number of agenetic teeth (third molars excluded) 
was 10 (IQR [8;14]). A total of 184 implants were placed ≥10 years previously at a median age of 20 (IQR 
[19;21]). Bone-augmentation was needed for 96 implants (52%), viz., with intraoral bone (n=31; 32%) 
or extraoral bone (n=65; 68%). 
Figure 1. Flow diagram patient selection. 
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Clinical assessment
Of the total 184 implants, 21 implants were excluded from evaluation for the following reasons: fixed 
prosthodontics were replaced by removable prosthodontics (n=7), implant was lost and replaced (n=9) 
or implant was lost and not replaced (n=5). Of the 14 lost implants, more implants were lost in the 
maxilla (n=9) in comparison to the mandible (n=5) and more implants were lost in regions where bone 
augmentation was performed (n=10) in comparison to no-augmented regions (n=4). The exclusion of 
the 21 implants resulted in a clinical evaluation of 163 implants with a median follow-up of 12 years 
[11;12]. Mean probing pocket depth was 2.5±0.9 mm (Table 2). 
   Over the years, aftercare was needed in 20 of 28 patients and included reparation after porcelain 
chipping (23 suprastructures, 13 patients), reattachment of the suprastructure as a result of a loose 
screw or debonding (13 suprastructures, 10 patients) and replacement of the abutment due fracture (2 
suprastructures, 2 patients). For 11 suprastructures (in 6 patients) reparation of the porcelain chipping/
wear was not possible and the suprastructure had to be replaced by a new one. Another reason for 
replacement of a suprastructure was the need for adjusting the color (8 suprastrastructures, 4 patients). 
Finally, in one patient 5 single crowns had to be replaced due to a dental trauma. In 4 patients implants 
had been placed before the age of 18. These patients received the implants 20-25 years ago. In none 
of these patients, implants had moved to an infra-position at last follow-up (>20 years after implant 
placement). 
Table 2. Clinical and radiographic assessment of 163 dental implants placed ≥10 years previously.
Clinical parameters (n=163)
Plaque index score (mean±sd) 0.06±0.44
Bleeding index score (mean±sd) 1.20±0.91
Pocket probing depth in mm (mean±sd) 2.52±0.94
Radiographic assessments (n=163)
Peri-implant bone loss in mm (median [IQR]) 1.53 [0.77;2.34]
Peri-implant bone loss in regions without bone augmentation in mm (median [IQR]) 1.29 [0.38;1.91]
Peri-implant bone loss in regions with bone augmentation in mm (median [IQR]) 1.96 [1.08;3.14]
Presence (%) of peri-implant mucositis and peri-implantitis(n=163)




The same 21 implants were excluded from radiographic assessments for the reasons mentioned above, 
thus 163 implants were available for evaluation. The median ≥10 year peri-implant bone loss was 
1.53 mm (IQR [0.77; 2.34]) (Table 2). Median peri-implant bone loss was higher for implants placed 
in augmented bone compared to those placed in regions without bone augmentation (median 1.96 
mm (IQR [1.08;3.14]) versus 1.29 mm (IQR [0.38;1.91]), respectively; p<.001; Mann-Whitney U test, 
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95%CI; Fig. 3). Peri-implant bone loss was higher for implants placed in augmented bone (p<.001; 
Mann-Whitney U test; Fig. 3).
Peri-implant mucositis and peri-implantitis
Of the 163 implants that were both clinically and radiographically evaluated, 18.5% (n=31) showed no 
signs of peri-implant mucositis or peri-implantitis (BoP=0, <2 mm radiographic bone loss). Peri-implant 
mucositis (BoP=1, <2 mm radiographic bone loss) was rather common (65.4%). Peri-implantitis (BoP=1, 
≥2 mm radiographic bone loss) was seen in 16.1% of the implants (Table 2). 
Patients’ satisfaction and oral health-related quality of life (OHrQoL)
The mean patients’ satisfaction score was 8.3±1.5 indicating that the patients were very satisfied. Of the 
five subscales, dental appearance scored lowest (mean 7.3±1.6, Table 3). The mean OHIP-NL49 score 
was 32.6±30.1 indicating an adequate OHrQoL. Satisfaction and OHrQoL were not associated with the 
number of agenetic teeth (≤10 versus >10, Table 3).   
Table 3. Mean (SD) satisfaction and OHIP-NL49 scores of clinical evaluation group (n=28). For satisfaction a high score means a high 
satisfaction level. For OHIP-NL49 a high score represents a low OHrQoL. No significant differences between number of agenetic teeth 
(≤10 versus >10) was found (Mann-Whitney U test). An r (effect size) of 0.1, 0.3 and 0.5 correspond with a small, medium and large 
effect size, respectively.




p-value Effect size (r)
Satisfaction
Ability to chew (max. score 10) 8.8 (1.2) 8.8 (1.3) 9.0 (1.0) 0.544 0.13
Dental appearance (max. score 10) 7.3 (1.6) 7.3 (1.6) 7.5 (1.6) 0.422 0.16
Ability to speech (max. score 10) 9.0 (1.1) 9.3 (1.0) 8.8 (1.2) 0.394 0.19
Treatment process (max. score 10) 8.2 (1.7) 8.6 (1.5) 7.7 (1.9) 0.294 0.22
Treatment result (max. score 10) 8.2 (1.6) 8.5 (1.2) 7.8 (1.9) 0.357 0.20
OHIP-NL49
Functional limitation (max. score 36) 7.6 (5.6) 8.4 (6.3) 6.6 (4.5) 0.599 0.10
Physical discomfort (max. score 36) 7.9 (5.7) 8.8 (6.2) 6.7 (4.9) 0.423 0.16
Psychological discomfort (max. score 20) 6.0 (6.5) 5.8 (6.9) 6.4 (6.2) 0.507 0.13
Physical disability (max. score 36) 4.9 (5.7) 5.1 (6.7) 4.7 (4.4) 0.568 0.11
Psychological disability (max. score 24) 3.1 (5.0) 3.4 (5.2) 2.7 (4.9) 0.802 0.06
Social disability (max. score 20) 1.3 (2.9) 1.6 (3.1) 1.0 (2.7) 0.698 0.10
Handicap (max. score 24) 1.6 (2.8) 1.9 (3.1) 1.3 (2.4) 0.732 0.08
OHIP-NL49 total score (max. score 196) 32.6 (30.1) 35.1 (33.7) 29.3 (25.6) 0.945 0.01
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Figure 2. Cumulative implant survival and 95% CI of 41 patients with a total of 258 implants with fixed prosthodontics placed ≥10 
years ago (Kaplan Meier). Number of implants under observation at 0, 5, 10, 15, 20 and 25 years are 258, 235, 204, 71, 24 and 2, 
respectively.  The 10-year cumulative implant survival of all 258 implants (n=41) was 89.1% (95%CI 85.2-93.0%). CI, confidence 
interval.
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Figure 3. Boxplots of peri-implant bone loss by group (no bone augmentation, bone augmentation) with outliers > 1.5 IQR from the 
whiskers depicted by a circle.
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Discussion
Very limited information is available about the long-term prognosis of dental implants in patients with 
oligodontia, hence the main focus of the present study. The long-term survival, satisfaction and OHrQoL 
results, reveal that implant treatment is a predictable and satisfactory treatment modality for oligodontia. 
However, peri-implant mucositis and peri-implantitis are common and implant survival is lower than 
that seen in patients missing teeth for other reasons than oligodontia.14-15 The higher prevalence of 
peri-implantitis is, in all probability, influenced by the frequent need for bone augmentation as marginal 
bone loss was, in our study, significantly higher in areas needing bone augmentation.  
   Peri-implant mucositis and peri-implantitis are common phenomena in non-oligodontia patients 
with dental implants, 30.7% and 9.6% respectively at implant level.4 In a 3-5 year follow-up study of 
implants in oligodontia, peri-implantitis was observed in 8 of the 179 implants (4.5%), 3 of which 
required implant removal.16 This prevalence (4.5%) is much lower than in our study and may be due 
to the rather short follow-up in the study of Zou et al. (2014), as peri-implantitis develops with time.16 
Zou et al. (2014) also applied a less strict and less commonly applied definition of peri-implantitis.16 
In our study, peri-implant mucositis and peri-implantitis are higher in oligodontia patients than 
in the above-mentioned non-compromised patients. This is probably linked to the need for bone 
augmentation in oligodontia before implant placement as marginal bone loss is significantly higher 
in those areas.17-18 These authors showed that augmented bone, especially vertical augmented bone 
(very necessary in oligodontia), is more susceptible to resorption than native bone,17 and thus might, at 
least partially, underlie the inherent higher risk of developing peri-implantitis.18 Furthermore, adequate 
plaque removal can be more complicated in oligodontia as many congenitally absent teeth are often 
complemented with implants provided with crowns or comprehensive multiple-unit suprastructures. 
Cleansing such structures is time consuming and requires proper and specific skills. Despite the low 
plaque scores in this study, which can be a consequence of increased time reservation and motivation 
for plaque removal before a regular oral check-up, the prevalence of peri-implant mucositis was high 
which emphasizes that plaque removal was not always as good as during the investigational check-up. 
Plaque has been identified as a major risk factor for the development of peri-implantitis and,19 moreover, 
patients with multiple implants (≥4) exhibit higher odds ratios for peri-implantitis.20
   The evaluation of the OHrQoL and satisfaction have to be interpret with caution as only 28 of the 
41 patients were able to participate and the data of the other 13 patients could not be collected. As 
the participators were generally satisfied and reasons for not participating was not due dissatisfaction, 
we presume that the patients’ satisfaction is generally high. Besides, a floor effect was noticed for 
the subdomains ‘Social disability’ and ‘Handicap’ of the OHIP questionnaire. Unfortunately, a more 
appropriate condition specific questionnaire for adults with oligodontia is not available. Despite the 
floor effect, the OHIP scores can be compared with other studies applying a prosthodontic treatment in 
patients with agenetic teeth. 
   The total mean OHIP score in our study was lower, which means a better OHrQoL, compared to 
the OHIP score reported for untreated patients with ≥4 congenital absence teeth.7 In patients with 
≥1 agenetic teeth, the OHrQoL is very favourable (low OHIP score) after treatment with tooth- or 
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implant-based fixed dental prostheses.21-22 The OHIP scores of those two studies are more favourable 
(better OHrQoL) than our post-treatment OHIP score, but the longer follow-up of our study might, at 
least in part, contribute this discrepancy in OHrQoL. For example, peri-implant problems that might 
develop with time as well as wear of a suprastructure might result in a lower satisfaction and OHrQoL. 
The Dueled et al. (2009) study agrees with our results, that OHrQoL is independent of the number 
of agenetic teeth (<6 versus ≥6).21 Regarding patient satisfaction, our favourable long-term results 
match those of Finnema et al. (2005),23 Stanford et al. (2008),24 and Zou et al. (2014),16 who reported 
favourable satisfaction too, though with short follow-up. 
   The major limitation of this study is the loss of follow-up of 13 of the 41 patients and this was 
inevitable due the retrospective design. Unfortunately, the resulting small study group limits statistical 
significance of the results. For subgroup analyses, larger groups are needed to assess which factors 
truly influences implants survival in oligodontia (e.g., augmentation versus no augmentation; maxilla 
versus mandible). Moreover, also the results of the subgroup analysis for OHrQoL and satisfaction (e.g., 
number of agenetic teeth) are limited by the small group numbers and have to be interpreted with 
caution. 
   In summary, although the treatment outcome is favourable and the patients are very satisfied, 
there seems to be a higher risk of complications after comparing peri-implant mucositis, peri-implantitis 
and implant loss in oligodontia patients with non-compromised patients. This is probably related to the 
frequent need for bone augmentation. 
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Abstract 
Background
The aim of computer-designed surgical templates is to attain higher precision and accuracy of implant 
placement, particularly for compromised cases.
Purpose
The purpose of this study is to show the benefit of a full three-dimensional virtual workflow to guide 
implant placement in oligodontia cases where treatment is challenging due compromised bone quantity 
and limited interdental spaces.
Patient and methods
A full, digitalized workflow was performed for implant placement in two oligodontia patients. Accuracy 
was assessed by calculating the coordinates of the entry point (shoulder) and apex (tip) as well as the 
angular deviation of the planned and actual implants.
Results
Implant placement could be well performed with the developed computer-designed templates in 
oligodontia. Mean shoulder deviation was 1.41 mm (SD 0.55), mean apical deviation was 1.20 mm (SD 
0.54) and mean angular deviation was 5.27° (SD 2.51).
Conclusion
Application of computer-designed surgical templates, as described in this technical advanced article, 
aid in predictable implant placement in oligodontia where bone quantity is scarce and interdental 
spaces are limited.
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Introduction
Oligodontia is the congenital absence of six or more permanent teeth, excluding third molars.1 The 
need for oral rehabilitation in patients with oligodontia is high as they often suffer from functional and 
aesthetic problems due a large number of missing teeth. Implant-based fixed prosthodontics seem to 
be favourable to improve oral function and dental appearance in oligodontia.2 
  Implant treatment in oligodontia is, in general, complex. The available bone volume is often limited 
for implant placement (e.g., above the mandibular nerve) due to jawbone underdevelopment in the 
area with the agenetic teeth as well as that the bone volume can be reduced due to physiological 
resorption of the alveolar process after a deciduous tooth without a successor has been lost. Moreover, 
the available interdental space and angulation of the neighbouring teeth are often unfavourable for 
implant placement in oligodontia cases.
  Computer-designed surgical templates based on (cone beam) computer tomographic ((CB)CT) 
images have enabled higher precision and accuracy in implant planning.3 Although this technique is 
promising, it has, as yet, not been tested in oligodontia. In this technical advanced article, we show the 
benefit of a full three-dimensional (3D) virtual workflow to guide implant placement in oligodontia, 




Implant planning and placement 
Pre-implant procedure and 3D planning
A CBCT (ICat, Image Sciences International, Hatfield, U.K., 576 slices, voxel size 0.3mm, FOV: 11x16cm) 
was made of two oligodontia patients (for patient details see Figs. 1 and 2) for implant planning. 
Detailed patient information was obtained with regard to the nerve position, bone quality and quantity. 
In addition, a digital intraoral scan was made to get a detailed 3D image of the dentition (Chairside Oral 
Scanner: C.O.S., LavaTM). 
  CBCT and intraoral scanning data were combined using Simplant Pro (Dentsply, Hasselt, Belgium) 
in order to obtain a detailed 3D model of both patients (Figs. 3a and 3b) for virtual implant planning. 
The intraoral scans, representing the dentition, were superimposed by a registration process, based on 
the contour of the corresponding dentition, onto the CBCTs. The intraoral scan data was imported into 
the 3D virtual plan software as a stl-file. First, the objects representing the upper- and lower dentition 
were globally positioned on the 3D data of the CBCT using manual translation functions. Next, exact 
positioning was determined using translation and rotation functions, starting in the mid-sagittal plane 
based on the contour of the model projected on the two-dimensional (2D) CT data. Refinements to the 
position were made while scrolling through the 2D CBCT data. 
  Virtual set-ups of the ultimate treatment goal were made for both patients with the virtual planning 
software Simplant Pro (Figs. 4a-4c). Virtual teeth were aligned in the 3D virtual model. Based on the 
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position of these teeth, the implants were planned in the optimal prosthodontic position; tooth size, 
optimal implant position, location of the mandibular nerve, bone quality and volume, and antagonists 
were also accounted for. The planning was done by the technical physician (J.K.) for both cases, and the 
implant positions were checked and optimized by the prosthodontist (M.F. and A.V.), orthodontist (K.J.) 
and surgeon (G.R.).
Figure 1a. Patient 1 – Panoramic radiogrpah at the age of 13.
Situation before extraction of the ankylosed deciduous teeth 55,54,65,74,75,84, and 85 and start of orthodontic treatment. Seven 
permanent teeth (excluding 4 third molars) were congenitally missing.
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Figure 1b. Patient 1 – Post-orthodontic situation at the age of 16. 
The top of the mandibular processus alveolaris is small (upper, left). The interdental space at location of the second premolars in the 
maxilla is 7 mm and 14 mm at location of the premolars in the mandible. Six dental implants were planned (locations 15, 25, 34, 35, 
44 and 45). Implant placement (inclusive bone augmentation with autogenous retromolar mandibular bone three months before 
implant placement at the place of the 25) was postponed until the age of 18. Essix retainers were used to retain the width of the 
diastemas. 
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Figure 2a. Patient 2 – Pre-implant panoramic radiogrpah at the age of 12.
Situation before start of orthodontic and implant treatment. Eleven permanent teeth (including two third molars) were congenitally 
missing and tooth 34 is impacted. To erect tooth 34, orthodontic treatment was desired. Due the lack of stable anchorages in the 
third quadrant it was decided to place one implant at tooth region 35 for orthodontic anchorage and future prosthetics. Due to very 
limited bone height virtual implant planning was needed to avoid damage to the mandibular nerve. 
Figure 2b. Patient 2 – Mandible, pre-implant intraoral situation at the age of 12. The 34 is not visible in the oral cavity.
8Three-dimensional computer-guided implant placement in oligodontia | 125
Figure 3a. Patient 1 - Detailed 3D model of the combined data from the CBCT and intraoral scan at the age of 18. 
Figure 3b. Patient 2 - Detailed 3D model of the combined data from the CBCT and intraoral scan at age of 12. 
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Figure 4a. Patient 1 - Virtual set-up of the ultimate treatment goal. 
Figure 4b. Patient 2 - Virtual set-up of the ultimate implant position. One short dental implant was planned in region 35, based on the 
location of the mandibular nerve (orange), the impacted 34 (pink), and the bone quality and volume.  
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Figure 4c. Patient 2 - Virtual set-up of the ultimate prosthetic treatment goal. 
Fabricating 3D templates 
Tooth-supported implant drilling templates were designed by the dental technician, based on the 
final virtual set-ups using the Geomagic Freeform software (3D Systems, Rock Hill, USA) and then 
fabricated out of polymethacrylate (Figs. 5a and 5b). The positioning of each implant was enabled with 
a 5-mm outer diameter metal drill sleeve (Nobel Guide, Nobel Biocare Holding AG, Zürich-Flughafen, 
Switzerland; Fig. 5a) as drill sleeves minimize deviation in drill position. The templates were checked for 
fit and stability in the intraoral situation. 
Implant placement
After raising a mucoperiostal flap, the dental implants were placed using the virtual developed 
tooth-supported drilling templates using metal inserts (Fig. 5c). It was checked whether no dehiscences 
of the implant surface were present.  
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Results
 
Clinical and radiographic assessments
The surgical guides fitted well and facilitated implant placement. All implants were placed in native 
bone. No dehiscences of the implant surface occurred. 
  Post-operative panoramic radiographs of patients 1 and 2 are shown in Figures 6 and 7. In patient 
1, six implants were placed (NobelParallel Conical Connection implants, Nobel Biocare Holding AG, 
Zürich-Flughafen, Switzerland; Length 8.5 mm; diameter 3.25 mm). In patient 2, one implant (Straumann 
Standard Plus, Institut Straumann AG, Basel, Switzerland; Length 4.0 mm; diameter 4.1 mm) was placed 
at region 35. For patient 2, after osseointegration, the temporary prosthetic construction with a bracket 
to erupt the 34 was placed. Eruption of the 34 was already seen after three months of orthodontic 
treatment (Figs. 7 and 8). Figure 9 shows the prosthodontic end result of patient 1.
Assessment of accuracy of implant placement 
To assess the accuracy of the implant placement, post-operative CBCTs were made of both patients. 
Three-dimensional models of the post-operative result were obtained and superimposed on the data 
of the implant planning using a surface based alignment method (iterative closest point algorithm) 
and the same threshold value as used for the pre-operative scans. To deal with the scattering on the 
post-operative CBCT images in the implant regions, all implants were virtually matched with cylindrical 
shapes, positioned on the 2D CT data. These cylinders had the same dimensions as the implants 
and thus adequately represented the implants. The implant placement accuracy was calculated by 
comparing the pre- and post-implant placement coordinates of the entry point (shoulder), apex (tip) 
and angular deviation of the implants. Table 1 shows the accuracy data as Euclidian distances (ED) in 
millimetres (mm) of the entry point (shoulder) and apex (tip) of the implants as well as the degree of 
angular deviation of all implants (n=7). Mean shoulder deviation was 1.41 mm (SD 0.55), mean apical 
deviation 1.20 mm (SD 0.54) and mean angular deviation 5.27° (SD 2.51). Figure 10 shows the actual 
differences in the planned and actual location of the implants of patient 1. 
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Table 1. Accuracy data: Euclidian distances (ED, mm) of the apex (tip) and entry point (shoulder), and the degree (°) of angular 





X Y Z ED 
(mm)
X Y Z ED 
(mm)
X Y Z (°)
1 15 planned 51.52 51.16 47.69  51.69 51.31 56.48  -0.02 -0.02 1.00  
15 actual 52.85 51.82 48.89 1.91 52.57 50.64 57.60 1.58 0.03 0.13 -0.99 9.10
1 25 planned 90.72 51.04 48.83  90.43 49.74 57.52  0.03 0.15 -0.99  
25 actual 91.42 50.29 51.04 2.43 90.88 49.60 59.78 2.31 0.06 0.08 -1.00 4.40
1 34 planned 89.21 47.78 16.06  88.12 45.53 24.49  0.12 0.26 -0.96  
34 actual 88.39 47.86 16.15 0.82 87.90 45.96 24.57 0.49 0.06 0.22 -0.97 4.40
1 35 planned 91.44 51.17 27.24  91.90 53.25 18.72  0.05 0.24 -0.97  
35 actual 91.02 51.17 26.14 1.18 91.44 54.07 18.00 1.18 -0.05 -0.34 -0.94 5.90
1 44 planned 58.46 48.01 14.10  58.28 46.58 22.77  0.02 0.16 -0.99  
44 actual 58.34 49.51 13.77 1.54 57.88 46.98 22.02 0.94 0.05 0.29 -0.96 7.90
1 45 planned 55.98 54.54 15.58  55.52 52.54 24.13  0.05 0.23 -0.97  
45 actual 55.44 54.48 15.03 0.78 54.95 52.78 23.41 0.95 0.06 0.24 -0.97 0.68
2 35 planned 129.71 50.02 66.16  129.68 50.06 71.34  0.01 -0.01 -1.00  
35 actual 128.5 50.28 66.15 1.24 128.70 49.99 71.31 0.98 -0.04 0.06 -1.00 4.50
Mean     1.41    1.20    5.27
SD     0.55    0.54    2.54
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Figure 5a. Drilling templates of patient 1. Printed model of the maxilla (left) and mandible (right) with drilling template and metal 
drilling inserts (Nobel biocare). 
Figure 5b. Drilling template for the mandible of patient 1. 
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Figure 5c. Implant placement patient 1. Dental implants placement in the mandible using the virtually developed tooth-supported 
templates and metal drilling inserts. 
Figure 6. Patient 1 - Post-operative panoramic radiograph at the age of 18.
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Figure 7. Patient 2 - Post-operative panoramic radiograph at the age of 13. Situation ten months after implant placement. Three 
months after starting the orthodontic treatment, tooth 34 is already erected.
Figure 8. Patient 2 - Intraoral situation during orthodontic treatment at the age of 14. A temporary crown with bracket is fixed on the 
dental implant. Eight months after start of orthodontic treatment, tooth 34 is already close to the planned end position.  
8Three-dimensional computer-guided implant placement in oligodontia | 133
Figure 9. Patient 1 - Prosthodontic end result five months after implant placement.
Figure 10. Patient 1 - Post-operative evaluation of placement accuracy of the implants in the mandible. Green is the planned position, 
blue is the actual position.
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Discussion
This technical advanced article illustrated the benefit of a full three-dimensional virtual workflow to 
guide implant placement in oligodontia cases as well as that implants can be reliably placed at the 
planned positions with the technique proposed.
  The described full 3D virtual workflow has several advantages. First, the surgeon is pre-operatively 
better informed about the requirements for the prosthodontic treatment with regard to the implant 
position. Second, the patient is pre-operatively better informed about the surgical procedure as well as 
the prosthodontic end result. The current costs are a limitation of this technique as fully digital planning 
is more expensive in comparison to a conventional approach. The expectation is that these costs will 
decrease with the time as this technique will be used more often in the future and probably the costs of 
the dental technician can also be reduced. At the moment, the extra costs for a full digital planning are 
reimbursed by Dutch health insurance companies. However, to the best of our knowledge, this (extra) 
reimbursement is not common in many other countries.
  The difference in position between the virtually planned and actually placed implants, according to 
our workflow, resembles the deviation in implant placement for virtually planned and placed implants 
in non-oligodontia patients.3-6 Schneider et al. (2009) report in their systematic review a mean deviation 
of 1.07 mm (95% CI: 0.76-1.22 mm) at the shoulder and 1.63 mm (95% CI: 1.26-2 mm) at the apex as 
well as a mean angular deviation of 5.26° (95% CI: 3.94–6.58°).4 More recent studies report similar 
results.3,6 Thus, the accuracy of virtual implant planning in oligodontia patients is comparable to that 
reported in non-oligodontia cases. 
  A variety of factors (i.e., technical, product, mechanical, procedure and environmental factors) 
can affect the accuracy of implant placement.7 Commonly, implant placement accuracy is higher by 
experienced surgeons,8 but patient-related factors are often less easy to control. Some progress has 
been made to control patient factors by using tooth-supported drilling templates, as demonstrated 
here; they enable a more precise transfer of the virtual implant planning to the surgical site than 
mucosa- or bone-supported templates.6,9 However, there is still a need to identify appropriate 
evaluation techniques and mechanisms capable of optimizing transfer precision and eliminating errors 
of three-dimensional planning and guiding systems for the partially dentate jaw.10 Planning is complex 
and high transfer precision is not always easy to accomplish, particularly in oligodontia cases with a 
large number of missing teeth. With the use of the described method, pre-operative implant planning 
is possible and placement is more predictable. 
Conclusion
This technical advanced article introduces a fully digitalized workflow for implant planning in complex 
oligodontia cases. The application of computer-designed surgical templates enables predictable implant 
placement in oligodontia, where bone quantity and limited interdental spaces can be challenging for 
implant placement. The stepwise approach described in this technical advanced article provides the 
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dentist and surgeon with a basis to plan and guide the preferred implant placement in oligodontia 
cases.  
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General discussion
Introduction
Hypodontia is a condition in which one or more permanent teeth are congenitally missing. When this 
concerns six or more teeth (third molars excluded), the term ‘oligodontia’ is used.1 The most severe form 
of hypodontia is anodontia, a rare phenomenon that is characterized by the absence of all permanent 
teeth. In this thesis, all research is about patients with several agenetic teeth (≥4, excluding third molars; 
also named severe hypodontia for the purpose of this PhD research). Patients with several agenetic 
teeth can develop aesthetic and functional problems because of the large number of missing teeth. 
This condition results in a compromised quality of life.2 Furthermore, one often sees underdevelopment 
of alveolar bone in the areas with one or more agenetic teeth, local resorption of the alveolar bone 
after loss of a deciduous tooth without a successor, microdontic teeth and the presence of diastemas. 
As a result, these patients often require rather complex oral rehabilitation. Depending on patients’ 
wishes, financial aspects, patients’ health and oral aspects (e.g., bone quantity, occlusion, width of 
the diastemas), several treatment options are available such as tooth-supported fixed prosthetics, 
(partially) removable prostheses and implant treatment.
  Although implant-based fixed prosthodontic rehabilitation is presumed to be a favourable 
treatment modality for patients with several agenetic teeth, with acceptable implant survival rates,3 
only short-term implant survival rates have been reported to date (chapter 2).4 Long-term survival 
(≥10 years), long-term prosthodontic performance and peri-implant health as well as their impact on 
quality of life had not been properly assessed. Therefore, the goal of the PhD research described in 
this thesis was to obtain long-term results for the use of dental implant treatment in patients with 
severe hypodontia. This general discussion indicates that implant treatment is indeed a good treatment 
modality in terms of favourable long-term implant survival, patient satisfaction and oral health-related 
quality of life.
Implant survival
Despite that long-term implant survival rates are lower in patients with severe hypodontia treated 
with implant-based fixed prosthodontics than in non-compromised patients, the implant survival rate 
is still favourable (chapter 6).5-7 The lower implant survival rates in patients with severe hypodontia 
are presumed to be caused by the lack of bone volume and the frequent need for bone augmentation 
at the implant sites. The results of this thesis show that there is more peri-implant marginal bone 
loss in augmented regions (chapter 7) and,8 as a consequence, this suboptimal peri-implant situation 
will possibly impede optimal oral self-care. As a result, the risk of developing peri-implantitis will 
increase and the chance of losing an implant will be higher. In this respect, it has to be emphasized 
that the oral hygiene of severe hypodontia patients needs close monitoring at centres with a wealth of 
experience in the treatment of such patients. In the early years (25 years ago), implant treatment was 
a new treatment modality and knowledge of implant care and implant aftercare, and how to prevent 
peri-implant problems, was limited. Furthermore, the reported higher odds ratios of peri-implantitis in 
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patients with ≥4 implants,9 can probably contribute to the higher implant failure in severe hypodontia 
as these patients usually receive multiple implants.
  The results of this thesis demonstrate that ‘age’ is another factor influencing implant survival, as 
implant survival is lower for implants placed in older patients (≥35 years)(chapter 6).7 As implant-based 
fixed prosthodontics was a rather new treatment modality 25 years ago, some patients were first treated 
with other treatment modalities and then with implants at a later age. As a consequence, pre-implant 
conditions were probably less optimal for these older patients as more local bone resorption had often 
occurred which then influenced implant survival. Nowadays, pre-implant treatment planning is done 
at an early age (including orthodontic treatment, preservation of primary teeth and early extraction 
of ankylosed primary teeth) and implants are placed soon after the patients have finished growing. 
Therefore, it is expected that fewer implants will be placed at an older age (≥35 years) which will 
probably have a positive influence on overall long-term implant survival in severe hypodontia patients. 
  Focusing on bone quality, Bergendal (2011) suggested that there is a higher risk of implant failure 
in patients with ectodermal dysplasia (i.e., syndromic hypodontia) due to “hard bone”, indicating 
that these patients’ bone density is different.10 In this thesis (chapter 6) however, we did not observe 
differences in implant survival between ectodermal dysplasia and non-ectodermal dysplasia cases of 
severe hypodontia. Other syndromes and gene mutations have also been linked to the development of 
hypodontia and oligodontia. As the full aetiology of (severe) hypodontia and oligodontia is not known 
yet, it is hoped that future research will provide more insight into the possible effects of different gene 
mutations and syndromes on bone density/quality and/or on implant survival.
Peri-implant health
Long-term prevalence of peri-implant mucositis and peri-implantitis seems to be higher in severe 
hypodontia patients than in non-compromised patients (chapter 7).8,11 This may be explained by the 
higher risk of bone resorption in augmented regions as well as the difficulty to perform the required 
level of oral hygiene and aftercare. The latter can be explained by the fact that in earlier years (25 
years ago), implant treatment was a rather new treatment modality and knowledge about the high 
need for close monitoring of implant care was lacking as well as about how to prevent peri-implant 
problems. These are now being addressed, presumably resulting in a lower prevalence of peri-implant 
mucositis and peri-implantitis. Another aspect is that most severe hypodontia patients receive multiple 
implants and adequate plaque removal can be difficult, especially for comprehensive multiple-unit 
suprastructures. Thus, it is of utmost importance that the patients are monitored closely with regard 
to their oral hygiene in centres with a lot of experience in the treatment of severe hypodontia patients.
  The prevalence of peri-implant mucositis was rather high in our study (chapter 7),8 but the 
prevalence will probably deviate per implant study depending on how the researchers use their probes 
and apply their scoring definitions. In our study, one isolated bleeding spot (bleeding index = 1) per 
implant was scored as being positive for peri-implant mucositis.12 This method, however, differ from the 
method used by Atieh et al. (2013) as they only scored positive for peri-implant mucositis when there 
was a bleeding index of ≥2.11,12
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Implant-based fixed suprastructures
Suprastructure loss and/or the need for replacements seems to be more frequent in severe hypodontia 
patients than in non-compromised implant patients, especially regarding bridge constructions (chapter 
6).5-7 The main reasons for suprastructure loss in our study were porcelain chipping and implant loss. 
As porcelain chipping is also a common finding in non-compromised patients, the lower suprastructure 
survival rate is probably a consequence of the increased implant failure rate in severe hypodontia 
patients. The lower suprastructure survival of bridges in comparison to crowns can also be declared by 
the higher implant failure rates for implants with bridge constructions in comparison to implants with 
single crowns (chapter 6).7 An explanation for the higher implant failure for bridge constructions may be 
that bridge constructions are chosen in situations where the diastema is too wide for a single implant. 
In those regions, probably more bone resorption occurs due to a deficit of functional stimulation of 
neighbouring teeth. As a consequence, peri-implant bone volume is scarce and bone augmentation is 
required, which negatively influences implant survival and oral hygiene maintenance as stated before. 
Despite this disadvantage, bridge constructions cannot be avoided in severe hypodontia patients. 
 
Oral health-related quality of life (OHrQoL) and satisfaction
Based on the literature, it was presumed that the OHrQoL of patients with severe hypodontia could be 
affected as a result of their missing teeth. The hypothesis was that final treatment with implant-based fixed 
prosthodontics improves OHrQoL as the congenitally missing teeth are permanently complemented. 
  Prior to orthodontic and implant treatment, the children’s OHrQoL is hardly affected compared 
to that of their non-affected peers. Eating and speaking do not seem to be influenced in children with 
severe hypodontia in comparison to their peers. This can be explained by the fact that most young 
severe hypodontia patients can still function with their retained deciduous teeth.13 However, the severe 
hypodontia patients do have concerns with regard to their dental appearance and the complexity of the 
treatment in comparison to their peers. The concern about dental appearance can be explained by the 
presence of diastemas, microdontic teeth and/or deciduous teeth as these phenomena are common 
characteristics in severe hypodontia. The concern about their treatment complexity can be explained 
by the fact that all patients knew their oral situation is complex as they were informed about their 
treatment trajectory prior to the completion of the questionnaire.
 The OHrQoL of older children (13-17 years old) seems to be more affected than of younger ones 
(<13 years old, chapter 4). It might be due the fact that children are more aware of their appearance 
during puberty. Another factor which negatively influences the OHrQoL at an older age might be that 
the patients still have to wait for their final treatment whilst their peers’ treatment has already been 
completed. To evince this, the OHrQoL of children has to be assessed prospectively to allow for within 
subject comparison e.g., during and after finishing orthodontic treatment. 
  Adolescents treated with implant-based fixed prosthodontics demonstrated favourable OHrQoL 
and satisfaction (chapter 5; chapter 7). However, a decrease in OHrQoL, measured with OHIP-49, 
was seen ≥10 years after implant placement in comparison to the 1-year observations. A possible 
explanation is that the OHrQoL is negatively influenced in the long-term by adverse events, which occur 
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with time. For example, the prevalence of peri-implantitis and the need for suprastructure replacement 
rises with time, as was also shown in this thesis. Thus, the need for aftercare is relatively high, which 
may come as a disappointment to patients. Therefore, patients should be told beforehand about the 
high need for maintenance and aftercare.
 A problem in this study when assessing the OHrQoL in severe hypodontia was the lack of 
standardized, condition specific, patient reported outcome measures (PROMs). As a consequence, 
other less appropriate measurements had to be used. The SF-36 is less suitable for severe hypodontia 
patients as the instrument is not oral specific and therefore not likely to be sensitive to oral complaints.14 
The OHIP-49 is only suitable for patients who are 18 years or older and a floor effect was seen for the 
subdomains ‘social disability’ and ‘handicap’. The ChildQoLDAT items, on the other hand, could only be 
used before the age of 18. As a consequence, it is impossible to perform OHrQoL-research nowadays in 
long-term prospective studies to assess the OHrQoL during the whole treatment trajectory. Standardized 
condition specific OHrQoL PROMs for severe hypodontia patients will improve the understanding of a 
lifelong condition and will help to elucidate how healthcare providers can enhance the health-related 
quality of life more effectively.15
Treatment strategy
Children have to be seen at a young age, i.e., soon after they are diagnosed with several missing teeth. 
This is because treatment planning has to be done early in life, especially in cases of dysgnathia and/
or aesthetic and/or functional problems. When indicated, patients can be treated orthodontically and 
prosthetically to prevent or confine the developmental, functional and aesthetic problems before the 
onset of puberty. Moreover, extra attention can be provided for the preservation of deciduous teeth, 
which is favourable for function and for implant treatment at a later age. 
 It is advisable to start orthodontic treatment as late as possible, before the pursued date of 
placement of the dental implants, to shorten the length of the whole active treatment and/or to reduce 
the orthodontic retention period. However, such an approach is not possible in cases of dysgnathia 
where orthodontic stimulation of growth is required. 
 There is an exception, in terms of timing, regarding the placement of implants before or after 
completion of growth. When all the teeth are missing in the mandible, implant treatment at a young 
age with two implants and an implant-based overdenture is a favourable treatment modality in terms of 
satisfaction, and surgical and prosthetic aftercare (chapter 3).16 However, as already mentioned in chapter 
3, these implants seem to incline with time as a consequence of mandibular rotation. Therefore, it is 
important to monitor them radiographically and clinically as inclination can lead to retention problems 
of the overdentures. Despite this possible side effect, the overall outcome of this treatment modality 
is favourable. When retention problems do occur due to mandibular rotation, re-implantation of two 
implants in the mandible is the preferred solution. Bergendal (2011) reported that re-implantation in 
young children with an anodont mandible is successful.10 However, it is important to inform the patient 
and parents about the eventuality of re-implantation in the future.
 Implant-based fixed prosthodontics are a favourable treatment modality in adolescents. We advise 
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to place implants at the moment growth has finished and pre-implant conditions are optimized (e.g., 
width of the edentulous regions and position of the neighbouring teeth). If possible, the deciduous 
teeth should be preserved for as long as possible, until implant placement can be performed, to prevent 
the need for considerable bone augmentation. However, this is not always possible due to early loss 
(e.g., tooth decay, tooth extraction for orthodontic reasons) or secondary retention of the deciduous 
teeth. As a consequence, in many severe hypodontia cases, bone augmentation is still needed.
Aftercare and costs
As the prevalence of peri-implant mucositis, peri-implantitis and the need for the replacement of 
suprastructures are high, it can be concluded that all severe hypodontia patients treated with implants 
require frequent and substantial aftercare. As a consequence, it is strongly recommended to instruct 
patients prior to the start of their treatment about the necessary intensive aftercare as well as the need 
for close monitoring of their oral hygiene in centres with a great deal of experience in the treatment 
of such patients. When there is a lack of motivation, alternative treatment modalities have to be 
considered.
 The use of standardized intraoral radiographs and measuring probing depths and bleeding 
indexes are indispensable for monitoring bone loss and peri-implant problems. However, there is still 
no consensus on the frequency for taking radiographs and measuring the clinical parameters. Making 
standardized intraoral radiographs and measuring clinical parameters should preferably be performed 
directly after placing the suprastructure, because that will allow future comparisons of peri-implant 
bone levels and conditions with the initial situation. Recall visits must take place at least once a year 
in centres with comprehensive knowledge about the treatment of patients with severe hypodontia. In 
addition, the selection of the recall intervals and the frequency of taking radiographs has to be based 
on the level of oral self-care, peri-implant conditions and the medical health of each individual patient.
  As implant and suprastructure loss is more frequent in severe hypodontia patients than in 
non-compromised patients, the patients and dentists have to be aware of the high costs of aftercare. 
However, in the Netherlands, there is no relevant financial constraint because dental treatment of 
severe hypodontia is covered by the national health insurance scheme. Nevertheless, in the future 
we have to strive to reduce costs by optimizing pre-implant conditions (e.g., with the help of digital 
planning, preventing (a lot of) bone augmentation by preserving the deciduous teeth) and encouraging 
strict aftercare to prevent peri-implant mucositis and peri-implantitis. 
Strengths and limitations
As every severe hypodontia patient is unique, each requires an individual treatment plan. It is therefore 
difficult to perform high-quality randomized clinical trials to compare treatment outcomes of different 
strategies. Secondly, due the low incidence of severe hypodontia, it is hard to perform prospective 
studies with respectable sample sizes. As a consequence, the evidential value of the results in this thesis 
was restricted by retrospective data (chapter 6; chapter 7) and/or small research populations (chapter 
3; chapter 4; chapter 5; chapter 7).
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   Despite the restrictions of retrospective studies, the strength of this thesis is the use of the data 
from the entire severe hypodontia population of the UMCG, with a large age-diversity and a follow-up 
of up to 25 years. All the included patients were treated in the same hospital by a multidisciplinary team 
working with a strict protocol (chapter 3; chapter 5; chapter 6; chapter 7; chapter 8). As a consequence, 
orthodontic treatment was performed on all patients who needed it (except the patients who refused 
orthodontic treatment) and this optimizes the pre-implant conditions. 
 Since all the patients from the severe hypodontia population of the UMCG who met the inclusion 
criteria were selected (chapter 3; chapter 5; chapter 6; chapter 7), selection bias was negligible and the 
results are representative of a severe hypodontia population in the north of the Netherlands. Moreover, 
treatment considerations did not depend on financial motives as the total treatment was paid for by the 
Dutch health insurance scheme in all cases. 
  
Future research
As a result of the low incidence of severe hypodontia, it is hard to achieve large sample sizes and 
therefore it is recommended to perform a multi-centre investigation in the future. Furthermore, for 
long-term results, regular assessment with standardized clinical and radiographic parameters are 
essential and patient-factors, like smoking behaviour, periodontal health, medical health and oral 
self-care, have to be reported for each individual. 
 Future research has to focus on the effect of using less or no bone augmentation on peri-implant 
health and implant survival. Therefore, the influence of the ‘time since loss of deciduous tooth’ factor 
on implants survival has to be determined, as it is expected that the shorter the period, the less bone 
resorption will have taken place and less bone augmentation will be required (deciduous teeth with 
secondary retention excepted). 
 The effect of digital implant planning on the treatment outcome has to be investigated, as 
pre-implant conditions can be optimized with this technique. Furthermore, treatment with short and 
small implants has to be assessed in patients with severe hypodontia as these implants are not or are 
less restricted by bone volume and anatomical structures (e.g., alveolar nerve, maxillary sinus) and 
bone augmentation can be prevented. The disadvantage of this method is the aesthetics, as it often 
requires a very outsized crown to attain occlusion.17
 Future research should also focus on peri-implant aesthetics. Recently, a study reported mucosal 
discoloration as a consequence of the loss of buccal alveolar bone in patients with severe hypodontia.18 
In this thesis, appearance was only assessed from patient reported outcomes but, to improve treatment 
outcomes in the future, the aesthetics have to be appraised further, clinically. 
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Conclusions
 
Implant treatment is a favourable treatment modality in terms of long-term implant survival, satisfaction 
and OHrQoL. The limiting factors with regard to treatment outcome are the quantity of the native bone 
and need for bone augmentation. In detail:
- Implant-based overdentures for young oligodontia children without erupted mandibular teeth   
 are a safe treatment modality when appropriate treatment and aftercare can be provided; 
- The impact of oligodontia on children’s OHrQoL, prior to their orthodontic treatment, is hardly  
 affected in comparison to their peers;   
- Adults’ OHrQoL and satisfaction regarding dental appearance, ability to chew and speech   
 improve  after implant placement;
- The 5-year cumulative implant survival of 95.7% (95% CI 94.2-97.2%) and 10-year cumulative   
 implant survival of 89.2% (95% CI 86.2-92.2%) are very acceptable considering the compromised  
 local conditions seen in oligodontia patients;
- Loss of implants and peri-implant marginal bone level is higher in regions where bone augmentation
  is performed in patients with oligodontia,
- Due to the high prevalence of peri-implant mucositis and peri-implantitis, and the frequent need  
 for the replacement of suprastructures, all severe hypodontia patients receiving implants require  
 strict and frequent aftercare; 
- The application of computer-designed surgical templates can aid in severe hypdontia cases   
 where bone volume is scarce and interdental spaces are limited.
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Summary 
Hypodontia is a condition in which one or more permanent teeth are congenitally missing. When this 
concerns six or more teeth (third molars excluded), the term ‘oligodontia’ is used. The most severe form 
of hypodontia is anodontia, a rare phenomenon that is characterized by the absence of all permanent 
teeth. Hypodontia is usually noticeable between 6-12 years of age when the deciduous teeth fail to 
shed or the permanent teeth do not emerge. In this thesis, all research is about patients with several 
agenetic teeth (≥4, excluding third molars; also named severe hypodontia for the purpose of the PhD 
research): a condition which is usually challenging to treat. 
  Common clinical characteristics of patients with several agenetic teeth include dysgnathia, 
underdevelopment of the jaw bone in the area with the agenetic teeth and local resorption of the alveolar 
bone after loss of a deciduous tooth without a successor. Other common phenomena are compromised 
interdental spaces, titling of the teeth and a class II relationship with a deep bite. As a result, the facial 
aesthetics of patients with several agenetic teeth are often unfavourable. Moreover, appearance and 
compromised oral functioning have been shown to negatively affect oral health-related quality of life 
(OHrQoL) as well as the fact that the patients usually need rather complex oral rehabilitation.
  Because of the large number of missing teeth, it is preferable to complement the missing teeth 
by prosthetic means. In particular, implant treatment is currently a favourable treatment modality 
in patients with several agenetic teeth. However, only short-term implant survival rates have been 
reported to date. Long-term survival results are needed, both for implants and prosthodontics. Even 
more strikingly, the effect of implant treatment on the OHrQoL has only been assessed generally in 
hypodontia patients (≥1 agenetic teeth) and not specifically in patients with several agenetic teeth (≥4). 
The overall aim of the PhD research presented in this thesis was to assess the long-term treatment 
outcome (implant survival, peri-implant health, prosthodontics, quality of life) of dental implant 
treatment in patients with severe hypdontia. 
As the presentation of the dentition in patients with several agenetic teeth is very heterogeneous, a 
variety of treatment modalities is used to rehabilitate these patients. Therefore, as there is no standard 
treatment approach for patients with several agenetic teeth yet, the literature was systematically 
reviewed with the focus on treatment outcomes (chapter 2). Medline, Embase and The Cochrane Central 
Register of Controlled Trials were searched (last search August 24, 2015). The search was completed 
with a manual search of the reference lists of the selected studies. To be included, the studies had to 
describe dental treatment outcome measure(s) from a population with a mean of six agenetic teeth or 
more. No language restrictions were applied. The methodological quality was assessed using MINORS 
criteria. Twenty-one studies were considered eligible for this review, but the diversity in type and quality 
did not allow for a meta-analysis. Seventeen studies had a retrospective design and 16 studies described 
the results of implant treatment. Treatment with (partial) dentures, orthodontics, fixed crowns or 
bridges were sparsely presented in the eligible studies. Implant survival, the most frequently reported 
treatment outcome, ranging from 35.7% to 98.7%, was presumed to be influenced by ‘location’ and 
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‘bone volume’. Nevertheless, the results of implant treatment in patients with several agenetic teeth 
were considered promising. It was concluded that, due to the condition’s heterogenic presentation, its 
low prevalence and the poor quality of the studies, evidence based decision making in the treatment of 
patients with several agenetic teeth was not feasible yet and required further research.
A common opinion is that implants should not be placed before growth has finished. However, young 
patients with an anodont mandible need treatment at a much younger age as these children usually 
suffer from functional and aesthetic problems because of their missing teeth. As the interforaminal 
region barely grows after eruption of the permanent mandibular incisors, dental implant treatment, viz. 
placement of two endosseous implants in the interforaminal area of the mandible, was considered to be 
a feasible treatment option in anodont children (chapter 3). Therefore, treatment outcome regarding 
satisfaction and surgical and prosthetic aftercare of an implant-retained mandibular overdenture 
on two implants in children without erupted mandibular teeth was assessed in four young children. 
Median follow-up of the children was 5.2 years (range 3.2-8.4 years). No implants were lost and no 
peri-implantitis occurred. Moreover, both the patients and parents were satisfied with this treatment 
modality and the need for surgical and prosthetic aftercare was low. Thus, a two implant-retained 
overdenture in children without erupted mandibular teeth is considered a safe treatment modality 
when appropriate treatment and aftercare are safeguarded.
In severe hypodontia patients with partially edentate jaws, final prosthodontic treatment is postponed 
until growth has finished. However, the initial stages of prosthodontic treatment begin at a much 
younger age, with orthodontic treatment often being the initial treatment. To obtain insight into 
condition specific OHrQoL of children prior to the start of active orthodontic treatment, 11-17 year old 
patients with oligodontia were approached (chapter 4). Twenty-eight oligodontia patients received a 
condition specific OHrQoL questionnaire prior to the commencement of their orthodontic treatment. 
Twenty-three non-oligodontia children in the same age group, but also requiring orthodontic treatment, 
were approached to serve as a control. The oligodontia patients’ scores were comparable to those of 
the controls except for the items about dental appearance and treatment complexity. It was concluded 
that the impact of oligodontia on the OHrQoL of 11-17 year old patients is limited when compared to 
that of the controls who required orthodontic treatment. 
Bone volume, interdental spaces and/or titling of the neighbouring teeth often interfere with implant 
placement. Thus, most cases require orthodontic treatment and/or bone augmentation prior to implant 
placement. The effect of implant-based fixed prosthodontics on patients with several agenetic teeth 
was not well understood. This is interesting as this is the final treatment step after a long treatment 
trajectory, preceded by orthodontic treatment and often by bone augmentation. Therefore, the effect of 
implant-based fixed prosthodontics on OHrQoL, general health status, and satisfaction regarding dental 
appearance, ability to chew and speech was assessed in patients with several agenetic teeth (chapter 
5). In this prospective cohort study, all patients (≥18 years) with at least four congenitally missing 
teeth (third molars excluded) who were scheduled for treatment with fixed dental implants between 
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September 2013 and July 2015 at the department of Oral and Maxillofacial Surgery of the University 
Medical Center Groningen (UMCG), were approached. The participants received a set of questionnaires 
before and one year after implant placement to assess OHrQoL (OHIP-NL49), general health status 
(SF-36) and satisfaction regarding dental appearance, ability to chew and speech. Twenty-five out of 31 
eligible patients (10 males, 15 females) with a median age of 20 [19; 23] years and 7 [5; 10] agenetic 
teeth were willing to participate in this study. Pre- and post-treatment OHIP-NL49 sum-scores were 
38 [28; 56] and 17 [7; 29], respectively (p<.001) indicating an improvement of the overall OHrQoL 
after implant placement. Also, the scores of all OHIP-NL49 subdomains decreased, reflecting improved 
OHrQoL per subdomain (p<.05). Moreover, satisfaction regarding dental appearance, ability to chew 
and speech increased (p<.001), while general health status did not change as a result of implant 
treatment (p>.05). It was concluded that treatment with implant-based fixed prosthodontics improved 
OHrQoL and satisfaction with the dental appearance, ability to chew and speech, whilst not affecting 
the general health status.
As shown in the previous chapters, implant-based fixed prosthodontics seems to be a favourable 
treatment modality. Long-term assessments of implant survival and treatment outcomes in patients 
with several agenetic teeth were lacking hence a retrospective clinical study was performed to assess 
which factors determine long-term implant survival and suprastructure survival (up to 25 years) in 
a cohort of patients with oligodontia, treated with implant-based fixed prosthodontics (chapter 6). 
The medical records of all the patients treated between January 1991 and December 2015 at the 
department of Oral and Maxillofacial Surgery of the University Medical Center Groningen (UMCG), the 
Netherlands, were assessed including the need for and mode of bone augmentation, implant survival, 
survival of the suprastructure and adverse events associated with the prosthodontics. A total of 126 
patients with oligodontia were treated with dental implants during this period. In total, 777 implants 
were placed of which 56 implants were lost resulting in a 5-year cumulative survival of 95.7% (95% CI 
94.2-97.2%) and a 10-year cumulative survival of 89.2% (95% CI 86.2-92.2%). Strikingly, the survival of 
implants placed in regions where bone augmentation surgery was needed was significantly lower than 
in non-augmented areas. With regard to the survival of suprastructures, the 5-year cumulative survival 
was 90.5% (95% CI 87.6-93.5%) and the 10-year cumulative survival was 80.3% (95% CI 75.3-85.3%). 
The performance of the screw-retained and cemented suprastructures was comparable, while the 
survival of single crowns was significantly better than the survival of bridge constructions (p<.001). It 
was concluded that implant treatment is a predictable treatment option for patients with oligodontia, 
with a favourable long-term outcome. 
There is also a lack of information about long-term (≥10 years) peri-implant health, patients’ satisfaction 
and OHrQoL in patients with several agenetic teeth rehabilitated with implant-based fixed prosthodontics 
(chapter 7). Therefore, all oligodontia patients treated ≥10 years previously with implant-based fixed 
prosthodontics at the University Medical Center Groningen, The Netherlands, were approached to 
participate. Clinical (plaque index, bleeding index, pocket probing depth) and radiographic (marginal 
bone level) data were collected between February and May 2016. Surgical implant details (e.g., bone 
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augmentation) and implant loss were recalled from the medical records. The patients completed a 
satisfaction questionnaire (maximum score 10, high score = favourably satisfied) and the Oral Health 
Impact Profile (OHIP-NL49, maximum score 196, low score = favourable OHrQoL) to rate their current 
OHrQoL. Forty-one patients had been treated with implant-based fixed prosthodontics (n=258 implants) 
≥10 years previously. The cumulative 10-year implant survival of these 41 patients was 89.1% (95% CI 
85.2-93.0%). Twenty-eight of these 41 patients (n=163 implants) were willing to visit us for additional 
clinical and radiographic assessments. In these 28 patients, most peri-implant bone loss was observed 
for implants placed in augmented bone (p<.001). Peri-implant mucositis (65.4%) and peri-implantitis 
(16.1%) were rather common. Patients’ satisfaction (8.3±1.5) and OHIP-NL49 scores (32.6±30.1) were 
favourable and not associated with the number of agenetic teeth (≤10 versus >10). Long-term survival, 
satisfaction and the OHrQoL results revealed that implant treatment is a predictable and satisfactory 
treatment modality for oligodontia patients, although peri-implant mucositis and peri-implantitis are 
common. 
It was presumed that implant treatment will benefit from the use of three-dimensional computer-guided 
implant placement for planning implants, especially in regions where bone quantity is scarce and 
interdental spaces are limited. Hence, a full, digitalized three-dimensional virtual workflow was 
performed for implant placement in two oligodontia patients (chapter 8). The aim of applying the 
computer-designed surgical templates was to attain more precision and accuracy of implant placement, 
particularly for compromised cases. Implant placement accuracy was assessed by calculating the 
coordinates of the entry point (shoulder) and apex (tip) as well as the angular deviation of the planned 
and actual implants. The study showed that the developed computer-designed templates enabled 
predictable implant placement in oligodontia. Mean shoulder deviation was 1.41±0.55 mm, mean 
apical deviation 1.20±0.54 mm and mean angular deviation was 5.27±2.51°. It was concluded that 
the application of computer-designed surgical templates aids in predictable implant placement in 
oligodontia where the bone quantity is scarce and interdental spaces are limited.
The findings of this thesis are discussed in chapter 9 and suggestions for future research are given. 
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Samenvatting
Hypodontie is het congenitaal ontbreken (agenesie) van één of meer gebitselementen. Wanneer er zes 
of meer gebitselementen niet zijn aangelegd (de verstandskiezen hierbij niet meegenomen), spreken 
we van oligodontie. De prevalentie van oligodontie voor het Kaukasische ras wordt geschat op 0.14%. 
Nog zeldzamer is anodontie: een vorm van hypodontie waarbij geen enkel  gebitselement is aangelegd. 
Hypodontie wordt doorgaans tussen het zesde en twaalfde levensjaar ontdekt, namelijk op het moment 
dat het wisselen van melkgebitselementen uitblijft en/of blijvende gebitselementen niet doorbreken. In 
dit proefschrift worden alleen resultaten getoond die gaan over populaties met meerdere agenesieën 
(≥4; verstandskiezen uitgezonderd). 
 Vaak resulteert de congenitale afwezigheid van meerdere gebitselementen in een onderontwikkeling 
van de processus alveolaris (dysgnathie), een onderontwikkeling van het kaakbot ter plaatse van de 
niet aangelegde gebitselementen en lokale botresorptie na verlies van een melkgebitselement zonder 
opvolger. Dit zijn typische aspecten voor patiënten met meerdere agenetische elementen. Voorts 
zijn vaak ruimtes tussen de gebitselementen (diastemen) aanwezig, is de stand van de aanwezige 
gebitselementen afwijkend, ligt de onderkaak terug (klasse II relatie) en is er sprake van een diepe beet. 
Al deze aspecten kunnen een negatieve invloed hebben op de esthetiek en functie van het gebit. Dit 
complex van symptomen en de daarmee samenhangende gevolgen voor het functioneren van de mond 
en voor het uiterlijk van de patiënt, kan de mondgezondheid-gerelateerde kwaliteit van leven (Oral 
Health-related Quality of Life; OHrQoL) negatief beïnvloeden. 
  Om de bovengenoemde problematiek te voorkomen of te verhelpen, moeten patiënten met 
meerdere agenesieën vaak een uitgebreide tandheelkundige behandeling ondergaan. Een belangrijk 
onderdeel van deze zorg bestaat tegenwoordig uit het vervaardigen van prothetische voorzieningen 
op implantaten. In dit promotieonderzoek werd onderzocht wat de lange termijn resultaten 
(implantaatoverleving, suprastructuuroverleving, conditie van de peri-implantaire weefsels, kwaliteit 
van leven) zijn van een implantaatbehandeling bij patiënten met meerdere agenetische elementen. 
Iedere patiënt met meerdere agenesieën is uniek aangezien de uitingsvorm van hypodontie sterk 
verschilt per individu. Om die reden is er geen standaard behandelprotocol en zal voor iedere patiënt 
een individueel behandelplan moeten worden gemaakt. Bij het opstellen van een dergelijk behandelplan 
is een veelheid aan behandelopties beschikbaar. Om te inventariseren wat al bekend was over deze 
behandelopties, werden verschillende databases (Medline, Embase, The Cochrane Central Register 
of Controlled Trials) systematisch doorzocht op literatuur die de behandelopties voor patiënten met 
meerdere agenesieën beschrijft (hoofdstuk 2). Om een artikel te includeren in onze studie, moest dit 
artikel minimaal één uitkomstmaat beschrijven en moest er sprake zijn van een onderzoekspopulatie 
met gemiddeld zes of meer agenetische elementen (verstandskiezen uitgezonderd). Een taalrestrictie 
werd niet toegepast en de methodologische kwaliteit van ieder studie werd beoordeeld op basis van 
de MINORS criteria. Eenentwintig studies voldeden aan de gestelde inclusie criteria. Vanwege de grote 
diversiteit in kwaliteit van de studies en het type onderzoek dat in de studies was beschreven, kon geen 
meta-analyse worden uitgevoerd. Zeventien van de 21 geïncludeerde studies hadden een retrospectief 
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studieontwerp, 16 studies beschreven de resultaten van implantaatbehandeling. Resultaten over 
behandeling met (partiële) kunstgebitten, orthodontie en kroon- en brugwerk werden nagenoeg niet 
beschreven. De meest gemelde uitkomstmaat was implantaatoverleving; de gerapporteerde overleving 
varieerde tussen de 35,7% en 98,7%. Voorts werd in de artikelen gesuggereerd dat implantaatoverleving 
afhangt van de locatie van het implantaat en het botvolume op de plaats waar het implantaat wordt 
geplaatst. Hoewel de resultaten van implantaatbehandeling overwegend positief waren, liet de 
beschikbare wetenschappelijke literatuur het niet toe om een algemeen geldend behandeladvies voor 
patiënten met meerdere agenesieën op te stellen. Nader onderzoek werd noodzakelijk geacht.
In zijn algemeenheid geldt dat tandheelkundige implantaten ten behoeve van prothetische 
voorzieningen niet moeten worden geplaatst voordat een individu is uitgegroeid. De behandelbehoefte 
van kinderen met anodontie is echter groot, omdat zij op jonge leeftijd al te kampen hebben met 
functionele en esthetische problemen. Aangezien het voorste deel van de onderkaak na het zesde 
levensjaar niet tot nauwelijks meer groeit, wordt verondersteld dat het plaatsen van twee implantaten 
ten behoeve van een overkappingsprothese (in de volksmond ook wel klikgebit genoemd) een goede 
optie is. Deze twee implantaten worden geplaatst in de regio van de hoektanden. In hoofdstuk 3 wordt 
een studie beschreven waarin de tevredenheid en de noodzaak voor chirurgische en prothetische 
nazorg werd geanalyseerd bij vier jonge kinderen (tussen 6 en 13 jaar) die waren behandeld met een 
dergelijke implantaat-gedragen overkappingsprothese in de onderkaak op de afdeling Mond- Kaak 
en Aangezichtschirurgie van het Universitair Medische Centrum in Groningen (UMCG). De mediane 
follow-up was 5,2 jaar (bereik 3,2-8,4 jaar). Geen van de implantaten ging verloren, ook peri-implantitis 
(ontsteking waarbij bot rondom het implantaat afgebroken wordt) werd niet waargenomen. Bovendien 
was er geen tot nauwelijks chirurgische en prothetische nazorg nodig en waren zowel kind als ouder(s) erg 
tevreden over de behandeling. Met andere woorden, een implantaat-gedragen overkappingsprothese 
op twee implantaten in de onderkaak lijkt voor jonge patiënten zonder gebitselementen in de onderkaak 
een veilige behandeloptie te zijn. 
Voor kinderen met meerdere agenesieën, maar waarbij een (groot) aantal van de gebitselementen 
wel is aangelegd, geldt dat de definitieve prothetische behandeling pas kan worden uitgevoerd nadat 
de patiënt is uitgegroeid. De voorbehandelingen beginnen gewoonlijk al op jonge leeftijd, waarbij 
orthodontie vaak een prominente plaats inneemt. Om inzicht te krijgen in de OHrQoL bij kinderen 
die nog niet gestart waren met de orthodontische behandeling werden, in de periode van oktober 
2014 tot maart 2017, 11-17 jarige kinderen met oligodontie gevraagd een vragenlijst over de 
kwaliteit van leven ten aanzien van hun gebitssituatie in te vullen voor de start van de orthodontische 
behandeling (hoofdstuk 4). De vragenlijst werd door 28 kinderen met oligodontie ingevuld. Als 
controle groep fungeerde een groep van 23 kinderen bij wie alle gebitselementen waren aangelegd 
en die voor een orthodontische behandeling in aanmerking kwamen. De OHrQoL scores van de 
onderzoeks- en controlegroep verschilden alleen voor de items die betrekking hadden op uiterlijk en 
behandelcomplexiteit. Met andere woorden, oligodontie lijkt slechts een beperkte invloed te hebben 
op de OHrQoL ten opzichte van een controle groep van kinderen die orthodontisch moesten worden 
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behandeld. 
 
Voor het plaatsen van tandheelkundige implantaten is het van belang dat er voldoende botvolume 
aanwezig is, aangezien een implantaat anders onvoldoende houvast heeft. Daarnaast kan het plaatsen 
van implantaten worden bemoeilijkt door de vaak beperkt beschikbare interdentale ruimte en een 
ongunstige inclinatie van de wortels van de buurelementen. Om de omstandigheden voor het plaatsen 
van implantaten te verbeteren is bij patiënten met meerdere agenetische elementen derhalve vaak een 
uitgebreide orthodontische voorbehandeling nodig, soms in combinatie met het aanbrengen van bot 
(botaugmentatie) op de plaats waar het element ontbreekt en later het implantaat zal worden geplaatst. 
Een dergelijk (pre-)implantologische behandeltraject kost veel tijd en inspanning van de patiënt. 
Derhalve werd in hoofdstuk 5 het effect geëvalueerd van de implantaatbehandeling met vaste kronen 
en bruggen op de OHrQoL, de algemene gezondheidsstatus en tevredenheid over uiterlijk, kauwfunctie 
en spraak. Hiertoe werden alle patiënten (≥18 jaar) met minimaal vier agenesieën (verstandskiezen 
uitgezonderd) die op korte termijn in het UMCG zouden worden behandeld met implantaat-gedragen 
kronen en bruggen, in de periode van september 2013 tot juli 2015, benaderd. De patiënten moesten 
voorafgaand aan het plaatsen van de implantaten en een jaar nadat de implantaten waren geplaatst 
een drietal vragenlijsten invullen, namelijk een OHrQoL vragenlijst (OHIP-NL49), een vragenlijst met 
betrekking tot de algemene gezondheidsstatus (SF-36) en tevredenheidsvragenlijst met betrekking tot 
uiterlijk, kauwfunctie en spraak. Vijfentwintig van de 31 geschikte patiënten waren bereid om mee 
te doen. De som-scores van de OHIP-NL49 voor en na implantaatbehandeling waren respectievelijk 
38 [28; 56] en 17 [7; 29] (p<.001). Deze uitkomst geeft aan dat de OHrQoL sterk verbeterde nadat de 
patiënt was voorzien van een prothetische constructies op implantaten. De OHrQoL verbeterde voor elk 
subdomein van de OHIP-NL49 (p<.05). Ook de tevredenheid met betrekking tot uiterlijk, kauwfunctie 
en spraak verbeterde significant (p<.001). Een effect op de algemene gezondheidsstatus (p>.05) werd 
niet gevonden. Uiteindelijk konden we stellen dat een behandeling met implantaat-gedragen kronen 
en bruggen positief bijdraagt aan de OHrQoL en de tevredenheid met betrekking tot het uiterlijk, de 
kauwfunctie en de spraak van de patiënt. Voor wat betreft de algemene gezondheidsstatus bleek er 
geen effect te zijn.  
Het vervaardigen van implantaat-gedragen kronen en bruggen bij patiënten met meerdere agenetische 
elementen lijkt een goede behandeloptie. Het is echter onbekend hoe de resultaten van deze 
behandeling op de lange termijn zijn, zowel met betrekking tot de overleving van de implantaten als 
de suprastructuren. In hoofdstuk 6 wordt een retrospectieve studie beschreven waarbij de gegevens 
uit de medische dossiers werden geanalyseerd van alle patiënten met oligodontie die tussen januari 
1991 en december 2015 in het UMCG waren behandeld met implantaat-gedragen kronen en bruggen. 
Gegevens met betrekking tot botaugmentatie, implantaatverlies en verlies en/of reparaties van de 
suprastructuren werden genoteerd. In deze periode werden er bij 126 patiënten 777 implantaten 
geplaatst. Zesenvijftig implantaten gingen verloren. De cumulatieve 5-jaar implantaatoverleving was 
95,7% (95% CI 94,2-97,2%), de 10-jaar cumulatieve implantaatoverleving 89,2% (95% CI 86,2-92,2%). 
Implantaten die waren geplaatst op plaatsen waar een botaugmentatie was verricht, hadden een 
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significant slechtere implantaatoverleving. De cumulatieve 5-jaar suprastructuuroverleving was 
90,5% (95% CI 87,6-93,5%) en de 10-jaar cumulatieve suprastructuuroverleving was 80,3% (95% CI 
75,3-85,3%), hierbij maakte het niet uit of de suprastructuren verschroefd of gecementeerd waren. 
Wel was de overleving van kronen significant beter dan die van bruggen (p<.001). Op basis van deze 
resultaten werd geconcludeerd dat een behandeling met implantaten een goede behandeloptie is voor 
patiënten met oligodontie.
 
In de literatuur bestaat ook een gebrek aan lange termijn resultaten betreffende de conditie van 
de peri-implantaire weefsels, de tevredenheid van patiënt en de OHrQoL. Om die reden werden 
alle patiënten met oligodontie benaderd die ten minste 10 jaar geleden waren behandeld met 
implantaat-gedragen kronen en/of bruggen in het UMCG (hoofdstuk 7). Deze patiënten werden 
opgeroepen voor een klinisch en röntgenologisch onderzoek. Klinische (plaque index, bloedingsindex, 
pocketdiepte) en röntgenologische (marginaal botniveau) gegevens werden verzameld tussen februari 
en mei 2016. Gegevens met betrekking tot de implantologische behandeling (bijv. botaugmentatie) en 
implantaatverlies werden ontleend uit de medische dossiers. Voorts werden de patiënten gevraagd 
een tevredenheidsvragenlijst (maximale score 10, hoge score = hoge tevredenheid) en de OHIP-NL49 
(maximale score 196, lage score = positieve OHrQoL) in te vullen. In totaal waren 41 patiënten ≥10 jaar 
geleden behandeld met implantaat-gedragen kronen en bruggen (n=258 implantaten). De cumulatieve 
10-jaar implantaatoverleving van deze 41 patiënten was 89,1% (95% CI 85,2-93,0%). Achtentwintig van 
de 41 patiënten (n=163 implantaten) waren bereid om naar het UMCG te komen voor de klinische en 
röntgenologische metingen. Uit deze metingen kwam naar voren dat meer peri-implantair botverlies 
op was getreden bij implantanten die waren geplaatst in geaugmenteerd bot in vergelijking met 
implantaten die geplaatst werden in niet geaugmenteerd bot (p<.001). Peri-implantaire mucositis 
(ontsteking van zachte weefsels rondom het implantaat; 65,4%) en peri-implantitis (16,1%) werden 
vaak gezien. De scores met betrekking tot de patiënt tevredenheid en OHrQoL waren positief. De 
tevredenheid en OHrQoL scores hingen niet samen met het aantal niet aangelegde gebitselementen 
(≤10 versus >10). De lange termijn resultaten (implantaatoverleving, tevredenheid en OHrQoL) laten 
zien dat een behandeling met implantaten een voorspelbare en veilige behandeloptie is voor patiënten 
met oligodontie. Peri-implantaire mucositis en peri-implantitis komen helaas wel veel voor. 
Een van de nieuwe ontwikkelingen binnen de implantaatbehandeling van patiënten met meerdere 
agenesieën is het gebruik van virtuele implantaatplanning. Deze toepassing lijkt vooral van waarde te 
zijn bij de behandeling van complexe patiënten bij wie het botvolume gering is en de interdentale 
ruimtes beperkt zijn. In hoofdstuk 8 werd de implantologische behandeling beschreven van twee 
patiënten met oligodontie, waarbij gebruik was gemaakt van een virtuele planning. Het boorsjabloon 
werd vervaardigd aan de hand van de virtuele planning met als doel hogere precisie en nauwkeurigheid 
van de implantaatplaatsing te kunnen bereiken. De nauwkeurigheid van de implantaatplaatsing werd 
berekend door de coördinaten van de schouder, de tip en de hoekafwijking van de geplande en de 
geplaatste implantaten te vergelijken. De resultaten laten zien dat virtueel ontworpen boorsjablonen 
goed toepasbaar zijn bij oligodontie patiënten. De gemiddelde afwijking van de schouder van het 
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geplaatste implantaat ten opzichte van de geplande positie was 1,41±0,55 mm, de gemiddelde 
afwijkingen van de tip van het implantaat was 1,20±0,54 mm en de gemiddelde hoekafwijking was 
5,27±2,51°. Deze twee casussen laten zien dat het plaatsen van implantaten aan de hand van een 
virtuele planning bijdraagt aan de voorspelbaarheid van de behandeling van patiënten met oligodontie 
waarbij er weinig botvolume is op de plaats waar de implantaten zouden moeten worden geplaatst en 
de interdentale ruimtes beperkt zijn. 
De in de verschillende hoofdstukken beschreven bevindingen van dit promotieonderzoek worden 
bediscussieerd in hoofdstuk 9. In dit hoofdstuk worden tevens suggesties voor vervolgstudies gegeven 
en worden aanbevelingen gedaan voor de te volgen behandelstrategie en nazorg bij patiënten met 








Prof. dr. A. Vissink, hooggeleerde eerste promotor, beste Arjan. Veel bewondering heb ik voor 
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Aangezichtschirurgie. Het tempo waarmee jij op mails reageert en teksten van feedback voorziet is 
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het is altijd weer goed als we elkaar zien en ik kan zeggen dat ik mij een rijk mens voel met zulke lieve 
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steeds in ons broek plassen van het lachen. Bedankt voor alle gezelligheid! 
Lieve Floris, Maarten en Rolf. Zo leuk om af en toe samen met jullie een biertje te drinken. Als vrouw 
tussen de mannen voel ik me altijd erg vereerd. 
Lieve Cansu, Frauke, Joni, Kirsten, Kyra, Marije, Monique, Linda, Petra en Rianne. Het begon allemaal 
in noorden, op de middelbare school en in onze studentenstad Groningen. Marije en Petra, met jullie 
168 | 
deed ik dik tien jaar geleden, op de kwelder van Schiermonnikoog, mijn eerste onderzoekservaring 
op. Wat een heerlijk tijd was dat! BINK, met jullie leerde ik roeien, door de Groningse grachten maar 
ook in het dagelijks leven. Soms zijn er ook tegenslagen en door de openheid van de groep was er 
altijd ruimte en aandacht voor elkaar. Ik heb veel van jullie geleerd en daar ben ik jullie dankbaar voor. 
Cansu, ik weet niet of het komt doordat we een aantal jaar samen gewoond hebben of door de manier 
waarop jij tijd en aandacht voor iemand hebt (ik denk dat laatste), maar het voelt altijd een beetje als 
familie en vriendin in één. Lieve vriendinnen, ondanks dat bijna iedereen Groningen inmiddels verlaten 
heeft, blijven we elkaar spreken en is het altijd een feestje als we elkaar weer zien. Trots met jullie als 
vriendinnen! 
Lieve (Tandheelkunde-) vriendinnen, lieve Annemarieke, Froukje en Jantine. Zeer waardevol om jullie 
als vriendinnen te hebben. Zowel om onze tandheelkundige ervaringen te delen als voor de gezellige 
afleiding na al dat harde gewerk. Bijzonder om de zwangerschappen en geboortes van Maxime, Loïs en 
Isabella mee te mogen maken. Bedankt voor jullie hulp en interesse. Hopelijk kunnen we over vijf jaar 
(weer) samen naar Tanzania.
Lieve Oeds, Wytske, Michiel en Judith. Bedankt voor jullie oprechte belangstelling voor mijn onderzoek 
en voor alle gezellige momenten.  
Lieve Maarten, lieve broer. Misschien was de allereerste keer dat ik bewust een tand bestudeerde wel 
samen met jou op het strand in Zeeland. Nee, niet relaxed zandkastelen maken of zwemmen in de zee 
maar hard werken om tussen alle kleine schelpjes de grootste haaientand te vinden. Zo daagden we 
elkaar op meerdere vlakken uit. Ik denk dat dit mij van jongs af aan gestimuleerd heeft om keihard mijn 
best te doen op school en dus ook uiteindelijk te komen waar ik nu ben. Tegenwoordig is het niet meer 
nodig om elkaar uit te dagen maar waarderen we de dingen die we allebei doen. Je streeft op veel 
vlakken naar perfectie, jaagt je droom na en werkt hier hard voor. Daar heb ik veel bewondering voor. 
Trots dat ik je zusje ben! 
Lieve Esther, lieve schoonzus. Zo leuk dat ik je nu officieel zo mag noemen: wat werd ik blij van het nieuws 
dat ik tante word. De laatste loodjes van mijn onderzoek waren af en toe best pittig, maar als ik hier aan 
dacht dan werd ik altijd weer blij. Fijn om jou in de familie te hebben.
Lieve Christian, lief broertje. Een leuke uitdaging: de Mont Ventoux beklimmen. Samen met jou heb ik 
dit gedaan. Iets waar ik nog vaak aan teruggedacht heb de laatste tijd, en niet voor niets dat deze berg 
op de kaft van mijn boekje staat. Ik heb veel bewondering voor de rust en het zelfvertrouwen waarmee 
jij alles aanpakt. Je hebt je eigen pad gekozen en de laatste jaren heb je veel nieuwe dingen ontdekt. 
Een gesprek met jou is altijd interessant en inspirerend omdat je je nieuwe inzichten graag deelt. Ik heb 
hier veel bewondering voor en ben erg trots op je!
Lieve papa en mama. Jullie ben ik nog het meest dankbaar, om wie ik ben geworden en om wie ik 
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mag zijn. Jullie kennen en begrijpen mij als geen ander en zonder jullie steun was mij dit allemaal 
niet gelukt. Niet gek dat ik de deur nog vaak bij jullie plat loop. Bedankt voor jullie goede zorgen en 
onvoorwaardelijke liefde en steun! 
Lieve Paul. Wat een geluk dat ik twee jaar geleden zo’n lieve, knappe en sportieve vent tegen 
mocht komen. We hebben elkaar de afgelopen tijd steeds beter leren kennen en ik weet dat ik 
volledig op je kan bouwen en vertrouwen. De laatste fase van mijn promotieonderzoek is niet 
altijd de gezelligste geweest, de laatste loodjes wogen zwaar en dit ging soms ten koste van mijn 
tijd en energie voor jou. Jij bleef me altijd steunen en hier ben ik je ontzettend dankbaar voor. 
Lieve Paul, bedankt dat je er altijd voor me was. Ik kijk nu al uit naar onze vakantie op Corsica . 
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